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A B S T R A C T
Background
Dysphagia (swallowing problems), which is common after stroke, is associated with increased risk of death or dependency, occurrence of
pneumonia, poor quality of life, and longer hospital stay. Treatments provided to improve dysphagia are aimed at accelerating recovery
of swallowing function and reducing these risks. This is an update of the review first published in 1999 and updated in 2012.
Objectives
To assess the effects of swallowing therapy on death or dependency among stroke survivors with dysphagia within six months of stroke
onset.
Search methods
We searched theCochrane StrokeGroupTrials Register (26 June 2018), theCochraneCentral Register of ControlledTrials (CENTRAL;
2018, Issue 6) in the Cochrane Library (searched 26 June 2018), MEDLINE (26 June 2018), Embase (26 June 2018), the Cumulative
Index toNursing andAlliedHealth Literature (CINAHL) (26 June 2018),Web of ScienceCoreCollection (26 June 2018), SpeechBITE
(28 June 2016), ClinicalTrials.Gov (26 June 2018), and theWorld Health Organization International Clinical Trials Registry Platform
(26 June 2018). We also searched Google Scholar (7 June 2018) and the reference lists of relevant trials and review articles.
Selection criteria
We sought to include randomised controlled trials (RCTs) of interventions for people with dysphagia and recent stroke (within six
months).
Data collection and analysis
Two review authors independently applied the inclusion criteria, extracted data, assessed risk of bias, used the GRADE approach to
assess the quality of evidence, and resolved disagreements through discussion with the third review author (PB). We used random-
effects models to calculate odds ratios (ORs), mean differences (MDs), and standardised mean differences (SMDs), and provided 95%
confidence intervals (CIs) for each.
The primary outcome was functional outcome, defined as death or dependency (or death or disability), at the end of the trial. Secondary
outcomes were case fatality at the end of the trial, length of inpatient stay, proportion of participants with dysphagia at the end of the
trial, swallowing ability, penetration aspiration score, or pneumonia, pharyngeal transit time, institutionalisation, and nutrition.
1Swallowing therapy for dysphagia in acute and subacute stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We added 27 new studies (1777 participants) to this update to include a total of 41 trials (2660 participants).
We assessed the efficacy of swallowing therapy overall and in subgroups by type of intervention: acupuncture (11 studies), behavioural
interventions (nine studies), drug therapy (three studies), neuromuscular electrical stimulation (NMES; six studies), pharyngeal electrical
stimulation (PES; four studies), physical stimulation (three studies), transcranial direct current stimulation (tDCS; two studies), and
transcranial magnetic stimulation (TMS; nine studies).
Swallowing therapy had no effect on the primary outcome (death or dependency/disability at the end of the trial) based on data from
one trial (two data sets) (OR 1.05, 95% CI 0.63 to 1.75; 306 participants; 2 studies; I² = 0%; P = 0.86; moderate-quality evidence).
Swallowing therapy had no effect on case fatality at the end of the trial (OR 1.00, 95% CI 0.66 to 1.52; 766 participants; 14 studies; I²
= 6%; P = 0.99; moderate-quality evidence). Swallowing therapy probably reduced length of inpatient stay (MD -2.9, 95% CI -5.65
to -0.15; 577 participants; 8 studies; I² = 11%; P = 0.04; moderate-quality evidence). Researchers found no evidence of a subgroup
effect based on testing for subgroup differences (P = 0.54). Swallowing therapy may have reduced the proportion of participants with
dysphagia at the end of the trial (OR 0.42, 95% CI 0.32 to 0.55; 1487 participants; 23 studies; I² = 0%; P = 0.00001; low-quality
evidence). Trial results show no evidence of a subgroup effect based on testing for subgroup differences (P = 0.91). Swallowing therapy
may improve swallowing ability (SMD -0.66, 95% CI -1.01 to -0.32; 1173 participants; 26 studies; I² = 86%; P = 0.0002; very low-
quality evidence). We found no evidence of a subgroup effect based on testing for subgroup differences (P = 0.09). We noted moderate
to substantial heterogeneity between trials for these interventions. Swallowing therapy did not reduce the penetration aspiration score
(i.e. it did not reduce radiological aspiration) (SMD -0.37, 95% CI -0.74 to -0.00; 303 participants; 11 studies; I² = 46%; P = 0.05;
low-quality evidence). Swallowing therapy may reduce the incidence of chest infection or pneumonia (OR 0.36, 95% CI 0.16 to 0.78;
618 participants; 9 studies; I² = 59%; P = 0.009; very low-quality evidence).
Authors’ conclusions
Moderate- and low-quality evidence suggests that swallowing therapy did not have a significant effect on the outcomes of death or
dependency/disability, case fatality at the end of the trial, or penetration aspiration score. However, swallowing therapy may have
reduced length of hospital stay, dysphagia, and chest infections, and may have improved swallowing ability. However, these results are
based on evidence of variable quality, involving a variety of interventions. Further high-quality trials are needed to test whether specific
interventions are effective.
P L A I N L A N G U A G E S U M M A R Y
Swallowing therapy for difficulties with swallowing in stroke survivors who have had a recent stroke
Question
We wanted to assess the effectiveness of swallowing therapy for stroke survivors with dysphagia (difficulty in swallowing). We looked
at swallowing therapy in survivors up to six months after stroke.
Background
Stroke often results in difficulty swallowing. This can lead to choking, chest infections, poorer quality of life, longer hospital stay, and
increased risk of death or discharge to a care home. Therapy to improve swallowing aims to speed up recovery of swallowing function
and reduce these risks.
Study characteristics
This is an update of the review originally published in 1999 and previously updated in 2012. We have now included a total of 41 studies
(2660 participants), and the evidence is current to June 2018. Swallowing therapy comprises several different treatment types, and we
looked at eight of these: acupuncture (11 studies), behavioural interventions (nine studies), drug therapy (three studies), neuromuscular
electrical stimulation (NMES; six studies), pharyngeal electrical stimulation (PES; four studies), physical stimulation (three studies),
transcranial direct current stimulation (tDCS; two studies), and transcranial magnetic stimulation (TMS; nine studies).
Key results
Swallowing therapy did not result in less death or disability among stroke survivors, nor did it lead to a safer swallow after treatment.
However, some individual swallowing therapies seemed to reduce hospital length of stay, lessen the chance of getting a chest infection
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or pneumonia, or improve swallowing ability and recovery from swallowing problems. Many of the swallowing therapies involved
different methods of delivery, so it is still not clear which approach is most effective for each type of therapy.
Quality of the evidence
The quality of the evidence was generally very low, low, or moderate. Additional high-quality studies are needed.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Swallowing therapy compared to placebo for dysphagia in acute and subacute stroke
Patient or population: dysphagia in acute and subacute stroke
Setting: in hospital
Intervention: swallowing therapy
Comparison: placebo
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with placebo Risk with swallowing
therapy
Death or dependency at
end of trial
Study populat ion OR 1.05
(0.63 to 1.75)
306
(2 RCTs)
⊕⊕⊕©
Moderate
a
693 per 1000 703 per 1000
(587 to 798)
Case fatality at end of
trial
Study populat ion OR 1.00
(0.66 to 1.52)
766
(14 RCTs)
⊕⊕⊕©
Moderate
b
197 per 1000 197 per 1000
(140 to 272)
Length of inpat ient stay
(days)
Mean length of inpa-
t ient stay (days) ranged
f rom 19 to 119
MD 2.9 lower
(5.65 lower to 0.15
lower)
- 577
(8 RCTs)
⊕⊕⊕©
Moderate
c
Proport ion of part ici-
pants with dysphagia at
end of trial
Study populat ion OR 0.42
(0.32 to 0.55)
1487
(23 RCTs)
⊕⊕©©
Low
d
570 per 1000 357 per 1000
(298 to 421)
Swallowing ability Mean swallowing abil-
ity was 0
SMD 0.66 lower
(1.01 lower to 0.32
lower)
- 1173
(26 RCTs)
⊕©©©
Very low
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Penetrat ion aspirat ion
score
Mean penetrat ion aspi-
rat ion score was 0
SMD 0.37 lower
(0.74 lower to 0 )
- 303
(11 RCTs)
⊕⊕©©
Low
f
Adverse event: chest in-
fect ion or pneumonia
Study populat ion OR 0.34
(0.17 to 0.71)
676
(10 RCTs)
⊕©©©
Very low
g
343 per 1000 151 per 100
(82 to 271)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial
GRADE Working Group grades of evidence.
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded by one level due to lack of precision (one study split into two trials).
bDowngraded by one level for indirectness of the evidence (i.e. mult iple dif f erent intervent ions).
cDowngraded by one level due to indirectness of the evidence (i.e. mult iple dif f erent intervent ions). Note also that two studies
had unclear blinding.
dDowngraded by two levels due to indirectness of the evidence and blinding - a large number of studies did not clarif y blinding
status.
eDowngraded by three levels due to indirectness of the evidence (i.e. mult iple dif f erent intervent ions), considerable
heterogeneity, and fair number of studies did not clarif y blinding status.
fDowngraded by two levels due to indirectness of the evidence (i.e. mult iple dif f erent intervent ions) and moderate
heterogeneity.
gDowngraded by three levels due to indirectness of the evidence (i.e. mult iple dif f erent intervent ions), substant ial heterogeneity,
and fair number of studies did not clarif y blinding status.
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B A C K G R O U N D
Description of the condition
Dysphagia after stroke is common, affecting 27% to 64% of stroke
survivors (Gordon 1987; Wolfe 1993; Odderson 1995; Smithard
1996; Mann 2000; Singh 2006a; Rofes 2013). Although dyspha-
gia improves spontaneously in many people with stroke (by two
weeks in about half ), some will die and 15% of stroke survivors
will still have swallowing problems at onemonth (Smithard 1993);
many of these individuals require long-term feeding with signifi-
cant impairment of function, recovery, and quality of life (Barer
1989; Smithard 1997;Mann 1999; Perry 2004). Complications of
dysphagia include aspiration leading to chest infection and pneu-
monia, malnutrition, inability to rehabilitate, increased risk of in-
fection, prolonged length of stay in hospital, and increased risk of
death (Smithard 1993;Odderson 1995; Finestone 1996; Smithard
1996; Sharma 2001; Martino 2005; Arnold 2016). Early identifi-
cation and management of dysphagia have been shown to reduce
pneumonia rates (Odderson 1995; Ramsey 2003; Hinchey 2005;
Lakshminarayan 2010). Cohen 2016 recently reviewed this topic.
Description of the intervention
Speech and language therapists (SLTs) often administer inter-
ventions for treating dysphagia. These interventions involve be-
havioural approaches that may be compensatory or rehabilitative
in nature. Compensatory approaches includemodification of fluid
and food consistencies, postural techniques such as adopting a chin
tuck position, and swallow strategies such as a supraglottic swal-
low. Rehabilitative methods include swallowing exercises that fo-
cus on muscle strength; resistance or skill training, or both, such as
tongue exercises, effortful swallow, and Mendelsohn’s manoeuvre
(Mendelsohn 1987); and the Shaker exercise (Shaker 2002). Re-
habilitative methods also include peripheral sensory stimulation,
such as physical stimulation with tactile, thermal, or sour stimula-
tion (Lazarra 1986; Logemann 1991; Logemann 1993; Rosenbek
1996; U1111-1188-0335); carbonation (Krival 2008); electrical
stimulation (Power 2006); and air pulses (Theurer 2013). Re-
searchers have also studied chemical and pharmacological agents,
including capsaicin, black pepper oil, cabergoline, angiotensin-
converting enzyme (ACE) inhibitors, and nifedipine (Arai 2003;
Ebihira 2004; Ebihira 2005).
Practitioners in China routinely use acupuncture techniques to
treat dysphagia (Wong 2012).
Several other stimulation methods to promote recovery from dys-
phagia post stroke have emerged in recent years, in particular pe-
ripheral and central stimulation methods. Peripheral methods in-
clude pharyngeal electrical stimulation (PES), as reported in Scutt
2015, and neuromuscular surface electrical stimulation (NMES),
as described in Chen 2016. Central stimulation methods, also
known as non-invasive brain stimulation, include transcranial
magnetic stimulation (TMS) (Momosaki 2016; Pisegna 2016), as
well as transcranial direct current stimulation (tDCS) (Momosaki
2016; Pisegna 2016).
How the intervention might work
The swallowing network is asymmetrically represented in both
cerebral hemispheres, with one hemisphere showing dominance
for swallowing (Hamdy 1998). Following unilateral stroke, TMS
studies have demonstrated that recovery from dysphagia is asso-
ciated with improved function of the non-lesioned hemisphere
(Hamdy 1998). The aim of most of the interventions described
in this review is to accelerate this process of plasticity in acute
and sub-acute stroke patients with dysphagia. The exact process
by which this is achieved is not fully understood, although it is
thought that some interventions specifically aim to improve swal-
lowing by enhancing sensory drive to the brain, causing increased
activity in motor swallowing areas.
Why it is important to do this review
Dysphagia post stroke affects quality of life, carries increased risks
of mortality and dependency (Smithard 1996; Arnold 2016), pro-
longs hospital stay (Smithard 1996; Smithard 1997; Arnold 2016),
increases healthcare costs, and often leads to discharge from hos-
pital to a care home (Smithard 1996; Arnold 2016). Despite all of
this, the previous two versions of this review concluded in 1999
and 2012 that overall, current evidence for interventions was in-
sufficient, and that no definitive treatments for dysphagia were
available (Bath 1999; Geeganage 2012).
An updated version of this review is therefore needed to ap-
praise current evidence regarding the effectiveness of interventions
for dysphagia post stroke. This information will provide support
for clinical practice; will inform stroke survivors, clinicians, and
healthcare funders regarding which interventions are most effec-
tive; andmay help guide policy and funding decisions. This review
assesses the effectiveness of swallowing therapy for treatment of
dysphagia in stroke survivors with acute or subacute stroke.
O B J E C T I V E S
To assess the effects of swallowing therapy on death or dependency
among stroke survivors with dysphagia within sixmonths of stroke
onset.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
We identified randomised controlled trials (RCTs) of swallowing
therapy for stroke survivors with acute or subacute stroke and
dysphagia.
We excluded trials if they compared two or more active treatments
(i.e. treatment was confounded), recruited participants after six
months following stroke onset, involved a large proportion of par-
ticipants with non-stroke causes of dysphagia, or used a cross-over
design by which we could not just use data from the first treatment
phase.
For this third version of the review, we removed most trials ex-
amining postural studies and all trials examining modified fluids
because they lacked a true control group. We also excluded tri-
als of free water protocols, oral hygiene, cough reflex testing, and
swallow screening, as we do not consider these to be interventions
for dysphagia per se. We also excluded trials involving the use of
antibiotics.
Types of participants
Definitions
Acute or subacute stroke
Participants recruited with a clinical diagnosis of stroke within six
months of onset.
Stroke type
Ischaemic or haemorrhagic.
Dysphagia
Diagnosed clinically (water swallow tests, modified diet or fluid
assessments, swallowing test scores) by a clinician (typically a nurse
or SLT), or by a videofluoroscopy swallow study (VFSS) or fibre-
optic endoscopic evaluation of swallowing (FEES).
Types of interventions
• Acupuncture versus no acupuncture or routine acupuncture
or sham acupuncture
• Behavioural interventions such as swallowing exercises, or
positioning versus limited, usual, or no treatment
• Drug intervention versus none or placebo
• Neuromuscular electrical stimulation (NMES) versus none
or sham stimulation
• Pharyngeal electrical stimulation (PES) versus none or
sham stimulation
• Physical stimulation such as thermal or tactile versus
limited, usual, or no treatment
• Transcranial direct current stimulation (tDCS) versus none
or sham stimulation
• Transcranial magnetic stimulation (TMS) versus none or
sham stimulation
We combined different interventions, collectively referred to as
’swallowing therapy’, for the purpose of analysing their effects on
the main outcomes. Given that the science of intervention devel-
opment for dysphagia is at an early stage, it is reasonable to ask the
question whether any intervention is better than no intervention,
and to try to establish where the most positive effects are seen and
for what topics more research is needed.
Types of outcome measures
We obtained information on the following outcome measures, as
available, for each trial.
Primary outcomes
• Functional outcome assessed as death or dependency
(modified Rankin Scale: mRS > 2), or death or disability
(Barthel Index: BI < 60), at the end of the trial
We chose functional outcome (i.e. death or dependency/disabil-
ity) as the primary outcome because dysphagia is associated with
increased risk of death or dependency in acute and subacute stroke.
Whilst swallowing therapy aims to reduce dysphagia, we needed to
assess whether evidences shows that people receiving swallowing
therapy are less likely to die or remain dependent. We listed other
important outcomes relevant to swallowing function as secondary
outcomes.
Secondary outcomes
• Case fatality at the end of the trial
• Length of inpatient stay
• Proportion of patients with dysphagia at the end of the trial
• Swallowing ability based on assessments of dysphagia
impairment using the dysphagia severity rating scale (DSRS), the
functional oral intake scale (FOIS), the dysphagia outcome and
severity scale (DOSS), or water swallowing tests
• Penetration Aspiration score determined by VFSS and
FEES and quantified on a scale such as the Penetration
Aspiration Scale (PAS)
• Chest infection or pneumonia, determined clinically or
radiologically
• Swallow timings from VFSS measurements (e.g. pharyngeal
transit time (PTT))
• Nutritional measure based on blood albumin
• Institutionalisation with discharge to a residential, care, or
nursing home, or to an extended care facility
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• Neurological impairment within four weeks (e.g. using
National Institutes of Health Stroke Scale (NIHSS) or
Scandinavian Stroke Scale)
• Quality of life (e.g. using Short Form-36 (SF-36) or
EuroQoL (measure of health-related quality of life))
Search methods for identification of studies
See the Cochrane Stroke Group search methods. We searched for
trials in all languages and arranged translation of relevant arti-
cles published in languages other than English. We have listed
publications requiring translation in the Characteristics of studies
awaiting classification section.
Electronic searches
We searched the Cochrane Stroke Group Trials Register (last
searched on 26 June 2018). In addition, we searched:
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 6) (Appendix 1) in the Cochrane
Library (searched 26 June 2018);
• MEDLINE Ovid (1946 to 26 June 2018) (Appendix 2);
• Embase (1974 to 26 June 2018) (Appendix 3);
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL EBSCO) (1982 to 26 June 2018) (Appendix 4);
• Science Citation Index Expanded, Social Sciences Citation
Index, Conference Proceedings Citation Index- Science (Web of
Science Core Collection; 1900 to 26 June 2018) (Appendix 5);
and
• SpeechBITE (searched 28 June 2018) (Appendix 6).
In an effort to identify further published, unpublished, and ongo-
ing trials, we searched:
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (www.clinicaltrials.gov; searched 26 June
2018; Appendix 7);
• World Health Organization International Clinical Trials
Registry Platform ( apps.who.int/trialsearch; searched 26 June
2018; Appendix 8); and
• Google Scholar (searched 7 June 2018; Appendix 9).
Searching other resources
Additionally, we searched the reference lists of relevant trials and
review articles and our own reference lists.
For a previous version of this review (Geeganage 2012), we con-
tacted researchers and the UK Royal College of Speech and Lan-
guage Therapists Special Interest Group for information on adult-
acquired dysphagia trials.
Data collection and analysis
Selection of studies
For this update, two review authors (HSL, LE) scanned the titles
and abstracts of records identified through searches of electronic
bibliographic databases and excluded obviously irrelevant articles.
We independently reviewed the full text of remaining studies and
selected relevant trials according to the listed inclusion criteria; we
resolved disagreements through discussion with the third review
author (PB).
Data extraction and management
For this update, two review authors (HSL, LE) extracted data us-
ing a predefined proforma, and entered the data into RevMan 5
(RevMan 2014); we resolved disagreements through discussion
and consultation with the third review author (PB). We assessed
information on randomisation, blinding, numbers of participants
randomised, timing of treatment from stroke, types of dyspha-
gia therapy, participant withdrawals and losses to follow-up, and
relevant outcomes (Types of outcome measures). We aggregated
outcome data from dose escalation or dose comparison trials into
one active treatment group.
Assessment of risk of bias in included studies
We assessed potential for bias using the ’Risk of bias’ tool as rec-
ommended in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). This assessment includes sequence
generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessment, incomplete outcome
data, selective outcome reporting, and other issues.
Measures of treatment effect
We assessedweighted estimate of the typical treatment effect across
trials using odds ratios (ORs) and 95% confidence intervals (CIs)
for binary data, mean differences (MDs) and 95% CIs for contin-
uous data, and standardised mean differences (SMDs) and 95%
CIs for continuous data based on different scales. We performed
analyses using RevMan 5 (RevMan 2014). We calculated OR us-
ing theMantel-Haenszel method, andMDs using the inverse vari-
ance method.
Unit of analysis issues
When outcome measures included different scores, we converted
these to grades in the same direction of mild to severe and analysed
them using MDs. When studies compared graduations of ther-
apy (high-medium-low intensity), we divided themiddle-intensity
group in two and analysed study data by comparing high intensity
versus medium intensity, and medium intensity versus low inten-
sity or no treatment. Similarly, if a trial compared high- versus low-
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frequency stimulation or unilateral versus bilateral stimulation,
we divided control group participants equally between treatment
groups to prevent control participants from being counted more
than once, and thereby artificially narrowing the CIs. We entered
each set of data as a separate trial.
Dealing with missing data
If a trial publication did not provide relevant data or if data were
missing but we felt it appropriate otherwise, we placed studies into
Characteristics of studies awaiting classification.
Assessment of heterogeneity
Weused the random-effects model to assess heterogeneity by look-
ing at forest plots to see how CIs overlapped (non-overlapping
studies are exhibiting statistical heterogeneity) along with the I²
statistic (Higgins 2011). We defined thresholds for interpreting
heterogeneity according to the Cochrane Handbook for Systematic
Reviews of Interventions, whereby 0% to 40%might not be impor-
tant; 30% to 60% may represent moderate heterogeneity; 50% to
90% may represent substantial heterogeneity, and 75% to 100%
represents considerable heterogeneity (Higgins 2011).
Assessment of reporting biases
We assessed selective outcome reporting as reported in the ’Risk
of bias’ table (Characteristics of included studies).
Data synthesis
Weperformedmeta-analysis using functionality within RevMan 5
(RevMan 2014): we used random-effects models (Mantel-Haen-
szel method) and presented data as number (%) or mean (stan-
dard deviation), with OR, MD, or SMD.We used random-effects
models because we expected that trials would be heterogeneous in
design and delivery, including different types of participants and
interventions.
Grade and ’Summary of findings’ table
We assessed the quality of the evidence using the fiveGRADE con-
siderations (study limitations, consistency of effect, imprecision,
indirectness, and publication bias), as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011),
for the following main outcomes of analysis.
• Death or dependency/disability at the end of the trial.
• Case fatality at the end of the trial.
• Length of inpatient stay.
• Proportion of participants with dysphagia at the end of the
trial.
• Swallowing ability.
• Penetration aspiration score.
• Adverse event: chest infection or pneumonia.
We have presented in Summary of findings for the main
comparison key findings of the review, including a summary of
the quantity of data, the magnitude of effect size, and the overall
quality of evidence.
Subgroup analysis and investigation of heterogeneity
We performed subgroup analyses on the eight different types of
swallowing therapy to provide more specific information pertain-
ing to the different interventions. We assessed for significant sub-
group interactions by testing for subgroup differences for each
main outcome.
Sensitivity analysis
We did not perform sensitivity analyses due to the small number
of studies.
R E S U L T S
Description of studies
We identified 27 new RCTs involving a total of 1777 acute or
subacute stroke survivors with dysphagia.
Results of the search
We have presented the PRISMA study flow diagram in Figure 1.
In total, we identified 2902 references, removed 860 duplicates,
and screened 2042 records. We excluded 1874 records, leaving a
total of 168 records. After full-text review, we excluded 41 studies.
We added these newly excluded studies to the existing list of 39
excluded studies, for a total of 80 (Excluded studies).We added 22
studies into the ongoing studies section (Ongoing studies).We also
added 78 new studies to the eight existing studies awaiting clas-
sification, yielding a total of 86 (Studies awaiting classification);
these studies have been completed and are awaiting publication
or are awaiting translation, or we are seeking full-text articles. Ex-
ternal assessment of this review led to a request to further update
the searches; an updated search revealed further potentially rel-
evant studies, and we have added these to the Studies awaiting
classification section; we will assess these when we prepare the next
update of this review. Finally, we added 27 new studies to the ex-
isting 14 studies, yielding a total of 41 included studies (47 data
sets) (Included studies). This resulted in the addition of 1777 par-
ticipants to the existing 883, for a total of 2660 participants.
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Figure 1. Study Flow Diagram, *86 studies awaiting classification.
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Included studies
We included 41 trials in this updated review (mean participant
age 67.8 years). These trials looked at various forms of swallowing
therapy after stroke.
When outcome measures included different scores, we converted
these to grades in the same direction of mild to severe and analysed
them using mean differences ( MDs). Two studies compared grad-
uations of therapy ( high-medium-low intensity) ( Yuan 2003i;
Yuan 2003ii; Carnaby 2006i; Carnaby 2006ii;); here, we divided
the middle-intensity group in two and analysed the study data by
comparing high intensity versus medium intensity, and medium
intensity versus low intensity or no treatment. Similarly, one trial
of TMS compared high- versus low-frequency stimulation or uni-
lateral versus bilateral stimulation ( Kim 2012i; Kim 2012ii; Du
2016i; Du 2016ii; Park 2016 (a) i; Park 2016 (a) ii); here, we di-
vided control groupparticipants equally between treatment groups
to prevent control participants frombeing countedmore thanonce
and thereby artificially narrowing the confidence intervals (CIs).
We entered each set of data as a separate trial; hence, although the
total number of included studies was 41, the total number of data
sets entered for analysis was 47.
Acupuncture
Eleven studies tested acupuncture in 998 participants (Liu 2000;
Han 2004; Liu 2004; Wei 2005; Jia 2006a; Bai 2007i; Bai 2007ii;
Huang 2010; Chan 2012; Chen 2016a; Xia 2016a).
Behavioural interventions
Nine studies investigated behavioural interventions in 632 par-
ticipants (Yuan 2003i; Yuan 2003ii; Song 2004; Carnaby 2006i;
Carnaby 2006ii; Kang 2012; Zheng 2014; Heo 2015; Park
2016b). Behavioural interventions consisted of swallowing exer-
cises, environmental modifications such as upright positioning for
feeding, safe swallowing advice, dietary modifications, kinesio-
taping, and expiratory muscle strength training.
Drug therapy
Three studies assessed several different drugs in 148 participants
(Perez 1997; Lee 2015; Warusevitane 2015). Drug interventions
included nifedipine in 17 participants (Perez 1997), lisinopril in
71participants (Lee 2015), andmetoclopramide in 60participants
(Warusevitane 2015).
Neuromuscular electrical stimulation (NMES)
Six studies testedNMES in 312 participants (Lim 2009; Xia 2011;
Park 2012; Lee 2014; Li 2014; Terre 2015). Researchers most
often compared NMES versus traditional dysphagia therapy. One
study combined NMES and effortful swallow (Park 2012).
Pharyngeal electrical stimulation (PES)
Four studies involving 214 participants assessed PES (Jayasekeran
2010a; Jayasekeran 2010b; STEPS 2016; Vasant 2016).
Physical stimulation (thermal, tactile)
Three studies enrolled 155 participants. Types of stimulation
included tactile stimulation (Bath 1997), electrical stimulation
(Power 2006), and Tongyan spray (Feng 2012).
Transcranial direct current stimulation (tDCS)
Two studies assessed tDCS in 34 participants (Kumar 2011;
Shigematsu 2013).
Transcranial magnetic stimulation (TMS)
Nine studies involving 167 participants investigated TMS (Khedr
2009; Khedr 2010; Kim2012i; Kim2012ii; Park 2013;Du 2016i;
Du 2016ii; Park 2016a (i); Park 2016a (ii).
Excluded studies
We excluded 80 studies from this updated review, most com-
monly because investigators compared two active treatments (con-
founded) or because the trials were not RCTs. We excluded 10
studies as reported outcomes were not relevant to this review. We
excluded 11 studies because of lack of outcome data; some of these
might be relevant to this review should outcome data become
available (Characteristics of excluded studies).
Risk of bias in included studies
Key sources of bias follow; we have summarised risk of bias in
Figure 2.
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Figure 2. ’Risk of bias’ graph: review authors’ judgements about each ’Risk of bias’ item presented as
percentages across all included studies.
Allocation
Random sequence generation
• Randomisation by computer occurred in 15 studies (low
risk of bias) (Bath 1997; Perez 1997; Carnaby 2006i; Carnaby
2006ii; Jayasekeran 2010a; Jayasekeran 2010b; Park 2012; Park
2013; Lee 2014; Li 2014; Lee 2015; Terre 2015; Chen 2016a;
STEPS 2016; Vasant 2016).
• Randomisation via random number tables occurred in 10
studies (low risk of bias) (Song 2004; Bai 2007i; Bai 2007ii;
Chan 2012; Feng 2012; Shigematsu 2013; Warusevitane 2015;
Du 2016i; Du 2016ii; Xia 2016a).
• Simple randomisation occurred in four studies (low risk of
bias) (Han 2004; Kumar 2011; Heo 2015; Park 2016b).
• Method of randomisation was unclear in 16 studies
(unclear risk of bias) (Liu 2000; Yuan 2003i; Yuan 2003ii; Liu
2004; Wei 2005; Power 2006; Khedr 2009; Huang 2010; Khedr
2010; Xia 2011; Kang 2012; Kim 2012i; Kim 2012ii; Zheng
2014; Park 2016a (i); Park 2016a (ii)).
• Two studies used non-randomised methods (high risk of
bias) (Jia 2006a; Lim 2009).
Allocation concealment
• Researchers ensured allocation concealment in 17 studies
(low risk of bias) (Han 2004; Carnaby 2006i; Carnaby 2006ii;
Khedr 2009; Chan 2012; Feng 2012; Park 2012; Park 2013;
Shigematsu 2013; Li 2014; Lee 2015; Warusevitane 2015; Chen
2016a; Du 2016i; Du 2016ii; Park 2016b; Vasant 2016).
• Allocation concealment was unclear in 28 studies (unclear
risk of bias) (Bath 1997; Perez 1997; Liu 2000; Yuan 2003i;
Yuan 2003ii; Liu 2004; Song 2004; Wei 2005; Power 2006; Bai
2007i; Bai 2007ii; Huang 2010; Jayasekeran 2010a; Jayasekeran
2010b; Khedr 2010; Kumar 2011; Xia 2011; Kang 2012; Kim
2012i; Kim 2012ii; Lee 2014; Zheng 2014; Heo 2015; Terre
2015; Park 2016a (i); Park 2016a (ii); STEPS 2016; Xia 2016a).
• Two studies did not ensure allocation concealment (high
risk of bias) (Jia 2006a; Lim 2009).
Baseline prognostic factors matching between intervention
and control groups
• Baseline factors were similar in 34 studies (low risk of bias)
(Perez 1997; Song 2004; Carnaby 2006i; Carnaby 2006ii; Bai
2007i; Bai 2007ii; Khedr 2009; Jayasekeran 2010b; Khedr 2010;
Xia 2011; Chan 2012; Feng 2012; Kang 2012; Kim 2012i; Kim
2012ii; Park 2012; Park 2013; Shigematsu 2013; Lee 2014; Li
2014; Zheng 2014; Heo 2015; Lee 2015; Terre 2015;
Warusevitane 2015; Chen 2016a; Du 2016i; Du 2016ii; Park
2016a (i); Park 2016a (ii); Park 2016b; STEPS 2016; Vasant
2016; Xia 2016a).
• Baseline factor matching was unclear in 13 studies (unclear
risk of bias) (Bath 1997; Liu 2000; Yuan 2003i; Yuan 2003ii;
Han 2004; Liu 2004; Wei 2005; Jia 2006a; Power 2006; Lim
2009; Huang 2010; Jayasekeran 2010a; Kumar 2011).
Blinding
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Performance bias
• Both participants and investigators were blinded in three
studies (low risk of bias) (Perez 1997; Kumar 2011;
Warusevitane 2015).
• Participants were blinded in nine studies (low risk of bias)
(Khedr 2009; Chan 2012; Park 2012; Park 2013; Terre 2015;
Du 2016i; Du 2016ii; STEPS 2016; Vasant 2016).
• Both participants and investigators were unblinded in five
studies (high risk of bias) (Carnaby 2006i; Carnaby 2006ii;
Chen 2016a; Park 2016a (i); Park 2016a (ii)).
• Blinding of participants and investigators was uncertain in
14 studies (unclear risk of bias) (Bath 1997; Han 2004; Bai
2007i; Bai 2007ii; Lim 2009; Jayasekeran 2010a; Jayasekeran
2010b; Khedr 2010; Xia 2011; Shigematsu 2013; Li 2014; Lee
2015; Park 2016b; Xia 2016a).
Detection bias
• Outcomes were blinded in 28 studies (low risk of bias)
(Perez 1997; Han 2004; Wei 2005; Carnaby 2006i; Carnaby
2006ii; Khedr 2009; Lim 2009; Jayasekeran 2010a; Jayasekeran
2010b; Khedr 2010; Xia 2011; Chan 2012; Park 2012; Park
2013; Shigematsu 2013; Li 2014; Lee 2015; Terre 2015;
Warusevitane 2015; Chen 2016a; Du 2016i; Du 2016ii; Park
2016a (i); Park 2016a (ii); Park 2016b; STEPS 2016; Vasant
2016; Xia 2016a).
• Outcomes were not blinded in three studies (high risk of
bias) (Bath 1997; Bai 2007i; Bai 2007ii).
Overall, 16 studies did not report on any blinding procedures (i.e.
for participants, investigators, or outcome assessors) (unclear risk
of bias) (Liu 2000; Yuan 2003i; Yuan 2003ii; Liu 2004; Song
2004;Wei 2005; Jia 2006a; Power 2006;Huang 2010; Feng 2012;
Kang 2012; Kim 2012i; Kim 2012ii; Lee 2014; Zheng 2014; Heo
2015).
Incomplete outcome data
• Ten studies reported no loss of participants during follow-
up (low risk of bias) (Han 2004; Jayasekeran 2010a; Chan 2012;
Kang 2012; Kim 2012i; Kim 2012ii; Park 2013; Shigematsu
2013; Lee 2014; Warusevitane 2015).
• Twelve studies reported loss of participants during follow-
up, but we judged them to be at low risk of bias (Perez 1997;
Carnaby 2006i; Carnaby 2006ii; Khedr 2009; Khedr 2010; Feng
2012; Park 2012; Du 2016i; Du 2016ii; Park 2016a (i); Park
2016a (ii); Vasant 2016).
• We judged seven studies to be at high risk of bias due to
incomplete outcome data (Lim 2009; Jayasekeran 2010b; Li
2014; Lee 2015; Chen 2016a; Park 2016b; STEPS 2016).
• Loss of participants during follow-up was unclear in 18
studies (unclear risk of bias) (Bath 1997; Liu 2000; Yuan 2003i;
Yuan 2003ii; Liu 2004; Song 2004; Wei 2005; Jia 2006a; Power
2006; Bai 2007i; Bai 2007ii; Huang 2010; Kumar 2011; Xia
2011; Zheng 2014; Heo 2015; Terre 2015; Xia 2016a).
• Data were not available for quality of life.
Selective reporting
• We judged 34 studies to be at low risk of reporting bias
(Perez 1997; Carnaby 2006i; Carnaby 2006ii; Power 2006;
Khedr 2009; Jayasekeran 2010a; Jayasekeran 2010b; Khedr
2010; Kumar 2011; Xia 2011; Chan 2012; Feng 2012; Kang
2012; Kim 2012i; Kim 2012ii; Park 2012; Park 2013;
Shigematsu 2013; Lee 2014; Li 2014; Zheng 2014; Heo 2015;
Lee 2015; Terre 2015; Warusevitane 2015; Chen 2016a; Du
2016i; Du 2016ii; Park 2016a (i); Park 2016a (ii); Park 2016b;
STEPS 2016; Vasant 2016; Xia 2016a).
• In the remaining 13 studies, it was unclear if reported data
were complete (unclear risk of bias) (Bath 1997; Liu 2000; Yuan
2003i; Yuan 2003ii; Han 2004; Liu 2004; Song 2004; Wei 2005;
Jia 2006a; Bai 2007i; Bai 2007ii; Lim 2009; Huang 2010).
Other potential sources of bias
We assessed seven studies based on translations of the original text
(Yuan 2003i; Yuan 2003ii; Song 2004; Wei 2005; Bai 2007i; Bai
2007ii; Huang 2010). Native Chinese speakers performed trans-
lations from Chinese to English.
We aggregated outcome data from dose escalation or comparison
trials to form one active treatment group in one trial (Jayasekeran
2010b).
Effects of interventions
See: Summary of findings for the main comparison Swallowing
therapy compared to placebo for dysphagia in acute and subacute
stroke
Summary of findings for main outcomes of
swallowing therapy in general
We entered the important outcomes in this review into Summary
of findings for themain comparison, andwe reported outcomes for
’swallowing therapy’ versus ’no swallowing therapy’. This means
that overall, for each outcome (e.g. length of inpatient stay), we
combined several different interventions to test for efficacy. In this
way, we have provided information on the effectiveness of swal-
lowing therapy as a whole for each outcome. We assessed three
additional outcomes (pharyngeal transit time, institutionalisation,
and nutrition) but did not include them in Summary of findings
for the main comparison (a maximum of seven outcomes are al-
lowed); therefore, we did not assess the quality of studies for these
outcomes using the GRADE approach, and we have not reported
their outcomes in the main findings.
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We also undertook subgroup analysis for each different type of
intervention.
The number of outcomes reported varied considerably across stud-
ies.
• Primary outcome of death or dependency/disability at end
of trial in one trial (split into two data sets).
• Case fatality at end of trial in 14 trials.
• Length of inpatient stay in eight trials.
• Proportion of patients with dysphagia at end of trial in 23
trials.
• Swallowing ability in 26 trials.
• Penetration aspiration score (PAS) in 11 trials.
• Chest infections or pneumonia in nine trials.
• Swallow timing in six trials.
• Nutrition in three trials.
• Institutionalisation in three trials.
Primary outcome
Functional outcome: death or dependency or death or
disability at end of trial
Swallowing therapy hadno effect ondeath or dependency, or death
or disability, at end of trial (odds ratio (OR) 1.05, 95% confidence
interval (CI) 0.63 to 1.75; 306 participants; 2 studies; I² = 0%; P
= 0.86: moderate-quality evidence; Analysis 1.1). One trial (two
data sets) of behavioural interventions reported on this outcome.
Secondary outcomes
Case fatality at end of trial
Swallowing therapy had no effect on case fatality at end of trial
(OR 1.00, 95% CI 0.66 to 1.52; 766 participants; 14 studies; I²
= 6%; P = 0.99: moderate-quality evidence; Analysis 1.2). Trials
of behavioural interventions, drug therapy, pharyngeal electrical
stimulation, physical stimulation, and transcranial magnetic stim-
ulation reported on this outcome.
Length of inpatient stay
Swallowing therapy probably reduced length of inpatient stay
(mean difference (MD) -2.90, 95% CI -5.65 to -0.15; 577 partic-
ipants; 8 studies; I² = 11%; P = 0.04: moderate-quality evidence;
Analysis 1.3). Trials of behavioural interventions and PES reported
on this outcome. Subgroup analysis showed that the interventions
did not differ (Analysis 1.3).
Proportion of participants with dysphagia at end of trial
Swallowing therapy probably reduced the proportion of partici-
pants with dysphagia at end of trial (OR 0.42, 95% CI 0.32 to
0.55; 1487 participants; 23 studies; I² = 0%; P = 0.00001: low-
quality evidence; Analysis 1.4). Trials of acupuncture, behavioural
interventions, drug therapy, NMES, PES, physical stimulation,
and tDCS reported on this outcome. Subgroup analysis showed
that acupuncture (OR 0.31, 95% CI 0.20 to 0.49; 676 partici-
pants; 8 studies; I² = 0%; P < 0.00001) and behavioural interven-
tions (OR 0.45, 95% CI 0.28 to 0.74; 511 participants; 6 studies;
I² = 28%; P = 0.001) each reduced dysphagia but did not differ
from each other (P = 0.91; Analysis 1.4).
Swallowing ability
Swallowing therapy probably improved swallowing ability (stan-
dardised mean difference (SMD) -0.66, 95% CI -1.01 to -0.32;
1173 participants; 26 studies; I² = 86%; P = 0.0002: very low-
quality evidence; Analysis 1.5). Trials of acupuncture, behavioural
interventions, drug therapy, NMES, PES, physical stimulation,
tCDS, and TMS reported on this outcome. Subgroup analysis
showed that behavioural interventions (SMD -0.56, 95% CI -
1.07 to -0.05; 121 participants; 3 studies; I² = 47%; P = 0.03) and
TMS (SMD -1.29, 95% CI -2.37 to -0.21; 141 participants; 8
studies; I² = 85%; P = 0.02) each improved swallowing ability but
did not differ from each other (P = 0.09; Analysis 1.5). Review
authors noted moderate to substantial heterogeneity between tri-
als (Analysis 1.5).
Penetration aspiration score
Swallowing therapy did not significantly reduce aspiration assessed
as penetration aspiration score (SMD -0.37, 95% CI -0.74 to
-0.00; 303 participants; 11 studies; I² = 46%; P = 0.05: low-
quality evidence; Analysis 1.6). Trials of behavioural interventions,
NMES, PES, and TMS reported on this outcome. However, given
that results show no overall benefit, we have not commented on
subgroup analysis (Analysis 1.6).
Chest infection or pneumonia
Swallowing therapy probably reduced the incidence of chest infec-
tion or pneumonia (OR 0.36, 95% CI 0.16 to 0.78; 618 partici-
pants; 9 studies; I² = 59%; P = 0.009: very low-quality evidence;
Analysis 1.7). Trials of behavioural interventions, drug therapy,
NMES, and PES reported on this outcome. Subgroup analysis
showed that drug therapy (OR 0.06, 95% CI 0.01 to 0.21; 60
participants; 1 study; I² not applicable; P < 0.0001) significantly
reduced the incidence of chest infection or pneumonia at end of
trial - a result that differed significantly from other interventions
(P = 0.008; Analysis 1.7).
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Pharyngeal transit time (PTT)
Swallowing therapy may have reduced PTT (MD -0.23, 95%
CI -0.32 to -0.15; 187 participants; 6 studies; I² = 29%; P <
0.00001; Analysis 1.8). Trials of drug therapy, NMES, PES, and
physical stimulation reported on this outcome. Subgroup analysis
showed that NMES (MD -0.23, 95% CI -0.39 to -0.08; 126
participants; 3 studies; I² = 63%; P = 0.003; Analysis 1.8) and
physical stimulation in one small study (MD -0.19; 95% CI -0.34
to -0.04; 16 participants; 1 study; I² not applicable; P = 0.01) each
reduced PTT but did not differ from each other, i.e. these findings
are likely due to chance and not-significant. (P = 0.98; Analysis
1.8).
Institutionalisation
Swallowing therapy did not reduce the incidence of institutionali-
sation (OR 0.75, 95%CI 0.47 to 1.19; 447 participants; 3 studies;
I² = 0%; P= 0.22; Analysis 1.9). Trials of behavioural interventions
and pharyngeal electrical stimulation reported on this outcome.
Nutrition (albumin)
Swallowing therapy did not reduce nutrition (MD 0.37, 95%CI -
1.5 to 2.24; 169 participants; 3 studies; I² = 0%; P = 0.70; Analysis
1.10). Trials of behavioural interventions and pharyngeal electrical
stimulation reported on this outcome.
Detailed subgroup analysis: summary of findings per
type of intervention
Not all interventions addressed all outcomes. We have reported
available data.
Acupuncture
Acupuncture resulted in significant results (i.e. < 1.0) for reducing
the proportion of participants with dysphagia at end of trial. How-
ever, these findings may be due to chance, given that testing for
subgroup differences did not yield significant results. Acupuncture
did not reduce swallowing ability. Data on the effects of acupunc-
ture on other outcomes were not available.
• Proportion of participants with dysphagia at end of trial
(OR 0.31, 95% CI 0.20 to 0.49; 676 participants; 8 studies; I² =
0%; P < 0.00001; Analysis 1.4).
• Swallowing ability (SMD -0.55, 95% CI -1.20 to 0.11; 496
participants; 6 studies; I² = 91%; P = 0.10). We noted significant
heterogeneity (Analysis 1.5).
Behavioural interventions
Behavioural interventions produced significant results (i.e. < 1.0)
for improving swallowing ability and reducing the proportion of
participants with dysphagia at the end of the trial. However, both
of these findings may be due to chance, given that testing for
subgroup differences for each outcome did not yield significant
results. Although behavioural interventions also reduced penetra-
tion aspiration score (i.e. < 1.0), results show no overall benefit for
this outcome and this finding is likely due to chance. Behavioural
interventions did not reduce length of inpatient stay, chest infec-
tion or pneumonia, case fatality at end of trial, functional out-
come, institutionalisation, or nutrition. Behavioural interventions
addressed more outcomes when compared with most interven-
tions.
• Swallowing ability (SMD -0.56, 95% CI -1.07 to -0.05;
121 participants; 3 studies; I² = 47%; P = 0.03; Analysis 1.5).
• Proportion of participants with dysphagia at end of trial
(OR 0.45, 95% CI 0.28 to 0.74; 511 participants; 6 studies; I² =
28%; P = 0.001; Analysis 1.4).
• Penetration aspiration score (SMD -0.88, 95% CI -1.68 to
-0.08; 27 participants; 1 study; I² not applicable; P = 0.03;
Analysis 1.6).
• Length of inpatient stay (MD -2.70, 95% CI -5.68 to 0.28;
370 participants; 4 studies; I² = 19%; P = 0.08; Analysis 1.3).
• Chest infection or pneumonia (OR 0.56, 95% CI 0.31 to
1.00; 473 participants; 6 studies; I² = 21%; P = 0.05; Analysis
1.7).
• Case fatality at end of trial (OR 0.83, 95% CI 0.46 to 1.51;
306 participants; 2 studies; I² = 0%; P = 0.54; Analysis 1.2).
• Functional outcome (OR 1.05, 95% CI 0.63 to 1.75; 306
participants; 2 studies; I² = 0%; P = 0.86; Analysis 1.1).
• Institutionalisation (OR 0.76, 95% CI 0.39 to 1.48; 306
participants; 2 studies; I² = 12%; P = 0.42; Analysis 1.9).
• Nutrition (albumin) (MD 0.20, 95% CI -4.77 to 5.17; 64
participants; 2 studies; I² = 0%; P = 0.94; Analysis 1.10).
Drug therapy
Drug therapy was probably effective for reducing chest infection
or pneumonia in one study - a result that differed from those of
other interventions. Drug therapy did not improve swallowing
ability, nor did it reduce case fatality, proportion of participants
with dysphagia at end of trial, or pharyngeal transit time. Data on
effects of drug therapy on other outcomes were not available.
• Chest infection or pneumonia (OR 0.06, 95% CI 0.01 to
0.21; 60 participants; 1 study; I² not applicable; P < 0.0001;
Analysis 1.7).
• Swallowing ability (SMD -0.46, 95% CI -0.93 to 0.01; 71
participants; 1 study; I² not applicable; P = 0.06; Analysis 1.5).
• Case fatality (OR 1.40, 95% CI 0.31 to 6.28; 148
participants; 3 studies; I² = 70%; P = 0.66; Analysis 1.2).
• Proportion of participants with dysphagia at end of trial
(OR 0.48, 95% CI 0.07 to 3.35; 17 participants; 1 study; I² not
applicable; P = 0.46; Analysis 1.4).
• Pharyngeal transit time (MD -0.21, 95% CI -0.91 to 0.49;
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17 participants; 1 study; I² not applicable; P = 0.56; Analysis
1.8).
Neuromuscular electrical stimulation (NMES)
NMESwas probably effective for reducing pharyngeal transit time
(i.e. < 1.0). NMES did not reduce the proportion of participants
with dysphagia at end of trial or penetration aspiration score, and
did not improve swallowing ability.
• Pharyngeal transit time (MD -0.23, 95% CI -0.39 to -0.08;
126 participants; 3 studies; I² = 63%; P = 0.003; Analysis 1.8).
• Proportion of participants with dysphagia at end of trial
(OR 0.51, 95% CI 0.18 to 1.49; 76 participants; 2 studies; I² =
7%; P = 0.22; Analysis 1.4).
• Penetration aspiration score (SMD 0.57, 95% CI -0.38 to
1.52; 18 participants; 1 study; I² not applicable; P = 0.24;
Analysis 1.6).
• Swallowing ability (SMD -1.34, 95% CI -3.39 to 0.71; 100
participants; 2 studies; I² = 93%; P = 0.20; Analysis 1.5).
Pharyngeal electrical stimulation (PES)
PES studies addressed many outcomes but did not show an effect
for case fatality, length of inpatient stay, proportion of participants
with dysphagia at end of trial, swallowing ability, penetration as-
piration score, chest infection or pneumonia, pharyngeal transit
time, institutionalisation, or nutrition.
• Case fatality (OR 0.92, 95% CI 0.38 to 2.26; 215
participants; 4 studies; I² = 0%; P = 0.86; Analysis 1.2).
• Length of inpatient stay (MD -6.05, 95% CI -16.40 to
4.31; 207 participants; 4 studies; I² = 27%; P = 0.25; Analysis
1.3).
• Proportion of participants with dysphagia at end of trial
(OR 0.55, 95% CI 0.15 to 2.11; 66 participants; 3 studies; I² =
0%; P = 0.39; Analysis 1.4).
• Swallowing ability (SMD 0.06, 95% CI -0.22 to 0.34; 194
participants; 3 studies; I² = 0%; P = 0.69; Analysis 1.5).
• Penetration aspiration score (SMD -0.17, 95% CI -0.53 to
0.19; 177 participants; 4 studies; I² = 12%; P = 0.35; Analysis
1.6).
• Chest infection (OR 0.43, 95% CI 0.06 to 3.09; 28
participants; 1 study; I² not applicable; P = 0.40; Analysis 1.7).
• Pharyngeal transit time (MD -0.15, 95% CI -0.67 to 0.37;
28 participants; 1 study; I² not applicable; P = 0.56; Analysis
1.8).
• Institutionalisation (OR 0.73, 95% CI 0.36 to 1.48; 141
participants; 1 study; I² not applicable; P = 0.38; Analysis 1.9).
• Nutrition (MD 0.40; 95% CI-1.62 to 2.42; 105
participants; 1 study; I² not applicable; P = 0.70; Analysis 1.10).
Physical stimulation (thermal, tactile)
Physical stimulation reduced pharyngeal transit time in one small
study (i.e. < 1.0). However, these findings may be due to chance,
given that testing for subgroup differences did not yield significant
findings.
Physical stimulation had no effect on case fatality at end of trial
nor on proportion of participants with dysphagia at end of trial
and did not improve swallowing ability.
• Pharyngeal transit time (MD -0.19, 95% CI -0.34 to -0.04;
16 participants; 1 study; I² not applicable; P = 0.01; Analysis
1.8).
• Case fatality at end of trial (OR 1.05, 95% CI 0.16 to 6.92;
19 participants; 1 study; I² not applicable; P = 0.96; Analysis
1.2).
• Proportion of participants with dysphagia at end of trial
(OR 0.65, 95% CI 0.07 to 5.85; 127 participants; 2 studies; I² =
0%; P = 0.70; Analysis 1.4).
• Swallowing ability (SMD -0.30, 95% CI -1.29 to 0.68; 16
participants; 1 study; I² not applicable; P = 0.55; Analysis 1.5).
Transcranial direct current stimulation (tDCS)
tDCS did not alter the proportion of participants with dysphagia
at end of trial and did not improve swallowing ability. Data on
other outcomes were not available.
• Proportion of participants with dysphagia at end of trial
(OR 0.29, 95% CI 0.01 to 8.39; 14 participants; 1 study; I² not
applicable; P = 0.47; Analysis 1.4).
• Swallowing ability (SMD -0.33, 95% CI -2.22 to 1.56; 34
participants; 2 studies; I² = 85%; P = 0.73; Analysis 1.5).
Transcranial magnetic stimulation (TMS)
TMS improved swallowing ability at end of trial (i.e. < 1.0), al-
though this finding may be due to chance, given that testing
for subgroup differences did not yield significant results. We also
noted considerable heterogeneity. TMS did not alter case fatality
at end of trial nor penetration aspiration score. Data on other out-
comes were not available.
• Swallowing ability (SMD -1.29, 95% CI -2.37 to -0.21;
141 participants; 8 studies = 8; I² = 85%; P = 0.02; Analysis 1.5).
• Case fatality at end of trial (OR 0.28, 95% CI 0.03 to 2.93;
78 participants; 4 studies; I² = 0%; P = 0.29; Analysis 1.2).
• Penetration aspiration score (SMD -0.53, 95% CI -1.22 to
0.16; 81 participants; 5 studies; I² = 51%; P = 0.13; Analysis 1.6).
In summary, acupuncture, behavioural interventions, and TMS
appeared to be individually effective for reducing some outcomes.
However, as results of testing for subgroup differences were not
significant, none of these interventions are convincingly different
from the summary result. Drug therapy was the only intervention
that was significantly less than 1.0, and findings were significantly
different for testing of subgroup differences, although this result
was based on very low-quality evidence.
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D I S C U S S I O N
Summary of main results
We included 41 studies in this updated review of swallowing ther-
apy in people with stroke.We identified 22 additional studies that
are ongoing (Characteristics of ongoing studies), along with 86
studies that are awaiting classification (Characteristics of studies
awaiting classification).
Researchers assessed eight types of stimulatory techniques -
acupuncture, behavioural therapy, drug therapy, neuromuscular
electrical stimulation (NMES), pharyngeal electrical stimulation
(PES), physical stimulation, transcranial direct current stimula-
tion (tDCS), and transcranial magnetic stimulation (TMS). Swal-
lowing therapy had no effect on functional outcomes (death or de-
pendency, or death or disability), although only one trial reported
this outcome (two data sets). Swallowing therapy also had no ef-
fect on case fatality at end of trial, nor on penetration aspiration
score. However, swallowing therapy probably reduced length of
inpatient stay, the proportion of participants with dysphagia at end
of trial, and the incidence of chest infection or pneumonia (with
one study reporting significant effects for drug therapy). Swallow-
ing therapy also probably improved swallowing ability. In the ab-
sence of significant effects on the primary outcome, statistically
significant findings in secondary and explanatory outcomes are
hypothesis-generating and might reflect chance, for example, due
to multiple-comparison testing. Hence, further trials are needed
to test these observations.
Overall completeness and applicability of
evidence
Results of this review are incomplete at this time because of the
significant number of ongoing studies and those awaiting classi-
fication identified by review authors. Nevertheless, the addition
of new studies to this version of the review has tightened con-
fidence intervals, although the overall conclusion that dysphagia
treatment does not alter functional outcome has not changed.
Quality of the evidence
The quality of evidence ranged from very low and low through
moderate to high, as presented in Summary of findings for the
main comparison. The most common reasons for reduced quality
of evidence were lack of blinding, moderate to considerable het-
erogeneity between trials, and lack of precision (i.e. inclusion of
multiple different interventions).
Potential biases in the review process
Results of the present analysis are subject to several caveats. First,
we combined different interventions together for analysis, to assess
whether trial results show any effect of swallowing therapy as a
whole as opposed to no intervention or usual care. This means that
decisions on which specific types of interventions are effective can-
not be made upon analysis of these data. Future reviews will focus
on assessing effects of specific interventions on main outcomes.
Second, we excluded 80 studies from the analysis. One common
reason for exclusion is that studies compared two active treatments
without including a control or placebo group. We also excluded
trials due to lack of uniformity in usage of outcome measures and
lack of data on clinical outcomes, such as dependency, mortality,
institutionalisation, and chest infection or pneumonia. Further,
included trials used various swallowing assessment techniques, cor-
tical excitability techniques, and videofluoroscopic measurements.
So, trialists are encouraged to design future trials that include a
control or placebo group, and to incorporate standard outcome
measures. Third, a further 86 studies are awaiting assessment, sub-
ject to the availability of full-text articles; such omission of multi-
ple studies will inevitably bias review results. Fourth, with regard to
acupuncture, data from three studies may have been confounded
due to use of ’routine’ acupuncture or a different type of acupunc-
ture as control, variation in delivery of therapy, and risk of lan-
guage bias, in that some of the acupuncture literature is available
in full only in Chinese language journals. Similarly, we included
data from an NMES study (Park 2012), which considered sensory
stimulation as a control; therefore we cannot be certain that this
trial is not confounded. Last, the present analysis included only
studies up to six months from stroke onset, and the effects of later
treatments for post-stroke dysphagia remain unclear.
It is important to note that many trials are ongoing and should
add substantially to the existing data once complete.
Agreements and disagreements with other
studies or reviews
This is the largest, most inclusive, and most up-to-date review on
this topic. It combines all current interventions for dysphagia in the
acute and subacute phases of stroke. A number of separate system-
atic reviews exploring individual interventions for stroke survivors
have been published, including some examining acupuncture in
stroke (Xie 2008; Long 2012; Wong 2012), behavioural interven-
tions in neurogenic dysphagia (Ashford 2009), TMS in stroke and
acquired brain injury (Yang 2015; Liao 2016; Momosaki 2016;
Pisegna 2016), tDCS in stroke and acquired brain injury (Yang
2015; Momosaki 2016; Pisegna 2016), NMES in stroke and neu-
rological impairment (Chen 2016; Ding 2016), and PES in stroke
(Scutt 2015). However, these reviews have examined the efficacy
of individual interventions, whereas the current review has exam-
ined the efficacy of swallowing therapy overall; hence direct com-
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parisons are difficult to make.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Information on effects of swallowing therapy on the primary out-
come of death or dependency/disability continues to be insuffi-
cient. Although some swallowing therapies appear to have a ben-
eficial effect on some outcomes, these results are based on lower-
quality evidence. At present, clinical decisions cannot be based on
reliable evidence from clinical trials.
Implications for research
On the basis of existing studies and the need to exclude many
others, future trials should consider the following design issues.
• Patients: include only those who have post-stroke
dysphagia, and limit recruitment to a particular temporal phase
after stroke. Researchers must specify clearly the time from stroke
onset to randomisation when reporting trials. Trialists should aim
for larger numbers of participants, ideally from multiple centres.
• Comparator: in the absence of any proven treatment, the
control group should receive only standard care, with the
treatment group receiving standard care plus the intervention
being tested.
• Outcomes: studies need to ensure that standardised
outcome measures are used to allow comparison of trials.
Functional outcome (death or dependency) should be included
in future trials, as should the number of participants who develop
chest infection or pneumonia, or who have signs of aspiration.
Trials should include outcomes of relevance to health economics,
such as length of inpatient stay and discharge to an institution, as
well as quality of life outcomes (e.g. EuroQoL Group Quality of
Life Questionnaire based on five dimensions (EuroQoL-5D),
Swallowing Quality of Life Questionnaire (SWAL-QOL)).
• Methods: researchers should endeavour to examine
common parameters (i.e. use similar methods), so that results
can be compared more readily across different studies.
• Quality of research: trialists must report full information on
randomisation, allocation concealment, blinding of treatment
and outcome assessment, and attrition.
• Future research: further research is needed to discover
which components of swallowing therapy are beneficial. A
number of studies assessing interventions for dysphagia are
ongoing (22 studies), and findings of these studies will add
further information on this topic (Characteristics of ongoing
studies). Several studies of mixed groups of chronic dysphagia
have been done or are ongoing: a systematic review of these
studies may further inform the management of acute and
subacute dysphagia post stroke.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bai 2007i
Methods Random numbers table
Outcomes not blinded
(medium-intensity vs low-intensity data set)
Participants 1 centre in China
111 participants within 2 weeks of stroke
Baseline characteristics similar
No cross-overs or dropouts identified
Dysphagia defined by Watian swallow test
Interventions A1: shallow needling (control) (n = 35) = low intensity
A2: single deep needling (n = 18) = medium intensity
B: deep multi-needling
Outcomes Watian drinking test grade
Return to normal diet
Notes Exclusions: needle phobia, infection risk, dementia, inability to co-operate with treat-
ment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomisation via a random numbers ta-
ble
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes not blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
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Bai 2007i (Continued)
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Translated from Chinese language
Bai 2007ii
Methods (High vs medium data set)
Participants As data set 1
Interventions A1: shallow needling (control)
A2: single deep needling (n = 17) = medium intensity
B: deep multi-needling (n = 40) = high intensity
Outcomes As data set 1
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomisation via a random numbers table
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes not blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Translated from Chinese
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Bath 1997
Methods Computerised randomisation by minimisation
Unblinded outcome assessment
Analysis by ITT
Cross-overs: 3 NGT to PEG, 0 PEG to NGT
Balancing of baseline prognostic factors between treatment groups unclear
Participants 1 centre in UK
19 participants: 8 male
Mean age 77 (SD 11) years
13 ischaemic stroke, 6 haemorrhagic stroke
100% CT
Enrolment within 2 weeks of stroke onset
Interventions Factorial trial: PEG vs NGT; intensive vs conservative swallowing therapy
PEG: NGT: up to 3 NGTs
Intensive swallowing therapy: as for conservative, plus voluntary control (tongue-hold-
ing), sensory stimulation (tactile, oromotor exercises, swallow practice)
Conservative swallowing therapy: review, advice regarding feeding route, postural/dietary
modification, safe swallowing methods
Outcomes Primary outcomes: resumption of safe feeding at 12 weeks, weight loss < 5% at 6 weeks,
discharge by 6 weeks
Secondary outcomes: impairment, disability, handicap, quality of life, tube failures, chest
infection, oropharyngeal delay time (by videofluoroscopy) at 4 weeks
Notes Exclusions: oro-gastrointestinal disease, concurrent severe illness, coagulopathy, premor-
bid dependency, severe dementia, psychiatric illness
Follow-up: 3 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation by minimi-
sation
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Unblinded outcome assessment
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Bath 1997 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Low risk None identified
Carnaby 2006i
Methods Computerised randomisation
Blinded outcome assessments by SLT
ITT
(Control vs low-intensity data set)
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in Australia
306 participants; baseline characteristics similar
Enrolment within 2 weeks of stroke onset: mean/median 2 days, range 0 to 12 days
Clinical and videofluoroscopic evidence of dysphagia
Interventions Rx 1: standardised high-intensity swallowing therapy (n = 102)
Rx 2: standardised low-intensity swallowing therapy (n = 102); split into (n = 51) for
each data set
C: usual care (n = 102)
Treatment for up to 1 month
Outcomes Outcomes: time to return to normal diet; aspiration pneumonia; dysphagia (PHAD
score < 85)
Notes Trial completed and published 2006
Exclusions: previous swallowing therapy, head and neck surgery, inability to consent
Follow-up: 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Treatment allocation based on a computer-
generated random numbers list generated
via the SPSS statistical package
Allocation concealment (selection bias) Low risk Randomisation schedule held at the trial
office, remote from the study environment;
assignment to 1 of 3 treatment options by
a telephone call to the trial office made by
the study speech pathologist
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Carnaby 2006i (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk All people involved in the study unaware
of treatment allocation, apart from partici-
pants and the study speech pathologist who
treated participants
Assigned to high-intensity and low-inten-
sity groups
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and speech pathologist aware
of treatment allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessed by an independent
speech pathologist, who was unaware of
treatment allocation, every month for 6
months after randomisation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 participants lost to follow-up before 6-
month analysis
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Carnaby 2006ii
Methods (High-intensity vs low-intensity data set)
Participants As data set 1
Interventions High intensity (n = 102)
Low intensity (n = 51)
Outcomes As data set 1
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Treatment allocation based on a computer-
generated random numbers list obtained via
the SPSS statistical package
Allocation concealment (selection bias) Low risk Randomisation schedule held at trial office,
remote from the study environment; assign-
ment to 1 of 3 treatment options by a tele-
phone call to the trial office made by the
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Carnaby 2006ii (Continued)
study speech pathologist
Blinding (performance bias and detection
bias)
All outcomes
High risk All people involved in the study unaware
of treatment allocation, apart from partici-
pants and the study speech pathologist who
treated participants
Assigned to high-intensity and low-inten-
sity groups
Blinding of participants and personnel
(performance bias)
All outcomes
High risk As above
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessed by an independent
speech pathologist, who was unaware of
treatment allocation, every month for 6
months after randomisation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3 participants lost to follow-up before 6-
month analysis
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk None identified
Chan 2012
Methods Randomisation by random sequences on black paper
Single-blind (participants blinded): outcome assessors blinded
Participants 1 centre in Hong Kong
87 participants with neurogenic dysphagia with similar baseline characteristics
60 (69%) participants with dysphagia due to cerebral infarct < 6 months; other causes of
neurogenic dysphagia include intracranial haemorrhage, vascular dementia, Parkinson’s
disease
Clinical evidence of dysphagia
Interventions All groups given routine swallowing therapy
Rx 1: true acupuncture (n = 20)
Rx 2: sham acupuncture that did not puncture true acupoints lying on a meridian (n =
19)
C: routine swallowing therapy only (n = 48)
Treatment for up to 4 weeks
Outcomes Outcomes: Royal BrisbaneHospitalOutcomeMeasure Scale (RBHOMS), swallow func-
tion by consistencies of ingested food and fluid
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Chan 2012 (Continued)
Notes Exclusions: structural oral, pharyngeal, or oesophageal disease; severe primary disease
of the liver, kidneys, hematopoietic system, or endocrine system; malignant tumour or
infectious disease; inability to follow commands
Follow-up: 3 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by random sequences
Allocation concealment (selection bias) Low risk Allocation concealed in opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk Single (participants) blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Single (participants) blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses to follow-up reported
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Chen 2016a
Methods Computer-generated random numbers by independent research staff
Assessors blinded
Participants Multi-centre trial in China
250 participants; 148 male
100% stroke within 2 to 7 days
Dysphagia identified by bedside swallowing assessment and videofluoroscopic swallow-
ing study
Baseline characteristics and prognostic values similar between both groups
Interventions Rx: acupuncture and conventional stroke rehabilitation care
C: conventional stroke rehabilitation care only
Duration: 3 weeks
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Chen 2016a (Continued)
Follow-up: 7 weeks
Outcomes Primary outcome: NIHSS index
Secondary outcomes: FMA for motor function, rate of recovery based on BSA, VFSS,
MMSE, and MoCA
Notes Exclusions: serious heart, liver, and kidney-related diseases; blood coagulation dysfunc-
tion; inability to complete the MMSE test or bedside swallowing assessment; congenital
disabilities; posterior circulation infarcts; receiving thrombolytic; participated in other
clinical trials within previous 3 months; pregnant or breastfeeding
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers
provided by independent research staff
Allocation concealment (selection bias) Low risk Random numbers placed into sequentially
numbered, opaque, sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
High risk Participants and acupuncturist aware of
treatment allocations. All allopathic med-
ical staff and rehabilitation therapists
blinded
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and acupuncturist not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk 5 participants lost to follow-up; 4 discon-
tinued intervention. Not all participants
given VFSS examination
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Du 2016i
Methods Randomisation by sequentially numbered sealed envelopes
Blinded outcome assessments by trained neurologist
(Sham vs low-frequency (1 Hz) data set)
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in China
40 participants; baseline characteristics similar
Enrolment within 2 months of stroke onset confirmed by CT or MRI scan
Clinical evidence of dysphagia
Interventions Rx 1: 1 Hz rTMS to unaffected hemisphere (n = 13)
Rx 2: 3 Hz rTMS to affected hemisphere (n = 13)
C: sham rTMS (n = 12), split into n = 6 for each data set
Treatment for up to 5 days
Outcomes Outcomes: swallow score using Standardised Swallow Assessment (SSA), BI, mRS, and
measures of mylohyoid MEPs
Notes Exclusions: other concomitant neurological diseases, fever, infection, prior administra-
tion of tranquilliser, severe aphasia or cognitive impairment, inability to complete the
follow-up, and other contraindications for rTMS
Follow-up: up to 3 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by sequentially numbered
sealed envelopes
Allocation concealment (selection bias) Low risk Allocation concealed by sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participant blinded; outcome assessor
blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participant blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessor blinded - measures eval-
uated by a trained neurologist who was
blinded to participants’ group allocation
throughout
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 participants lost to follow-up
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Du 2016i (Continued)
Selective reporting (reporting bias) Low risk Only NIHSS not recorded at the end; all
other measures reported on for all 3 time
points
Other bias Low risk None identified
Du 2016ii
Methods (High-frequency vs sham data set)
Participants As data set 1
Interventions High = 102 (high intensity)
Sham = 51 (low intensity)
Outcomes As data set 1
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by sequentially numbered sealed
envelopes
Allocation concealment (selection bias) Low risk Allocation concealed by sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participant blinded; outcome assessor blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participant blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessor blinded - measures evaluated by
a trained neurologist who was blinded to partici-
pants’ group allocation throughout
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 participants lost to follow-up
Selective reporting (reporting bias) Low risk Only NIHSS not recorded at the end; all other
measures reported on for all 3 time points
Other bias Low risk None identified
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Feng 2012
Methods Randomisation by random numbers table
Blinding unclear
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in China
122 participants; baseline characteristics similar
Enrolment within 2 weeks to 6 months of stroke onset
Clinical evidence of dysphagia
2 participants lost to follow-up
Interventions Rx: tongyan spray (n = 60)
C: placebo (n = 60)
Treatment for up to 28 days
Outcomes Outcomes: swallow safety and function using the SSA
Notes Exclusions: consciousness disorder; unstable life sign and accompanied by serious diseases
(heart, kidney, etc.), non-compliance with examination and treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table
Allocation concealment (selection bias) Low risk Concealed via sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 participant dropouts (1 from each group)
Selective reporting (reporting bias) Low risk All outcomes listed reported
Other bias Low risk None identified
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Han 2004
Methods Randomisation by sealed opaque envelope. Assessors blinded
Participants People with acute stroke, dysphagia, and dysarthria
1 centre in China
66 participants
100% with stroke within 30 days of onset. Degrees of dysphagia not stated
Interventions Rx: scalp and neck acupuncture with electroacupuncture with standardWestern medical
treatment
C: standard Western medical treatment only
Outcomes Dysphagia at end of trial after 3 treatment sessions
Notes Exclusions: reduced consciousness, poor compliance, infections at acupoints
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by sealed opaque envelopes
Allocation concealment (selection bias) Low risk Allocations concealed by opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Low risk None identified
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Heo 2015
Methods Participants were randomly allocated for radiographic inspection and treatment with or
without kinesiotaping by drawing lots
Blinding unknown
Participants 1 centre in Republic of Korea
44 participants
100% with dysphagia and stroke within 3 months of diagnosis
Baseline characteristics similar
Interventions Rx: kinesiotaping
C: no kinesiotaping
Outcomes Kinematic analysis of movement of the hyoid bone (movements measured in both hor-
izontal and vertical sections)
Angular variation of the epiglottis using human anatomy-based co-ordinates
Swallow score: FDS
Notes Exclusions: none
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants randomly allocated by drawing
lots
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Huang 2010
Methods Method of randomisation unknown
Blinding unknown
Only data for groups 2 and 3 included
Participants 1 centre in China
97 participants with post-stroke dysphagia
Interventions Group 1: electrical stimulation (n = 35)
Group 2: rehabilitation training (n = 30)
Group 3: acupuncture (n = 32)
Outcomes Swallowing function
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unknown
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unknown
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Translated from Chinese language
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Jayasekeran 2010a
Methods Dose comparison protocol (only data from the group that were stimulated once a day
over 3 days were included)
Computerised randomisation by minimisation
Blinded outcome measures
Balancing of prognostic baseline factors between treatment groups unclear
Participants 1 centre in UK
10 participants with acute anterior circulation cerebral infarct (< 3 weeks)
Mean age 73 years
Interventions Rx: bedside pharyngeal electrical stimulation
C: sham stimulation
Duration: once daily for 3 consecutive days
Outcomes Airway aspiration at 2 weeks’ post intervention
Notes Exclusion: dementia, pacemaker or implantable cardiac defibrillator, severe receptive
aphasia, unstable cardiopulmonary status, distorted oropharyngeal anatomy (e.g. pha-
ryngeal pouch), brainstem stroke, dysphagia resulting from conditions other than hemi-
spheric stroke
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation by minimi-
sation
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded outcome measures
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Jayasekeran 2010b
Methods Parallel-group design protocol
Computerised randomisation by minimisation
Blinded outcome measures
Prognostic baseline factors between treatment groups similar
Participants 2 centres in UK
28participantswith acute anterior circulation cerebral infarct or haemorrhage (<3weeks)
Mean age 75 years
Interventions Rx: bedside pharyngeal electrical stimulation
C: sham stimulation
Duration: once daily for 3 consecutive days
Outcomes Airway aspiration at 2 weeks post intervention
Notes Exclusion: dementia, pacemaker or implantable cardiac defibrillator, severe receptive
aphasia, unstable cardiopulmonary status, distorted oropharyngeal anatomy (e.g. pha-
ryngeal pouch), brainstem stroke, dysphagia resulting from conditions other than hemi-
spheric stroke
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation by minimi-
sation
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded outcome measures
Incomplete outcome data (attrition bias)
All outcomes
High risk 3 participants lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Jia 2006a
Methods Randomisation: participants randomised in visiting sequence
Blinding: unclear
ITT: unclear
Balancing of all prognostic factors not reported; only for age, gender, and stroke duration
Participants 1 centre in China
72 inpatients, stroke confirmed by CT orMRI scan but unclear patient inclusion criteria
- 2 out of 5 symptoms as hemiplegia, coma, slurred speech, unilateral sensory disturbance,
wry mouth and tongue; difficulty in swallowing
Mean age: treatment group = 55.4 years, control = 54.8 years
Interventions Group 1: acupuncture + rehabilitation training
Group 2: rehabilitation training only
Outcomes Primary outcomes: therapeutic assessment of swallowing function using 1 to 10 point
scale with categories basic cure; marked improvement; improvement and failure
Notes Not having above symptoms; cannot co-operate to do chemical examination and treat-
ment; severe primary disease in the liver, kidneys, hematopoietic system, and endocrine
system
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Participants randomised in visiting se-
quence
Allocation concealment (selection bias) High risk Allocation not concealed
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Only 1 outcome chosen and reported - im-
provement in swallowing at end of trial
Other bias Unclear risk Unclear
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Kang 2012
Methods Method of randomisation unclear
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in Korea
25 participants; baseline characteristics similar
Enrolment within 6 weeks of stroke onset
Clinical and videofluoroscopic evidence of dysphagia
Interventions Rx: additional exercise programme for dysphagia with thermal-tactile stimulation
C: thermal-tactile stimulation only
Treatment for up to 2 months
Outcomes Videofluoroscopy, Functional Oral Intake Scale, transition from tube to oral feeding,
incidence of aspiration pneumonia
Notes Exclusions: previous history of other diseases, which may have caused dysphagia; severe
cognitive disorder, such as dementia; inability to carry out videofluoroscopy due to
incapability of sitting posture; inability to follow study instructions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation unclear
Allocation concealment (selection bias) Unclear risk Blinding unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk None reported
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk Unclear
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Khedr 2009
Methods Method of randomisation unclear: participants were assigned randomly to receive real
or sham rTMS using closed envelopes
Blinded outcome assessment
Allocation sequence concealed from participants
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in Egypt
26 participants between 5th and 10th days post stroke (monohemispheric)
Mean age 56 years
Interventions Rx: repetitive transcranial magnetic stimulation of the affected motor cortex (n = 14)
C: sham stimulation (n = 12)
Outcomes Primary outcome: score on the dysphagia rating scale
Secondary outcomes: motor power of hand grip, BI, measures of oesophageal motor
evoked potentials from both hemispheres before and 1 month after sessions
Notes Exclusion: head injury or neurological disease other than stroke, unstable cardiac dys-
rhythmia, fever, infection, hyperglycaemia, prior administration of tranquilliser
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Low risk Allocation sequence concealed from partic-
ipants
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants and outcome assessors not
aware of allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants informed of which group they
had been allocated to at the end of the last
assessment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants apart from 1 in the sham
treatment group who died completed the
trial and follow-up periods
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Khedr 2010
Methods Methodof randomisationunclear: participants fromboth the lateralmedullary infarction
(LMI) group and the other brainstem infarction group were each randomly classified
into 2 groups - to receive real or sham repetitive transcranial magnetic stimulation
Blinded primary outcome assessment
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in Egypt
Total of 22 participants with hemispheric stroke split into having lateral medullary
infarction or other brainstem infarction
Mean age 58 years
Interventions Rx: repetitive transcranial magnetic stimulation of the affected motor cortex (n = 11)
C: sham stimulation (n = 11)
Outcomes Primary outcome: score on the dysphagia rating scale
Secondary outcomes: motor power of hand grip, BI, NIHSS
Notes Exclusion: head injury or neurological disease other than stroke, unstable cardiac dys-
rhythmia, fever, infection, hyperglycaemia, epilepsy, prior administration of tranquilliser
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants apart from 2 in the sham
treatment group who died completed the
trial and follow-up periods
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Kim 2012i
Methods Method of randomisation unclear
Blinding unclear
(High frequency data set vs control)
Participants 1 centre in Korea
30 participants with acute brain injury; baseline characteristics similar
Clinical and videofluoroscopic evidence of dysphagia
Interventions Rx 1: high-frequency (5 Hz) rTMS (n = 10)
Rx 2: low-frequency (1 Hz) rTMS (n = 10)
(Using high frequency data set)
C: sham stimulation. (n = 10); control = 5
Treatment for 2 weeks
Outcomes Functional Dysphagia Scale and Penetration Aspiration Scale
Notes Exclusions: prior diagnosis of another neurological disease, unstable medical condition,
severe cognitive impairment, severe aphasia, history of seizure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Kim 2012ii
Methods (Low-frequency data set vs control)
Participants As data set 1
Interventions Low-frequency rTMS = 10
Control (sham stimulation) = 5
Outcomes As data set 1
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Kumar 2011
Methods Randomisation via simple randomisation
Double-blind
Analysis by ITT unclear
Balancing of prognostic baseline factors between treatment groups unclear
Participants 1 centre in USA
14 participants with subacute (24 to 168 hours) unilateral hemispheric infarction
Mean age 75 years
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Kumar 2011 (Continued)
Interventions Rx: anodal transcranial direct current stimulation
C: sham stimulation
For 5 consecutive days
Outcomes Swallowing impairment using dysphagia outcome and severity scale
Notes Exclusions: difficulty following instructions because of obtundation or cognitive impair-
ment, pre-existing swallowing problems; other contraindications to transcranial direct
current stimulation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation via simple randomisation
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Low risk Double-blind
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-blind
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Low risk All outcomes reported and explained
Other bias Low risk None identified
Lee 2014
Methods Randomisation via computer-generated block randomisation
Blinding unclear
Analysis by ITT unclear
Prognostic baseline factors between treatment groups similar
Participants 1 centre in Korea
57 participants with dysphagic stroke within 10 days of onset (men 42, women 15)
Mean age 65 years
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Lee 2014 (Continued)
Interventions Rx: NMES combined with traditional dysphagia therapy (n = 31)
C: traditional dysphagia therapy only (n = 26)
5 days per week for 3 weeks
Outcomes Swallowing function, Functional Oral Intake Scale
Notes Exclusion: presence of dysphagia before stroke, previous history, unstable cardiopul-
monary status, serious psychological disorder or epilepsy, tumour or radiotherapy of
the head and neck region, swallowing therapy before participation in the present study,
unstable medical conditions that may interfere with VFSS
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated block randomisation
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants appeared to have been fol-
lowed up at 12 weeks
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Lee 2015
Methods Randomisation by computer-generated random sequence
Outcome assessors blinded
Participants Multi-centre trial in Hong Kong
93 participants with cerebrovascular disease; onset unclear although study states recent
hospitalisation in the previous 3 months
Baseline characteristics and prognostic factors similar
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Lee 2015 (Continued)
Interventions Rx: lisinopril 2.5 mg once daily at bedtime
C: placebo
Outcomes Incidence of pneumonia, mortality, and Royal Brisbane Hospital Outcome Measure
Scale score
Notes Exclusion: life expectancy < 6 months, baseline systolic blood pressure less than 100 mm
Hg, known intolerance to ACE inhibitors, current use of ACE inhibitor or angiotensin
receptor blockers, symptomatic chronic lung disease or cardiac failure, frequent with-
drawal of enteral tube by patients, serum creatinine > 150 mmol/L, serum potassium >
5.1 mmol/L
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random sequence
Allocation concealment (selection bias) Low risk Allocations concealed by coding files kept
confidential to all parties involved until the
end of the trial
Blinding (performance bias and detection
bias)
All outcomes
Low risk All parties involved not aware of allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk All parties involved not aware of allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessor blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk 22 participants did not complete trial
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Li 2014
Methods Randomisation via minimisation software
Single-blind - assessors blinded
No significant differences in baseline comparability tests in all groups of participants
Participants Recruitment through newspaper advertisements and flyers in China
118 participants with dysphagia and hemispheric stroke
Interventions Rx 1: neuromuscular electrical stimulation (VitalStim)
Rx 2: combined NMES and traditional swallowing therapy
C: traditional swallowing therapy
(Data from Rx 2 vs control used in this review)
Outcomes Swallow score, oral transit time, pharyngeal transit time, laryngeal closure duration, PAS
Notes Exclusion: progressive stroke, other neurological disease, neoplastic disease, previous
surgery to swallowing apparatus, nasogastric tube
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation via minimisa-
tion software
Allocation concealment (selection bias) Low risk Allocation concealed by sealed envelope
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessor blinded
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and technicians not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk As above
Incomplete outcome data (attrition bias)
All outcomes
High risk 17 participant dropouts
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Lim 2009
Methods Method of randomisation unclear: participants divided into 2 groups according to order
of enrolment
Blinding of outcomes unclear
Analysis by ITT unclear
Balancing of prognostic baseline factors between treatment groups - not reported for
dysphagia severity, only for previous treatment of pneumonia
Participants 1 centre in Korea
22 participants with CT or MRI confirmed stroke < 6 months from onset
Mean age 64 years
Interventions Rx: neuromuscular electrical stimulation + thermal-tactile stimulation (n = 13)
C: thermal-tactile stimulation (n = 9)
Outcomes Swallow function scoring system, PAS and PTT
Notes Exclusions: inability to receive treatment for 1 hour, neurological disease other than
stroke, combined behavioural disorder that interfered with administration of therapy,
current illness or upper gastrointestinal disease, inability to give informed consent because
of cognitive impairment or receptive aphasia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Participants divided into 2 groups accord-
ing to order of enrolment
Allocation concealment (selection bias) High risk Not concealed
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No details available
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No details available
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Doctor blinded to groups performed vide-
ofluoroscopic examination; measured PTT
as well as swallow function scoring system
and Rosenbek penetration aspiration scale
Incomplete outcome data (attrition bias)
All outcomes
High risk 36 enrolled to the study. Only 28 partici-
pants completed the study (16 in the exper-
imental group and 12 in the control group)
Selective reporting (reporting bias) Unclear risk Swallow scores not fully reported (unclear
on the range of median values)
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Lim 2009 (Continued)
Other bias Low risk None identified
Liu 2000
Methods Method of randomisation unclear
Blinding of outcomes unclear
Analysis by ITT unclear
Balancing of prognostic baseline factors between treatment groups unclear
Participants 1 centre in China
84 participants with bulbar palsy and CT/MRI-documented stroke: 54 men, 30 women
Age 50 to 78 years
Infarct 56, haemorrhage 28
Enrolment within 2 months of stroke onset
Interventions Rx: acupuncture - Tiantu (CV 22), Lieque (LU 7), Zhaohai (KI 6) - once daily for 10
days (n = 54)
C: (n = 30)
Outcomes Outcome: bulbar function (phonation, swallowing, cough reflex)
Timing unclear
Notes Exclusions: not given
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
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Liu 2000 (Continued)
Selective reporting (reporting bias) Unclear risk Unclear - no clear aim of study
Other bias Unclear risk Unclear
Liu 2004
Methods RCT
Participants 1 centre in China
82 participants with cerebral infarction or haemorrhage and CT/MRI-documented
stroke: 49 men, 33 women
Age 40 to 80 years
Infarct 72, haemorrhage 10
Enrolment within 6 months of stroke onset
Interventions Rx: scalp acupuncture + sublingual needling (n = 44)
C: scalp acupuncture + control needling (n = 38)
Outcomes Recovery of function (swallowing food and water, movement of the tongue, disappear-
ance of dyslalia and hoarseness)
Notes Exclusion: severe arrhythmia, coma, asthma, dilating myocardiopathy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear aim of study - only 1 outcome reported
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Liu 2004 (Continued)
Other bias Unclear risk Unclear
Park 2012
Methods Computer-generated randomisation sequence
Outcomes and participants blinded
Participants Study in Korea
20 participants with stroke > 1 month
Baseline characteristics similar, except stimulation intensities. Unclear baseline degree of
dysphagia between groups
Dysphagia defined by videofluoroscopy
Interventions Rx: effortful swallow with infrahyoid motor electrical stimulation
C: effortful swallow with infrahyoid sensory electrical stimulation (placebo stimulation)
Outcomes Vertical laryngeal and hyoid movements, maximum width of UES opening, PAS
Notes Exclusions: subarachnoid haemorrhage, carotid stenosis, inability to overcome stimula-
tion, which was determined by observation and palpation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation se-
quence
Allocation concealment (selection bias) Low risk Automated assignment system
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants and outcome assessors blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 participant dropouts (1 from each group)
Selective reporting (reporting bias) Low risk All outcomes reported
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Park 2012 (Continued)
Other bias Low risk None identified
Park 2013
Methods Computer-generated randomisation sequence
Outcomes and participants blinded
Participants Study in Korea
18 participants with stroke > 1 month
Baseline characteristics similar
Dysphagia confirmed by videofluoroscopy
Interventions Rx: active high-frequency rTMS (5 Hz) at the contralesional intact cortex
C: sham rTMS
Outcomes VDS, PAS
Notes Exclusions: metal implants or a pacemaker in the body, history of seizures
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation se-
quence
Allocation concealment (selection bias) Low risk Automated assignment system
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants and outcome assessors blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Park 2016a (i)
Methods Randomisation unclear
Outcome assessor blinded
(unilateral stimulation vs sham data set)
Participants 1 centre in Korea
35 participants with subacute stroke defined as onset < 3 months
Swallowing dysfunction confirmed by videofluoroscopy
Baseline characteristics similar
2 participants lost to follow-up
Interventions Rx 1: unilateral stimulation group with (10 Hz) rTMS on ipsilesional cortex and sham
on contralesional cortex (n = 11)
Rx 2: bilateral stimulation group with (10 Hz) rTMS on ipsilesional and contralesional
cortex (n = 11)
C: sham rTMS over bilateral hemispheres (n = 11)
Control group split into n = 5 for data set 1 and n = 6 for data set 2
Therefore for this data set, unilateral stimulation (n = 11) vs sham stimulation (n = 5)
Outcomes Clinical Dysphagia Scale, Dysphagia Outcome and Severity Scale, PAS, VDS
Notes Exclusion: history of swallowing problems caused by other underlying neurological dis-
eases, such as Parkinson’s disease, dementia, or motor neuron disease; history of in-
tractable seizure; metallic implants in the brain
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Blinding unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
High risk Single-blinded (assessors only)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Reported only as single-blinded (assessors
only)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
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Park 2016a (i) (Continued)
Other bias Low risk None identified
Park 2016a (ii)
Methods As per Park 2016a
(bilateral stimulation vs sham data set)
Participants As data set 1
Interventions Bilateral stimulation (n = 11) vs sham stimulation (n = 6)
Outcomes As data set 1
Notes As data set 1
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Blinding unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
High risk Single-blinded (assessors only)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Reported only as single-blinded (assessors
only)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
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Park 2016b
Methods Randomisation by randomly selected envelopes containing a code specifying the group
Outcomes partially blinded (for VFSS only but not for sEMG evaluation)
Participants 1 centre in Korea
33 participants with dysphagia (inclusion criteria states stroke onset within 6 months)
Dysphagia confirmed by videofluoroscopy
Baseline demographics and prognostic factors balanced
Interventions Rx: EMST with a 70% threshold value of maximal expiratory pressure, using an EMST
device
C: training with sham device
Treatment for 4 weeks
Outcomes Swallow function using VFSS, PAS, Functional Oral Intake Scale
Notes Exclusion: stroke before that resulting in dysphagia; severe oro-facial pain including
trigeminal neuropathy; significant malocclusion or facial asymmetry; unstable breathing
and pulse; tracheostomy; severe communication disorder such as severe aphasia; inade-
quate lip closure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by randomly selected en-
velopes containing a code specifying the
group
Allocation concealment (selection bias) Low risk Concealed by coded envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Participant blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes partially blinded (surface EMG
evaluation not blinded; however this out-
come not relevant in this review)
Incomplete outcome data (attrition bias)
All outcomes
High risk 6 participants lost to follow-up
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
66Swallowing therapy for dysphagia in acute and subacute stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Perez 1997
Methods Computerised randomisation
Triple-blind trial; outcomes assessed by blinded therapist
Analysis by ITT
No cross-overs or losses to follow-up
1 participant withdrawn with heart failure (nifedipine group)
Baseline prognostic factors balanced between treatment groups
Participants 1 centre in UK
17 participants; 8 men
Mean age 77 (SD 7) years
All first ischaemic stroke
100% CT
Enrolment 2 weeks after stroke
Interventions Rx: nifedipine (30 mg orally daily, Bayer, UK) (n = 8)
Pl: matching tablet; treatment for 4 weeks (n = 9)
Outcomes Primary outcome: clinical improvement in swallowing
Other outcomes: incidence of silent aspiration, pharyngeal transit time and response
duration, swallowing delay (all assessed by videofluoroscopy), death
Notes Exclusions: inability to sit, high clinical risk of aspiration, receptive dysphasia, cognitive
impairment, pre-stroke dysphagia, existing neurological or psychiatric disease, current
treatment with calcium channel blockers or aminophylline
Follow-up: 4 weeks. 1 participant withdrawn with heart failure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation
Allocation concealment (selection bias) Unclear risk Not stated
Blinding (performance bias and detection
bias)
All outcomes
Low risk Triple-blind trial
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Triple-blind trial
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes assessed by blinded therapist
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 participant withdrawn with heart failure
(nifedipine group)
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Perez 1997 (Continued)
No cross-overs
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Power 2006
Methods Method of randomisation unclear
CT scans analysed by aneuroradiologistwhowas blinded topatients’ clinical presentation
and videofluoroscopic swallowing status
Baseline data not including dysphagia severity of baseline groups
Participants 1 centre in UK
16 participants
Interventions Rx: actual electrical stimulation following threshold setting exercise to faucial pillars
C: single episode of sham electrical stimulation following threshold setting exercise
Outcomes Changes on videofluoroscopy 60 minutes post intervention
Notes Exclusions: prior dysphagia, intercurrent illness, other neurological disease
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Low risk All outcomes reported
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Power 2006 (Continued)
Other bias Low risk None identified
Shigematsu 2013
Methods Participants randomised using code numbers issued by coauthor
Outcomes blinded
Participants 1 centre in Japan
20 participants with stroke > 4 weeks
Baseline characteristics similar
Clinical, video endoscopic, and videofluoroscopic evidence of dysphagia
Interventions Rx: 1-mA anodal tDCS
C: sham tDCS (n = 10)
Treatment for 10 days
Outcomes Dysphagia Outcome and Severity Scale, PAS, VFSS, video endoscopic evaluation of
dysphagia
Notes Exclusions: subarachnoid haemorrhage, history of epileptic seizures, severe consciousness
disturbance, organic neck disease, history of surgery except for tracheotomy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised via code numbers issued by
coauthor
Allocation concealment (selection bias) Low risk Allocation concealed by code numbers
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Participant blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes blinded (rehabilitation doctor
and speech-language hearing therapists did
not know participants’ group allocation)
Incomplete outcome data (attrition bias)
All outcomes
Low risk None lost to follow-up
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Shigematsu 2013 (Continued)
Selective reporting (reporting bias) Low risk Results of the Dysphagia Outcome and
Severity Scale reported pre-, post-, and at
1-month follow-up
Other bias Low risk None identified
Song 2004
Methods Method of randomisation: random numbers table
Allocation method and concealment unclear
Participants 1 centre in China
53 participants; 46 men
All dysphagia identified by water swallow test
Baseline characteristics reported as similar
Interventions Rx: nurse-led swallowing exercises, oral stimulation and oral care (n = 29)
C (n = 24)
Follow-up: 1 month
Outcomes Primary and secondary outcomes not defined
Resolution of dysphagia by water swallow test and dietary ability, pneumonia rates
Notes Exclusions and whether ITT not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Method of randomisation: random num-
bers table
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
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Song 2004 (Continued)
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Translated from Chinese language
STEPS 2016
Methods Computerised randomisation
Single-blind; outcome assessor blinded
Analysis by ITT
Baseline characteristics balanced
Participants International, multi-centre trial
162 participants; 94 men
Mean age 74.4 years
Dysphagia identified clinically and by videofluoroscopy
Interventions Rx: active pharyngeal electrical stimulation
C: sham pharyngeal electrical stimulation
Follow-up: up to 12 weeks
Outcomes Primary: change in PAS at 2 weeks from baseline
Secondary: safety outcomes, clinical dysphagia (Dysphagia Severity Rating Scale, PAS
at 12 weeks), dependency (mRS), activities of daily living/disability (BI), impairment
(NIHSS), health-related quality of life (European Quality of Life-5 Dimensions (EQ-
5D), nutritional measures (weight, mid-arm circumference, and blood albumin))
Notes Exclusions: history of dysphagia, dysphagia from a condition other than stroke, ad-
vanced dementia, implanted pacemaker or cardiac defibrillator in situ, unstable car-
diopulmonary status or a condition that compromised cardiac or respiratory status, dis-
torted oropharyngeal anatomy, additional diagnosis of progressive neurological disorder,
receiving continuous oxygen treatment, pregnant or nursing mother
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by computer-generated
permuted blocks
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Low risk Researcher delivering the intervention not
blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Assessor and participant blinded
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STEPS 2016 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk 181participants randomised; only 123par-
ticipants completed all 3 treatments
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Terre 2015
Methods Computerised randomisation
Double-blinded study
Outcome assessors blinded
Participants Study completed in Spain
20 participants with neurological oropharyngeal dysphagia (14 stroke participants in the
posterior circulation; 6 with traumatic brain injury)
Baseline characteristics similar between groups
All within 5 months of diagnosis
Dysphagia identified by videofluoroscopy and Functional Oral Intake Scale
Interventions Rx: active NMES with conventional therapy
C: sham NMES with conventional therapy
Outcomes Clinical, videofluoroscopic, and oesophagealmanometric analyses of swallow; Functional
Oral Intake Scale
Notes Exclusion: previous stroke or traumatic brain injury, previous dysphagia secondary to
any other etiology, other metabolic or neurological disease
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised randomisation
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Low risk Double-blinded
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Terre 2015 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants and assessors blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Vasant 2016
Methods Computerised randomisation
Single-blind trial; outcomes assessed by blinded therapist
Analysis by ITT
Participants 3 centres in UK
36 participants; 22 men
All dysphagia identified by bedside screening swallow test and videofluoroscopy
Baseline characteristics reported as similar
1 participant withdrawn and lost to follow-up
Baseline prognostic factors similar between groups
Interventions Rx: pharyngeal electrical stimulation n = 18
C: sham n = 18
Duration: 3 days
Follow-up: 3 months
Outcomes Death, swallow function, dysphagia
Notes Exclusions: advanced dementia, other neurological conditions that may explain dyspha-
gia, previous history of dysphagia, presence of cardiac pacemaker or implanted cardiac
defibrillator, diagnosis other than stroke (e.g. brain tumour), significant structural ab-
normalities of the mouth or throat and requiring continuous oxygen treatment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation through a concealed com-
puter programme
Allocation concealment (selection bias) Low risk Concealed via a computerised programme
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Vasant 2016 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Researcher delivering the intervention not
blinded
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants and assessors blinded to group
allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 participant lost to follow-up (withdrawn)
, 2 participants (1 from each group) died
before follow-up at 3 months
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Warusevitane 2015
Methods Randomisation via a random numbers list generated by an independent statistician
Double-blind
Analysis by ITT unclear
Participants 1 centre in UK
60 participants within 7 days of acute ischaemic or haemorrhagic stroke confirmed by
CT scan of the brain who required nasogastric feeds for > 24 hours
Mean age: 78
No significant differences between baseline characteristics
Interventions Rx: 10 mg metoclopramide (10 mL)
C: 10 mL normal saline
Treatment duration: 21 days or until NGT no longer needed
Outcomes Swallowing impairment using dysphagia outcome and severity scale
Notes Exclusions: signs and symptoms of pneumonia after stroke onset, history of chronic
neurodegenerative disease that could affect swallowing (e.g. Parkinson disease, motor
neuron disease), oesophageal disorders, contraindications to metoclopramide
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by numbers list generated
by an independent statistician
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Warusevitane 2015 (Continued)
Allocation concealment (selection bias) Low risk Allocation sequence concealed from partic-
ipants
Blinding (performance bias and detection
bias)
All outcomes
Low risk Double-blind trial
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-blind trial
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Researcher and medical team involved in
participants’ care blinded to treatment al-
location
Incomplete outcome data (attrition bias)
All outcomes
Low risk All 60 participants analysed at end of trials
(none excluded)
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Wei 2005
Methods Method of randomisation unclear
Outcomes blinded
Participants 1 centre in China
68 participants; timing post stroke unclear but suggests acute
Dysphagia defined by water swallow test
Interventions Rx: Shuiti acupoint injection with stellate ganglion block for 40 days of treatment (n =
32)
C: standard medical care, which included some acupuncture (n = 33)
Outcomes Resolution of dysphagia: water swallow test score
BI
Chinese Neurological Score
Fugl-Meyer Assessment
Notes Exclusions: needle phobia, organ failure, head and neck tumours
Exclusions and dropouts accounted for but not analysed by ITT
Risk of bias
Bias Authors’ judgement Support for judgement
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Wei 2005 (Continued)
Random sequence generation (selection
bias)
Unclear risk Unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Translated from Chinese language
Xia 2011
Methods Method of randomisation unclear
Outcomes blinded
Participants 1 centre in China
120 participants, timing post stroke unclear but suggests acute
Dysphagia defined by water swallow test
Baseline characteristics similar
Interventions Rx 1: combined VitalStim therapy + conventional swallowing training (n = 40)
Rx 2: VitalStim therapy (n = 40)
C: conventional swallowing training (n = 40)
For the purpose of this review, treatment group Rx 1 used as the treatment arm only
Outcomes VFSS, Standardised Swallowing Assessment (SSA), surface EMG, Swallowing Quality
of Life (SWAL-QOL)
Notes Exclusion criteria not specified
Risk of bias
Bias Authors’ judgement Support for judgement
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Xia 2011 (Continued)
Random sequence generation (selection
bias)
Unclear risk Randomisation unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcomes blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk Unclear
Xia 2016a
Methods Randomisation by random numbered tables
Outcomes blinded
Participants 1 centre in China
124 participants, timing post stroke unclear but suggests acute based on mean days from
onset of stroke
Dysphagia identified by videofluoroscopy and Dysphagia Outcome Severity Scale
No significant differences in baseline characteristics between groups
Interventions Rx: combined acupuncture with standard swallowing training (n = 62)
C: standard swallowing training only (n = 62)
Treatment for 4 weeks
Outcomes Primary: Standardized Swallowing Assessment, Dysphagia Outcome Severity Scale
Secondary: Modified BI, Swallowing Quality of Life (SWAL-QOL)
Notes Exclusion: presence of serious diseases of the liver, kidney, hematological system, or
endocrine system; psychiatric disorders; severe cognitive impairment; severe aphasia;
other diseases that potentially impaired swallowing function, such as head and neck
tumours, oesophageal neoplasms, craniocerebral injury, myasthenia gravis, and Guillain-
Barre syndrome
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Xia 2016a (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by random numbers table
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 4 participant dropouts from study in total
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified
Yuan 2003i
Methods Method of randomisation unclear
Blinding unclear
(traditional liquid diet with swallowing therapy vs control)
Participants 1 centre in China
64 participants; timing unclear
All dysphagia as defined by Watian Swallow Test
Interventions R1: enteral nutrition agent with thickener and swallowing therapy (n = 18)
R2: traditional liquid diet and swallowing therapy (n = 22). This data set was split (n=
11)*
C: liquid diet only and no swallowing therapy (n = 24)
(R1 and R2 had NGTs for an uncertain amount of time)
*Compared in data set 1
Outcomes Length of stay, pneumonia rates, nutritional measures, resolution of dysphagia (swallow
test grade)
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Yuan 2003i (Continued)
Notes Exclusions: terminal illness, organ failure
Unclear if any blinding of interventions or outcomes occurred
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Translated from Chinese language
Yuan 2003ii
Methods (Enteral nutrition agent with thickener and swallowing therapy vs traditional liquid diet
and swallowing therapy data set)
Participants As data set 1
Interventions R1: enteral nutrition agent with thickener and swallowing therapy (n = 18)
R2: traditional liquid diet and swallowing therapy (n = 22). This data set was split (n =
11)
Outcomes As data set 1
Notes -
Risk of bias
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Yuan 2003ii (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Unclear risk Unclear
Other bias Unclear risk Unclear
Zheng 2014
Methods Randomisation unclear
Blinding unclear
Participants 1 centre in China
88 participants; onset of stroke within 2 weeks
Dysphagia identified by water swallow test
Baseline characteristics similar
Interventions Rx: individualised multi-disciplinary rehabilitation programme (n = 44)
C: conventional rehabilitation programme (n = 44)
Treatment for 4 weeks
Outcomes Swallowing function by the water swallow test
Notes Exclusion: comprehension difficulty, such as Wernicke aphasia
Risk of bias
Bias Authors’ judgement Support for judgement
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Zheng 2014 (Continued)
Random sequence generation (selection
bias)
Unclear risk Unclear
Allocation concealment (selection bias) Unclear risk Unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Unclear
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk Unclear
ACE: angiotensin-converting enzyme
BI: Barthel Index
BSA: body surface area
C: control group
CT: computed tomography
EMG: electromyography
EMST: expiratory muscle strength training
EQ-5D: EuroQoL Group Quality of Life Questionnaire based on five dimensions
FDS: Functional Dysphagia Scale
FMA: Fugl-Meyer Assessment
Hz: Hertz
ITT: intention-to-treat analysis
LMI: lateral medullary infarction
MD: mean difference
MEPs: motor evoked potentials
MMSE: Mini Mental State Examination
MoCA: Montreal Cognitive Assessment
MRI: magnetic resonance imaging
mRS: modified Rankin Scale
NGT: nasogastric tube
NIHSS: National Institutes of Health Stroke Scale
NMES: neuromuscular electrical stimulation
OR: odds ratio
PAS: Penetration Aspiration Scale
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PEG: percutaneous endoscopic gastrostomy
PHAD: Paramatta Hospital’s Assessment for Dysphagia score
Pl: placebo group
PTT: pharyngeal transit time
RBHOMS: Royal Brisbane Hospital Outcome Measure Scale
rTMS: repetitive transcranial magnetic stimulation
Rx: treatment group
SD: standard deviation
sEMG: surface electromyography
SLT: speech and language therapy
SPSS: Statistical Package for the Social Sciences
SSA: Standardised Swallow Assessment
SWAL-QOL: Swallowing Quality of Life Questionnaire
tDCS: transcranial direct current stimulation
UES: upper oesophageal sphincter
VDS: videofluoroscopic dysphagia scale
VFSS: videofluoroscopy swallow study
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Akamatsu 2009 RCT assessing transcutaneous electrical stimulation vs control
12 participants with chronic stroke and episodes of choking while eating or drinking
Outcome: latency time in swallowing reflex
Excluded: no relevant outcome data
Aoki 2016 Study looking at effect of implementing multi-disciplinary swallowing team approach in lowering the
rate of pneumonia (between-team organisation vs after-team organisation)
Outcomes: rates of pneumonia
Excluded: not a true RCT
Arai 2003 RCT
Group 1: cabergoline (n = 13)
Group 2: amantadine (n = 14)
Group 3 : ACE inhibitor (n = 12)
Group 4: control
Excluded: (1) > 3 months post stroke; (2) definition of aspiration non-standard; (3) randomisation
unclear; (4) insufficient information
Beom 2011 Study comparing conventional dysphagia management (CDM) vs CDMwith repetitive electrical stim-
ulation of the suprahyoid muscles
Outcomes: swallow score
Excluded: not true RCT - non-concurrent comparative design
Beom 2015 Randomised trial in dysphagic participants with stroke, traumatic brain injury, or brain tumour
NMES on suprahyoid (Stimplus) vs NMES on suprahyoid and infrahyoid (VitalStim)
Outcomes: swallow scores
Excluded: confounded - comparison between 2 treatment groups
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(Continued)
Byeon 2016 Randomised trial comparing neuromuscular electrical stimulation vs thermal-tactile stimulation in
subacute stroke patients with dysphagia
Outcomes: swallow scores (Functional Dysphagia Scale using VFSS)
Excluded: confounded - comparing 2 active treatments
Bülow 2008 RCT assessing neuromuscular electrical stimulation vs traditional swallowing therapy in 25 stroke
patients with dysphagia
Outcomes: video radiographic swallowing evaluation, nutritional status, oral motor function test, visual
analogue scale for self-evaluation of complaints
Excluded: (1) no available outcome data, (2) confounded, comparing 2 direct treatments
Cai 2015 Randomised trial comparing tongue acupuncture vs conventional (neck and wrist) acupuncture in post-
stroke dysphagia patients
Outcomes: dysphagia at end of trial, NIHSS, pneumonia
Excluded: (1) confounded - both groups received active treatment
Chaudhuri 2006 RCT assessing effectiveness of electric stimulation vs traditional dysphagia therapy in participants with
acute stroke (< 6 weeks)
Outcomes: American Speech Language Hearing Association National outcome measurement system
swallowing level
Excluded: no available outcome data
Chen 2002 RCT assessing tongue acupuncture + ice massage + general medical treatment (n = 50) vs general
medical treatment (n = 46) in acute dysphagic stroke patients
Outcome: dysphagia recovery assessed by videofluoroscopy
Excluded: no available outcome data
Chen 2003 RCT assessing electroacupuncture + rehabilitation (n = 34) vs rehabilitation alone (n = 34) in dysphagia
patients with pseudobulbar palsy including stroke
Treated for 10 days
Outcome: dysphagia recovery after stroke
Excluded: no available outcome data
ChiCTR-ONC-17012326 RCT examining effects of acupuncture and rTMS for acute patients - duration of stroke and dysphagia
between 1 and 6 months
Outcomes: VFSS score
Excluded: confounded - comparing acupuncture and rTMS
ChiCTR-TRC-14005233 RCT comparing validity and safety of telerehabilitation (exercise rehabilitation and myoelectrical feed-
back) vs conventional rehabilitation in dysphagic patients with ischaemic cerebral stroke
Outcomes: Barthel Index assessment; NIHSS assessment; water drinking test assessment; surface elec-
tromyography
Excluded: confounded - comparing 2 active treatment groups
DePippo 1994 RCTcomparing 3 active interventions in 115dysphagic stroke patients taught compensatory swallowing
techniques
Group 1: patient/family choice of diet and food consistency (n = 38)
Group 2: therapist-prescribed diet and food consistency (n = 38)
Group 3: therapist-prescribed diet and food consistency, with daily reinforcement of compensatory
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swallowing techniques (n = 39)
Outcomes: pneumonia, dehydration, caloric-nitrogen deficit, death
Excluded: 3 active treatment groups with no control group (confounded)
Dou 2012 Randomised trial comparing effects of active vs passive balloon dilatation therapy on swallowing func-
tion in participants with cricopharyngeal dysfunction due to neurological disorders
Outcomes: swallow score, changes in upper oesophageal sphincter opening
Excluded: confounded - comparison between 2 active treatments
Ebihira 2004 RCT
Group 1: theophylline 200 mg once daily
Group 2: placebo
N = 85 with ’mild to moderate’ dysphagia (definition unclear)
Outcome: latency of swallow
Excluded: (1) nursing home residents (not acute), proportion of stroke patients not stated; (2) > 3
months post stroke
Ebihira 2005 RCT
Group1: capsaicin troche 1.5 mcg (n = 34)
Group 2: placebo (blinded) (n = 33) for 4 weeks
Excluded: (1) ’predominantly’ stroke (% not stated) nursing home-dependent residents; (2) definition
of dysphagia unclear; (3) > 3 months post stroke; (4) outcomes: latency of swallow not relevant to
review
El-Tamawy 2015 RCT evaluating effects of a designed physical therapy programme that consists of therapeutic physical
exercises in addition to neuromuscular electrical stimulation on severe swallowing disorders (oropha-
ryngeal dysphagia) in people with acute ischaemic cerebrovascular stroke
Outcomes: oral transit time, hyoid/laryngeal elevation, oesophageal sphincter opening, incidence of
penetration and aspiration
Excluded: no available outcome data
Fraser 2002 RCT including 16 acute stroke (< 4 days from ictus) participants with dysphagia
TMS vs none
Outcome: pharyngeal electromyographic responses
Excluded: no relevant outcome data
Freed 1996 Controlled clinical trial comparing 3 active interventions in 112 participants with aspiration
Group 1: electrical stimulation
Group 2: thermal stimulation
Group 3: both - failed thermal stimulation followed by electrical stimulation
Outcome: regain oral intake
Excluded: (1) dysphagia of mixed aetiology (stroke ?%); (2) not an RCT; (3) 2 active treatment groups
with no control group (confounded)
Freed 2001 Quasi-RCT (alternate assignment) comparing electrical stimulation vs thermal-tactile stimulation in
110 dysphagic stroke patients
Outcome: swallow score
Excluded: (1) 2 active treatment groups with no control group (confounded)
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Hagg 2015 Prospective comparative study of 2 groups of post-stroke 4-quadrant facial dysfunction and dysphagic
patients - palatal plate training (2005-2008) vs training with oral IQoro® (2009-2012)
Outcome: facial activity, swallow function
Excluded: (1) not a true RCT, (2) confounded - comparing 2 active treatment protocols
Inui 2017 Quasi-experimental study to compare the incidence of pneumonia as a dependent variable between
before (control) and after (intervention group) intervention with pyriform sinus suctioning as an inde-
pendent variable
Outcomes: incidence of pneumonia
Excluded: (1) not an RCT - not randomised
ISRCTN18137204 RCT comparing electrical pharyngeal stimulation vs sham stimulation in severely dysphagic tra-
cheotomised stroke patients
Outcomes: intention to decannulate based on FEES performance; feeding status at discharge (dysphagia
severity rating scale, functional oral intake scale); mRS; length of stay (ICU/hospital), time from
stimulation to discharge
Excluded: outcomes not relevant to the review
ISRCTN97286108 RCT assessing dose response of transcranial direct current stimulation for dysphagia after acute stroke
Outcome: swallow safety
Excluded: trial terminated due to problems in recruitment (according to study author)
Jin 2014a RCT assessing effects of magnetic-ball sticking therapy at auricular points against acupuncture in 90
participants with chronic post-stroke dysphagia
Outcomes: swallow score (VFSS), PAS, pneumonia, malnutrition
Excluded: (1) confounded - all participants received treatment, (2) duration of stroke unknown
KCT0001907 Study looking at effects of NMES according to electrode placement in stroke patients with dysphagia
Outcomes: videofluoroscopic dysphagia scale; PAS; functional oral intake scale
Excluded: (1) confounded (comparing electrode placement on suprahyoid vs infrahyoid), (2) time post
onset unclear
Kikuchi 2014 Double-blind RCT on participants > 65 years old with stroke and dysphagia from 2 hospitals and 2
nursing homes in Sendai, Japan
Group 1: press needles (Pyonex; Seirin Corporation, Shizuoka, Japan) at 2 points on the legs (ST36
and KI3)
Group 2: sham patches on acupuncture points
Group 3: press needles on sham points
Excluded: no relevant outcomes
Kobayashi 1996 Randomised crossover trial assessing levodopa in 27 participants with basal ganglia infarction and 20
healthy volunteers
Outcomes: swallowing latency
Excluded: (1) cross-over trial, (2) outcomes (swallowing latency) not relevant to this review, (3) < 50%
stroke
Kulnik 2015 Single-blind RCT in acute stroke patients
Expiratory training vs inspiratory training vs sham training
Outcomes: peak expiratory cough flow of maximal voluntary cough, pneumonia
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Excluded: most participants do not have clinical dysphagia
Kushner 2013 Case-control study comparing the efficacy of NMES in addition to traditional dysphagia therapy
including progressive resistance training vs that of traditional dysphagia therapy/progressive resistance
training alone in participants with acute post-stroke dysphagia
Outcomes: swallow score, dysphagia at end of trial
Excluded: non-randomised trial
Lan 2013 Single-blind clinical intervention trial comparing biomechanical properties of swallowing in brainstem
stroke patients with dysphagia following modified balloon dilation therapy vs regular dysphagia therapy
Outcomes: Functional Oral Intake Scale, pharyngeal maximum pressures and duration, and upper
oesophageal sphincter residual pressure and duration during swallowing were measured using high-
resolution manometry
Excluded: non-randomised trial
Logemann 2009 RCT assessing traditional swallowing therapy or the Shaker exercise in participants with prolonged
oropharyngeal dysphagia and aspiration
Outcomes: occurrence of aspiration (preswallow, intraswallow, postswallow) at 6-week follow-up period;
occurrence of residue in the oral cavity, valleculae, or pyriform sinuses; Performance Status Scale for
Diet
Excluded: (1) head and neck cancer and stroke (< 50%); (2) no relevant outcome data
Ma 2014 Randomised trial comparing acupoint injection, neural electrical stimulation, combination of both and
swallowing training
Outcomes: swallow function using water swallow test
Excluded: confounded - comparing 3 active treatments
Ma 2015 Randomised trial comparing effects of acupuncture and neck-skin electrical stimulation on dysphagia
in participants with cerebral infarction
Outcomes: swallow function using water swallow test and food-intake scale
Excluded: confounded - comparing 2 active treatments
Maeda 2017 RCT
43 participants who were prescribed in-hospital dysphagia rehabilitation (most with history of stroke)
Sensory stimulation vs sham stimulation
Outcomes: cough latency times, functional oral intake scale scores, oral nutritional intake
Excluded: (1) majority of participants without stroke (48.8% stroke participants), (2) timing of stroke
unclear
Mao 2016 Non-randomised interventional study
Standard swallowing training vs standard swallowing training with acupuncture
All participants with post-stroke dysphagia
Excluded: not an RCT - not randomised
McCullough 2012 Cross-over study investigating effects of intensive exercise using Mendelsohn manoeuvre on swallowing
movement
All 18 participants with stroke and dysphagia
Outcomes: videofluoroscopic swallow assessment, swallow score
Excluded: (1) not a true RCT - cross-over design, (2) majority of participants chronic
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McCullough 2013 Cross-over study assessing effect of Mendelsohn manoeuvre on hyoid movement
All 18 participants with post-stroke dysphagia
Outcomes: assessment of hyoid movements, upper oesophageal sphincter opening
Excluded: (1) not a true RCT - cross-over design, (2) no relevant outcomes
Mepani 2009 RCT comparing traditional swallowing therapy vs Shaker exercise in 6 stroke and 5 cancer patients
Outcome: deglutitive thyrohyoid shortening before and after completion of assigned therapy regimen
Excluded: (1) no time of onset for stroke patients, (2) no separate results for stroke, (3) no relevant
outcome data
Messaggi-Sartor 2015 RCT comparing effects of short-term inspiratory and expiratory muscle training on respiratory muscle
strength in subacute stroke patients
Outcomes: respiratory muscle strength (maximum inspiratory and expiratory pressures)
Excluded: (1) outcomes not relevant to review, (2) not all participants had dysphagia
Michou 2010 RCT comparing transcranial magnetic stimulation vs sham stimulation in 12 stoke participants with
dysphagia
Outcome: pharyngeal electromyographic responses
Excluded: no relevant outcome data
Michou 2011 RCT comparing transcranial magnetic stimulation vs pharyngeal electrical stimulation vs paired asso-
ciative stimulation vs sham stimulation in 14 dysphagic stroke participants
Outcome: videofluoroscopic swallowing assessments
Excluded: no available outcome data
Nakamura 2013 Cross-over study assessing the effect of ice massage in triggering the swallow reflex
Outcomes: videofluoroscopic assessment of swallowing
Excluded: not a true RCT - cross-over design
Nakayama 1998 RCT comparing 5mg imidapril or placebo in randomised, double-blind, cross-over design. Participants
were normotensive patients with at least 1 episode of aspiration and healthy volunteers
Outcome: swallowing reflex
Excluded: no relevant outcome data
Nam 2012 Randomised trial comparing 2 neuromuscular stimulation techniques (VitalStim vs Stimplus DP 200)
Outcomes: swallow function using videofluoroscopic swallowing studies
Excluded: confounded - comparison of 2 treatment groups
NCT00376506a Implanted neuroprosthesis (neuro control implantable receiver-stimulator) to stimulate the laryngeal
nerve vs sensory training in dysphagic participants including stroke > 6 months post onset
Excluded: (1) no control group, 2 active groups compared, (2) no outcome data
NCT00376506b RCT assessing intramuscular stimulation device implanted in the neck vs vibrotactile stimulation of
the throat in 20 participants with dysphagia secondary to stroke or chronic neurological disease
Outcome: swallowing safety for 10mLof thin liquid and 5mL of pudding with andwithout stimulation
Excluded: comparing 2 active treatments vs no control (confounded)
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NCT01971320 Single-blind RCT comparing active vs fake Urostim I stimulation in hemispheric stroke patients with
oropharyngeal dysphagia
Outcomes: evaluation of oropharyngeal dysphagia symptoms
Excluded: no outcome data as trial terminated due to lack of recruitment
Nishiyama 2010 RCT comparing nicergoline (15 mg tds) vs control in 50 ischaemic stroke patients
Outcome: substance P level
Excluded: no relevant outcome data
Ortega 2016 RCT comparing 2 x 10-day treatment groups (transient receptor potential vanilloid 1 agonist vs tran-
scutaneous sensory electrical stimulation)
Outcomes: swallow function (videofluoroscopic), dysphagia at end of trial
Excluded: (1) < 50% participants with stroke - duration unknown, (2) confounded - comparing 2
active treatments
Permsirivanich 2009 RCT
Group 1: NMES (n = 12)
Group 2: rehabilitation swallowing therapy (n = 11)
All stroke
Excluded: confounded, i.e. comparison of 2 active treatments
Pownall 2008 RCT assessing thickened fluids vs postural and/or swallowing strategies in 50 participants with post-
stroke dysphagia: a further group of participants who were not dysphagic for liquids and who were
given normal fluids compared with RCT
Outcome: development of chest infection and dehydration
Excluded: no control group - 2 interventional groups were compared in the RCT
Pryor 2011 RCT comparing NMSE vs vibrotactile stimulation in dysphagic participants
Outcomes: swallow function, PAS
Excluded: (1) mixed patient population, (2) confounded - comparison of 2 active interventions
Reidnauer 2006 RCT comparing vital stimulation (and electrotherapy intervention) vs traditional treatment in post-
stroke participants with dysphagia
Outcomes: swallow scores
Excluded: no available outcome data
Rofes 2014 Double-blind RCT comparing effects of 2 doses of piperine (dual TRPV1/TRPA1 agonist) on the
swallow response of dysphagic participants
Participants were randomised into 2 groups: 1 group received 150 lM piperine and the other group
received 1 mM
Outcome: PAS, swallowing analysis with videofluoroscopic images
Excluded: dose-response trial - all groups received treatment (either low or high dose of piperine)
Rosenbek 1991 Randomised cross-over trial assessing thermal stimulation in 7male dysphagic participantswithmultiple
previous strokes
Outcome: duration of stage transition
Excluded: (1) cross-over trial, (2) most participants recruited > 3 months after stroke onset, (3) ran-
domisation status unclear
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Rosenbek 1996 Randomised cross-over trial assessing thermal stimulation in 23 dysphagic participants with multiple
previous strokes
Outcome: duration of stage transition, total swallow duration
Excluded: (1) cross-over trial, (2) 14 participants recruited > 3 months after stroke onset
Rosenbek 1998 Dose comparison RCT of thermal stimulation (150, 300, 450, 600 trials per week) in 45 dysphagic
stroke participants recruited within 12 weeks
Outcome: number of trials delivered, treatment time, duration of stage transition, aspiration (PAS)
Excluded: no control group
Sdravou 2012 Interventional study comparing effects of carbonated thin liquids vs non-carbonated thin liquids on
oropharyngeal swallowing in adults with neurogenic dysphagia
Outcomes: oral transit time, pharyngeal transit time, PAS
Excluded: (1) non-RCT, (2) many participants with chronic stroke (> 6 months)
Seki 2005 Randomised trial
Group 1: acupuncture (n = 18)
Group 2: no intervention (n = 14)
Excluded: (1) incomplete outcome data, (2) time from stroke unclear
Shaker 2002a RCT comparing head-raising exercise vs sham exercise in 27 dysphagic participants
Outcomes: upper oesophageal sphincter function, functional swallow status
Excluded: (1) dysphagia of mixed aetiology (cerebrovascular disease 56%), (2) most participants re-
cruited > 3 months after stroke onset, (3) individual patient data unavailable, so not possible to analyse
subgroup of appropriate participants
She 2014 RCT comparing acupuncture in 8 neck-occiput points vs meridian points
Outcomes: speech and swallowing dysfunction at end of trial
Excluded: (1) confounded - comparing 2 different treatment groups
SQACU01 2001 RCT comparing acupuncture vs sham acupuncture for 16 sessions in participants with dysphagia due
to recent stroke
Outcomes: tube feeding, pneumonia, mortality, each at 6 months
Excluded: no outcome data
Steele 2016 RCT comparing 2 treatment protocols: tongue pressure profile training or tongue pressure strength-
and-accuracy training
Outcomes: swallow function
Excluded: confounded - comparison between 2 treatment protocols
Sukthankar 1994 RCT assessing swallowing therapy (biofeedback) in 9 participants with dysphagia secondary to stroke
or head injury
Group 1: regular therapy (n = 4)
Group 2: regular therapy and oral exercises (n = 2)
Group 3: regular therapy and oral exercises with visual and audio biofeedback (n = 3)
Excluded: (1) dysphagia of mixed aetiology, (2) outcome measures (tongue and lip motor force) not
relevant to this review
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Suntrup 2015 RCT comparing electrical pharyngeal stimulation vs sham stimulation (control) in severely dysphagic
tracheotomised stroke participants
Outcomes: ability to decannulate based on FEES performance; feeding status at discharge (FOIS);
mRS; length of stay (ICU/hospital) and time from stimulation to discharge
Excluded: outcomes (decannulation) not relevant to review (only data regarding decannulation available
before trial unblinded)
Suzuki 2012 Randomised trial investigating the relationship between body position during nasogastric feed and
aspiration pneumonia in acute stroke participants
Outcomes: aspiration pneumonia rates
Excluded: pseudo-randomised study; assessment of body position
Tai 2014 Quasi-experimental trial to investigate effectiveness of the chin-down swallowing technique in improve-
ment of dysphagia in stroke participants
Outcomes: Dysphasia Assessment Scale and Swallow Self-assessment
Excluded: not an RCT - not randomised
Teramoto 2008 RCT assessing swallowing function using cilostazol vs placebo in 48 participants with dysphagia sec-
ondary to stroke
Outcome: swallowing function
Excluded: (1) onset of stroke to randomisation, 1 to 6 months, (2) cross-over study, no access to data
on the first phase
Terre 2012 Randomised, alternating, cross-over study assessing effectiveness of chin-down posture in preventing
aspiration in participants with neurogenic dysphagia secondary to acquired brain injury
Outcomes: aspiration prevention
Excluded: (1) pseudo-randomised study, (2) assessment of posture
Toyama 2014 Non-randomised interventional study comparing NMES and conventional treatment vs conventional
treatment only
Outcomes: swallow scores (VDS, FOIS), hyoid and laryngeal displacement
Excluded: not an RCT - not randomised
Ueda 2004 21 participants
Group 1: functional swallowing training (n = 11)
Group 2: oral care (n = 11) in nursing home residents (% stroke unknown) who are tube fed
Excluded: (1) < 50% stroke, (2) non-acute, (3) randomisation unclear
Varma 2006 Group 1: motor control programme (n = 30)
Group 2: home exercise programme (n = 30)
Randomisation method unclear
Excluded: (1) insufficient data, (2) outcome methods unclear
Wang 2016 Randomised interventional trial comparing differences in effects between awn-like needle at Tiantu
(CV 22) and filiform needle for dysphagia after cerebral infarction
Outcomes: standard swallowing assessment scale and modified Bathel index
Exlcuded: confounded - comparing 2 different treatment groups
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(Continued)
Xia 2016 RCT with 130 participants with post-stroke dysphagia
In treatment group, acupuncture based on meridian differentiation was adopted. The main acupoints
were Neiguan (PC 6), Shuigou (GV 26), Sanyinjiao (SP 6), Fengchi (GB 20), Lianquan (CV 23),
Jialianquan (Extra), Jinjin (EX-HN 12), Yuye (EX-HN 13), etc
Control group: points were selected 5 cm lateral to the acupoints used in the observation groups and
stimulated with shallow puncture
Outcomes: standardised swallowing assessment, VFSS, modified Barthel Index and swallowing-related
quality of life (SWAL-QOL)
Excluded: confounded - comparing 2 treatments
Zhang 2011 RCT comparing different depth of Chonggu (EX-HN 27) by electroacupuncture in participants with
dysphagia after stroke
Chonggu (EX-HN 27) deep insertion group (n = 99)
Chonggu (EX-HN 27) shallow insertion group (n = 94)
Traditional acupuncture group (n = 90)
Outcomes: Kubota’s Water Drinking Test Scale, standard swallowing function scale, and TCM Scale
of Dysphagia After Stroke
Excluded: no available outcome data
Zhang 2018a RCT comparing effects of electroacupuncture with different frequencies in participants with dysphagia
after stroke
Low-frequency (2Hz) electroacupuncture group vs high-frequency (100 Hz) electroacupuncture group
Outcomes: VFSS, standardised swallowing assessment
Excluded: not an RCT - dose-response study (no control group)
Zhang 2018b Randomised interventional trial to assess clinical improvement of nursing intervention in swallowing
dysfunction of elderly stroke participants
Conventional nursing service vs nursing interventions (psychological intervention, health education,
rehabilitation exercises, diet intervention)
Outcomes: dysphagia at end of trial, functional outcomes (GQOL-74)
Excluded: confounded - comparing 2 different treatment groups
Zhao 2015 Randomised trial of participants with stroke and swallowing disorders
Group A: normal acupuncture
Group B: NMES combined with acupuncture with uniform reinforcing-reducing manipulation as well
as the piercing and blood-letting method
Outcomes: Kubota water test, dysphagia at end of trial
Excluded: confounded - comparison between 2 treatment groups
ACE: angiotensin-converting enzyme
CDM: conventional dysphagia management
CXR: chest x-ray
FEES: Fibreoptic Endoscopic Evaluation of Swallowing
FIM: Functional Independence Measure
FOIS: Functional Oral Intake Scale
GQOL-74: Generic Quality of Life Inventory
ICU: intensive care unit
IOro®: Orofacial device
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mRS: modified Rankin Scale
NGT: nasogastric tube
NIHSS: National Institutes of Health Stroke Scale
NMES: neuromuscular electrical stimulation
PEG: percutaneous endoscopic gastrostomy
RCT: randomised controlled trial
rTMS: repetitive transcranial magnetic stimulation
SAH: subarachnoid haemorrhage
SWAL-QOL: Swallowing Quality of Life Questionnaire
TCM: Traditional Chinese Medicine
TMS: transcranial magnetic stimulation
VDS: videofluoroscopic dysphagia scale
VFSS: videofluoroscopy swallow study
Characteristics of studies awaiting assessment [ordered by study ID]
Azimov 2017
Methods RCT although randomisation method unclear
Participants 34 participants with ischaemic stroke and dysphagia at onset 2 to 7 points of PAS Scale
Interventions Experimental group: amantadine (200 mg/d) and levodopa (125 mg/d) after standard treatment (n = 17)
Control group: standard treatment, including citicoline and anticholinesterase (n = 17)
Outcomes PAS divided into group PAS score 2 to 4 and group PAS score 5 to 7; recheck after 2 months
Notes Study completed; awaiting full published data
Carnaby 2012
Methods RCT
Participants 53 stroke participants from a subacute rehabilitation facility
Interventions Group 1: usual care
Group 2: McNeill Dysphagia Therapy plus sham NMES
Group 3: McNeill Dysphagia Therapy plus active NMES
Outcomes Increase of 10 or more points on the Mann Assessment of Swallowing and improvement of 2 or more scale points
on the Functional Oral Intake Scale, without significant weight loss or complication
Notes In the process of retrieving full-text article and data
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Chang 2014
Methods RCT
Participants 74 participants with dysphagia after stroke
Interventions Functional electrical stimulation vs a combination of electrical stimulation and acupuncture
Outcomes Swallow score, removal rate of nasogastric tube
Notes In the process of retrieving full-text article
Chaudhuri 2008
Methods RCT
Participants People with stroke and dysphagia
Interventions Traditional dysphagia treatment vs combined neuromuscular electrical stimulation and traditional treatment
Outcomes Swallow score (ASHA NOMS)
Notes Awaiting published data (full text)
Chen 2017
Methods RCT
Participants People with dysphagia due to stroke (onset 2 to 7 days)
Interventions Levetiracetam (Keppra) vs carbidopa/levodopa (Sinemet) vs placebo
Outcomes Qualitative and quantitative swallow function
Notes Study published; in the process of extracting data
Cheng 2005
Methods RCT
Participants People with Ischaemic stroke with pseudobulbar palsy
Interventions Early throat muscle training vs control
Outcomes Effects on vertebral and basilar artery blood flow
Notes In the process of retrieving full-text article
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Cheng 2014
Methods RCT
Participants 180 participants with post-stroke dysphagia
Interventions Group 1 (Acupuncture A): acupuncture at Lianquan (CV 23)
Group 2 (Acupuncture B): acupuncture at Hegu (LI 4) and Neiguan (PC 6)
Group 3 (Control): rehabilitation group
Outcomes NIHSS scores, VFSS scale, pneumonia, clinical efficacy
Notes In the process of retrieving full-text article
ChiCTR-TRC-07000010
Methods RCT
Participants People with dysphagia in the convalescence phase of stroke (2 and 6 months)
Interventions Combination of body acupuncture, scalp acupuncture, and electroacupuncture vs routine rehabilitation training
Outcomes Safety and tolerability of acupuncture
Notes Study completed; awaiting published data
ChiCTR-TRC-08000463
Methods RCT
Participants People with stroke 2 to 60 days from onset
Interventions Dysphagia therapeutic apparatus on acupoints vs regular dysphagia rehabilitation vs both
Outcomes Swallowing function and mastication function
Notes Study completed; awaiting published data
ChiCTR-TRC-14004235
Methods RCT
Participants People with dysphagia symptoms appearing within 1 to 6 months after stroke
Interventions Modified Dihuang Yinzi Decoction (herb treatment group) vs control
Outcomes Swallowing rehabilitation improvement diagnosed by videofluoroscopy, adverse events
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ChiCTR-TRC-14004235 (Continued)
Notes Study completed; awaiting published data
ChiCTR-TRC-14004955
Methods Randomised parallel controlled trial
Participants 60 people with stroke; onset of stroke at least 2 times but occurrence of stroke at least 1 month before admission
Interventions Manipulation + sham tDCS
Manipulation + tDCS
Outcomes Lingual movement; buccofacial apraxia; Modified Assessment of Swallowing Ability; VFSS; EEG non-linear analysis
Notes Study likely completed; website not updated; awaiting published data
Choi 2017
Methods RCT
Participants Stroke survivors with dysphagia
Interventions Experimental group: Shaker exercise + conventional therapy (n = 16)
Control group: conventional therapy (n = 16)
Outcomes PAS and oral diet level
Notes In the process of retrieving full-text article
Chu 2017
Methods RCT
Participants Dysphagia patients with pseudobulbar palsy
Interventions Basic treatment vs GAO neck acupuncture at Fengchi (GB 20), Yiming (EX-HN 14), Gongxue (Extra), Lianquan
(CV 23), Wai Jinjin Yuye (Extra), Tunyan (Extra), Zhiqiang (Extra), Fayin (Extra) with basic treatment
Outcomes Repetitive saliva-swallowing test, standardised swallowing assessment, swallow quality-of-life questionnaire
Notes In the process of retrieving full-text article
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de Fraga 2017
Methods RCT
Participants 10 participants with ischaemic stroke and speech therapy-diagnosed oropharyngeal dysphagia
Interventions Rx: myofunctional therapy plus voice therapy
C: myofunctional therapy only
Outcomes Swallow function
Notes Study published; in the process of extracting data
Eom 2017
Methods RCT
Participants Stroke patients with oropharyngeal dysphagia
Interventions Resistance expiratory muscle strength training vs sham expiratory muscle strength training
Outcomes Videofluoroscopic dysphagia scale, PAS
Notes In the process of retrieving full-text article
Erfmann 2017
Methods RCT
Participants Subacute stroke patients with oropharyngeal dysphagia
Interventions Expiratory muscle strength training; no further details available
Outcomes No further details available at the time
Notes In the process of retrieving text
Fan 2007
Methods RCT
Participants 60 post-stroke patients with dysphagia
Interventions Experimental group: acupuncture plus Western drugs
Control group: Western drugs
Outcomes Swallowing test
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Fan 2007 (Continued)
Notes In the process of retrieving full-text article
Feng 2016
Methods RCT
Participants 60 cases of post-stroke dysphagia
Interventions Rx: deep acupuncture at Lianquan (CV 23) and Yifeng (TE 17) with swallowing training
C: swallowing training only
Outcomes VFSS dysphagia evaluation scale and Watian water swallow test
Notes In the process of retrieving full-text article
Gao 2016
Methods RCT
Participants 90 patients with dysphagia after cerebral infarction
Interventions Chin tuck resistance vs Shaker exercise vs control
Outcomes VFSS, Self-Rating Depression Scale, PAS
Notes In the process of retrieving full-text article
Guillen-Sola 2017
Methods RCT
Participants Subacute ischaemic stroke (1 to 3 weeks) and dysphagia confirmed by videofluoroscopic study with a score ≥ 3 on
the 8-point PAS
Interventions Group I: standard swallow therapy
Group II: inspiratory and expiratory muscle training + standard swallow therapy
Group III: neuromuscular electrical stimulation of suprahyoid muscles, sham inspiratory and expiratory muscle
training, and standard swallow therapy
Outcomes Respiratory muscle function (baseline, 3 weeks, and 3 months), severity of dysphagia (PAS) (baseline and 3 months)
, and occurrence of respiratory complications (chest x-ray, fever); also volume-viscosity swallow test (V-VST), Func-
tional Oral Intake Scale, and Dysphagia Outcome and Severity Scale (baseline, 3 weeks, and 3 months)
Notes Study published; in the process of extracting data
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Hamada 2017
Methods Study design not clear
Participants 56 people with acute stroke and dysphagia
Interventions General dysphagia therapy vs combination of surface electrical stimulation and general dysphagia therapy
Outcomes Pulmonary infection
Notes In the process of retrieving full-text article
Hong 2011
Methods RCT
Participants People with cerebral apoplexy and dysphagia
Interventions Strengthened diet nursing vs control
Outcomes Incidence of aspiration, malnutrition, dehydration
Notes In the process of retrieving full-text article
Huang 2008
Methods RCT
Participants 66 participants with dysphagia post-ischaemic stroke
Interventions Group 1: electro-acupuncture group
Group 2: rehabilitation training combined with acupoint percutaneous electrical stimulation
Group 3: rehabilitation training combined with acupoint token puncturing
Outcomes Quality of life scale specified for dysphagia (name not stated)
Notes In process of retrieving full-text article
Huang 2014
Methods RCT
Participants People with acute stroke and dysphagia
Interventions Traditional swallowing vs oropharyngeal NMES vs combined NMES/traditional swallowing
Outcomes Swallow score, PAS, VFSS
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Huang 2014 (Continued)
Notes In process of retrieving relevant outcome data
Huimin 2015
Methods RCT
Participants 76 people with pharyngeal dysphagia after stroke
Interventions Surface electromyographic biofeedback with conventional therapy vs conventional therapy only
Outcomes Degree of openness of upper oesophageal sphincter, pharyngeal transit time, maximum displacement of the hyoid
bone
Notes In the process of retrieving full-text article
Jefferson 2008
Methods RCT
Participants People with chronic stroke and dysphagia
Interventions Repetitive transcranial magnetic stimulation vs sham stimulation over the unaffected pharyngeal motor cortex
Outcomes Measurements of cortico-pharyngeal excitability
Notes In the process of retrieving full-text article
Ji-Ye 2017
Methods RCT
Participants Dysphagia patients with ischaemic stroke and pseudobulbar palsy
Interventions Oral aspirin vs acupuncture (XNJ-AI at Fengchi (GB 20)) with oral aspirin
Outcomes Water-swallowing test, plasma thromboxane B2 and 6-keto-prostaglandin F1a levels
Notes In the process of retrieving full-text article
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Jia 2006
Methods RCT
Participants 40 cases of post-apoplectic dysphagia with 2 out of 5 symptoms such as hemiplegia, coma, slurred speech, unilateral
sensory disturbance, dry mouth and tongue, difficulty in swallowing
Interventions Treatment group was treated by acupuncturing points Fengchi (GB 20), Tianzhu (BL 10), Tongli (HT 5), and
Lianquan (CV 23) plus rehabilitation exercises
Control group only by rehabilitation exercise
Outcomes Therapeutic effect assessed by 1 to 10 point scale
Notes Study published; in the process of extracting data
Jiang 2014
Methods RCT
Participants People with stroke and dysphagia
Interventions Electroacupuncture group vs VitalStim group vs combined group
Outcomes Water swallow test, swallow score
Notes In the process of retrieving full-text article
Jing 2016
Methods RCT
Participants 60 people with dysphagia after stroke
Interventions NMES with conventional therapy vs conventional therapy only
Outcomes Curative effects, swallowing function, aspiration, laryngeal elevation, food residue, food intake scores
Notes In the process of retrieving full-text article
Kim 2017
Methods RCT
Participants People with post-stroke oropharyngeal dysphagia confirmed by VFSS
Interventions Tongue-to-palate resistance training vs control
Outcomes Swallowing function - videofluoroscopic dysphagia scale and PAS
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Kim 2017 (Continued)
Notes Study published; in the process of extracting data
Koch 2015
Methods RCT
Participants People with stroke and dysphagia
Interventions Swallowing training using surface electromyography as biofeedback vs standard treatment
Outcomes Swallow score
Notes In the process of retrieving full-text article
Konecny 2018
Methods RCT
Participants 54 people with early-stage stroke and dysphagia
Interventions Transcutaneous electrical nerve stimulation of suprahyoid muscles vs control
Outcomes Swallow function - videofluoroscopic study, oral transit time, pharyngeal transit time
Notes Study published; in the process of extracting data
Koyama 2017
Methods RCT
Participants 16 participants with stroke-related dysphagia
Interventions Modified jaw opening exercise vs control
Outcomes Swallow function - videofluorographic swallowing study, distance between the mental spine and the hyoid bone,
hyoid displacement
Notes Study published; in the process of extracting data
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Lee 2015b
Methods RCT
Participants 24 people with dysphagia after ischaemic stroke
Interventions Treatment: 10 Hz rTMS over the brain cortex where motor evoked potential was obtained from the suprahyoid
muscle
Control: 10 Hz rTMS over the brain cortex where motor evoked potential was obtained from the abductor pollicis
brevis muscle
Outcomes Functional Dysphagia Scale, PAS, Dysphagia Outcome and Severity Scale
Notes Study published; in the process of extracting data
Li 2008
Methods RCT
Participants 60 people with ischaemic stroke and dysphagia
Interventions Group 1: acupuncture group and routine treatment and rehabilitation training
Group 2: routine treatment and rehabilitation training
Outcomes Not stated
Notes In the process of retrieving full-text article
Li 2009
Methods RCT
Participants 60 people post stroke with dysphagia
Interventions Experimental group: acupuncture plus feeding and swallowing rehabilitation training
Control group: swallowing and feeding rehabilitation training
Outcomes Swallowing test
Notes In the process of retrieving full-text article
Li 2016
Methods RCT
Participants 60 people with pseudobulbar palsy paralysis dysphagia
Interventions Treatment: 5 needles of the Nape acupuncture
Control: routine acupuncture (Lian Quan, Tong Li, Zhao Hai)
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Li 2016 (Continued)
Outcomes Curative effect dysphagia (unclear)
Notes In the process of retrieving full-text article
Liu 2018
Methods RCT
Participants 100 people with dysphagia caused by pseudobulbar palsy
Interventions Nape acupuncture with rehabilitative swallowing training vs rehabilitative swallowing training only
Outcomes Repetitive saliva-swallowing test, water swallow test, standardised swallowing assessment, swallow quality-of-life
questionnaire (SWAL-QOL)
Notes In the process of retrieving full-text article
Ma 2016
Methods RCT
Participants 80 people with dysphagia and pseudobulbar palsy
Interventions Quick needle insertion at Aqiang point vs routine acupuncture at Lianquan (CV 23)
Outcomes Water swallow test, curative rate
Notes In the process of retrieving full-text article
Malik 2017
Methods RCT
Participants People with dysphagia (95% of patients with stroke aetiology)
Interventions Thermal stimulation vs swallowing manoeuvres vs combination of both
Outcomes Function Outcome Swallowing Scale
Notes Study published; in the process of extracting data
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Mehndiratta 2017
Methods RCT
Participants 98 people with dysphagia within the first month after ischaemic stroke
Interventions Sensory-level electrical stimulation to bilateral masseter muscles vs sham stimulation
Outcomes Bedside Dysphagia Score, Neurological Examination Dysphagia Score, Total Dysphagia Score, Mann Assessment of
Swallowing Ability test, flexible fibreoptic endoscopic evaluation of swallowing
Notes Study published; in the process of extracting data
Meng 2015
Methods RCT
Participants 251 people with dysphagia after stroke
Interventions Group 1: deep acupuncture with conventional glossopharyngeum acupuncture
Group 2: shallow acupuncture with conventional glossopharyngeum acupuncture
Group 3: conventional glossopharyngeum acupuncture only (control)
Outcomes Water swallowing test evaluation scale
Notes In the process of retrieving full-text article
Meng 2018
Methods RCT
Participants 30 people with post-stroke dysphagia
Interventions 2 groups given surface NMES at different sites of patients’ neck vs control
Outcomes Water swallow test, repetitive saliva swallowing test, dysphagia outcome and severity scale
Notes In the process of retrieving full-text article
Moon 2017
Methods RCT
Participants 18 people with stroke and dysphagia
Interventions Expiratory muscle strength training vs control
Outcomes Functional dysphagia scale, PAS, vallecular residue, pyriform sinuses residue
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Moon 2017 (Continued)
Notes Study published; in the process of extracting data
Moon 2018
Methods RCT
Participants 16 people with subacute stroke and dysphagia
Interventions Tongue pressure strength and accuracy training vs control
Outcomes Maximum isometric tongue pressures of the anterior and posterior tongue, Mann Assessment of Swallowing Ability,
Swallowing-Quality of Life
Notes In the process of retrieving full-text article
NCT00722111
Methods Randomised, open label
Participants 200 people post stroke
Interventions Group 1: lingual press (high-intensity, oral, non-swallowing)
Group 2: effortful swallowing (high-intensity swallowing)
Group 3: natural swallowing (high-frequency, low-intensity swallowing)
Group 4: non-oral sham (control) exercise
Outcomes Composite score of PAS and Residue Scale with no worsening of either at baseline, week 4, and week 8
Notes Study completed; awaiting published data
NCT01081444
Methods RCT
Participants People with dysphagia and first episode of stroke
Interventions Active vs sham rTMS
Outcomes Videofluoroscopy and high-resolution manometry
Notes Study completed; awaiting published data
105Swallowing therapy for dysphagia in acute and subacute stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
NCT01085903
Methods Randomised, double-blind (participant, investigator), cross-over assignment
Participants People with stroke, neglect, dysphagia
Interventions Modafinil 200 mg once daily vs placebo for 3 days
Outcomes Predicting response to modafinil among participants with neglect, dysphagia
Notes Study completed; awaiting published data
NCT01777672
Methods RCT
Participants 100 people with oropharyngeal dysphagia due to stroke episode within last 3 months
Interventions Control group: recommendations from patient healthcare providers
Experimental group 1: oral TRPV1 (natural capsaicin) plus recommendations from patient healthcare providers
Experimental group 2: pharyngeal electrical stimulation plus recommendations from patient healthcare providers
Experimental group 3: transcutaneous electrical stimulation plus recommendations from patient healthcare providers
Outcomes VFSS-PAS, oropharyngeal reconfiguration, timing and extent of hyoid motion, bolus propulsion force of tongue
Episodes of aspiration pneumonia and lower respiratory tract infection
Clinical outcomes of nutritional status, complications and clinical symptoms, mortality rates, cause of death
Notes Study completed; awaiting published data
NCT02090231
Methods RCT
Participants Post-stroke dysphagia more than 3 months
Interventions Real 5 Hz rTMS vs sham 5 Hz rTMS
Outcomes Dysphagia severity, swallow function
Notes Study completed; awaiting published data
NCT02379182
Methods RCT
Participants 90 people with stroke > 3 months
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NCT02379182 (Continued)
Interventions Control group: standard clinical care
Sensory group: transcutaneous electrical stimulation at sensory level
Motor group: transcutaneous electrical stimulation at motor level
Outcomes PAS; incidence of all adverse events; change in pharyngeal residue prevalence; change in Eating Assessment Tool-10
scores; frequency of chest infection; time from randomisation to death
Notes Study completed; awaiting published data
Nowicki 2003
Methods RCT
Participants People with stroke and dysphagia
Interventions Manual + electro-acupuncture (6 to 8 treatments 2 to 3 times per week for 3 weeks) vs control
Outcomes Not available in the study summary
Notes In the process of retrieving full-text article
Oshima 2009
Methods Unclear design (not stated in abstract)
Participants 218 people with stroke complicated by dysphagia
Interventions Group 1: swallowing training with nutritional and high-risk management
Group 2: control (none of the above)
Outcomes Time taken to oral intake, nutritional status, incidence rate of infection, activities of daily living
Notes In the process of retrieving full-text article
Pan 2015
Methods RCT
Participants 70 people with post-stroke dysphagia
Interventions Acupoint massage vs control
Outcomes Improvement rate in swallow function
Notes In the process of retrieving full-text article
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Park 2017
Methods RCT
Participants 40 participants with dysphagia after stroke 6 months < stroke onset
Interventions Group 1: head lift exercise and conventional dysphagia therapy
Group 2: conventional dysphagia therapy
Outcomes Movement of hyolaryngeal complex; PAS
Notes Study completed; in the process of retrieving data
Park 2018
Methods RCT
Participants People with dysphagia following subacute stroke
Interventions Chin tuck against resistance exercise vs control
Outcomes Functional dysphagia scale, PAS
Notes In the process of retrieving full-text article
Shao 2017
Methods RCT
Participants 64 people with post-stroke upper oesophageal sphincter dystrophy and severe dysphagia
Interventions Drug therapy and conventional swallowing rehabilitation training vs columnar balloon dilatation combined with
drug therapy and conventional swallowing rehabilitation training
Outcomes Upper sphincter dynamics and dysphagia scores
Notes In the process of retrieving full-text article
Su 2010
Methods RCT
Participants 60 people with dysphagia after stroke
Interventions Group 1: electroacupuncture
Group 2: swallowing training
Outcomes VFSS and Kubota water swallowing function test
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Su 2010 (Continued)
Notes In the process of retrieving full-text article
Sun 2008
Methods RCT
Participants People with dysphagia after stroke
Interventions Acupuncture at Lianquan, Yamen, and Tian Zhu acupoints vs VitalStim therapy
Outcomes Swallowing function
Notes In the process of retrieving full-text article
Sun 2018
Methods RCT
Participants People with stroke and dysphagia
Interventions Treatment group treated by intradermal needle-embedding at Lianquan (CV 23), Jialianquan-point, Yifeng (TE 17)
, Ashi-point, etc. (once every other day for 20 days) on the basis of treatments used in the control group
Control group was treated with conventional medicines, NMES of the bilateral midlines of the neck, and swallowing
function training
Outcomes Swallowing function (0 to 10 point scaling), surface electromyography
Notes Study published; in the process of extracting data
Suntrup-Krueger 2018
Methods RCT
Participants People with dysphagia due to stroke
Interventions Experimental group: transcranial direct current stimulation vs sham group: sham stimulation
Outcomes Fibreoptic Endoscopic Dysphagia Severity Scale, diet at discharge, dysphagia severity rating score, endoscopically
assessed swallow function
Notes Study completed; in the process of retrieving data
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Tageldin 2017
Methods RCT
Participants 30 people with dysphagia following brain stem infarction
Interventions rTMS vs sham rTMS on bilateral supratentorial motor area
Outcomes Modified dysphagia outcome and severity scale
Notes Study completed; awaiting full published data
Umay 2017
Methods RCT
Participants 98 people with dysphagia within the first month after ischaemic stroke
Interventions Sensory-level electrical stimulation vs sham sensory-level electrical stimulation to bilateral masseter muscles
Outcomes Bedside Dysphagia Score, Neurological Examination Dysphagia Score, Total Dysphagia Score, andMann Assessment
of Swallowing Ability test, flexible fibreoptic endoscopic evaluation of swallowing
Notes Study published; in the process of extracting data
Wang 2010
Methods RCT
Participants 84 people with cerebral stroke and dysphagia
Interventions Group 1: routine therapy and acupuncture
Group 2: routine therapy
Outcomes Not stated
Notes In the process of retrieving full-text article
Wang 2014
Methods RCT
Participants 54 nasal feeding patients with pseudobulbar palsy or bulbar palsy after acute ischaemic stroke
Interventions Integrated swallowing function rehabilitation training vs routine treatment
Outcomes Swallow score, oral intake function
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Wang 2014 (Continued)
Notes In the process of retrieving full-text article
Wang 2015
Methods RCT
Participants 91 people with post-stroke deglutition disorders
Interventions Acupuncture using the Tong Guan Li Qiao needling method vs control
Outcomes Standard Swallowing Assessment (Modified Barthel Index), Swallowing-relatedQuality of Life, HamiltonDepression
Scale
Notes In the process of retrieving full-text article
Wang 2017
Methods RCT
Participants 96 people with dysphagic stroke
Interventions Observation group to receive Rood intervention; control group to receive routine oral intervention
Outcomes Swallowing function, nutritional status and interventional effect - no further details
Notes Study published; in the process of extracting data
Wei 2017
Methods RCT
Participants 30 people with upper oesophageal sphincter dysfunction due to unilateral brainstem stroke
Interventions Modified balloon dilatation therapy vs control
Outcomes Amplitude of bilateral submentalmotor evoked potentials induced by transcranial magnetic stimulations over bilateral
motor cortex, diameters of upper oesophageal sphincter opening, maximal displacement of hyoid
Notes Study published; in the process of extracting data
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Wu 2011
Methods RCT
Participants 229 people with dysphagia after stroke
Interventions Group 1: acupuncture
Group 2: acupuncture and rehabilitation training
Group 3: control group with rehabilitation training
Outcomes Traditional Chinese medicine swallowing assessment, swallowing test, Swallowing Quality of Life Scale - SWAL-
QOL
Notes In the process of retrieving full-text article
Wu 2013
Methods RCT
Participants 90 people with dysphagia after stroke
Interventions Group 1: routine acupuncture group + routine treatment and swallowing training
Group 2: acupuncture kinesitherapy simultaneously at ezhongxian, lianquan (RN23), jialianquan points + routine
treatment, and swallowing training
Group 3: routine treatment and swallowing training
Outcomes Water drinking test and brainstem auditory evoked potential
Notes In the process of retrieving full-text article
Xia 2010
Methods RCT
Participants 120 people with dysphagia after stroke
Interventions Experimental group: feeding-swallowing training and acupuncture treatment
Control group: feeding-swallowing training
Outcomes Standardised Swallowing Assessment, VFSS, Modified Barthel Index, Swallowing Quality of LIfe Scale - SWAL-
QOL
Notes In the process of retrieving full-text article
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Xie 2011
Methods RCT
Participants 148 people with stroke and dysphagia
Interventions Acupuncture group (body acupuncture, electrical acupuncture, and scalp acupuncture) vs rehabilitation group
Outcomes Intention-to-treat analysis and on-treatment/per-protocol analysis, Watian swallowing ability, pulmonary infection
rate, mortality
Notes In the process of retrieving full-text article
Xu 2013
Methods RCT
Participants 140 people with stroke
Interventions Experimental group: acupuncture and Western medicine
Control group: Western medicine
Outcomes Water drinking test
Notes In the process of retrieving full-text article
Xue 2004
Methods RCT
Participants People with post-stroke dysphagia
Interventions Early rehabilitation + acupuncture vs control
Outcomes Not available in the study summary
Notes In the process of retrieving full-text article
Yang 2008
Methods RCT
Participants People with post-stroke dysphagia
Interventions Functional electrical stimulation 40 minutes/d vs functional electrical stimulation 40 minutes twice daily
Outcomes Swallowing function
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Yang 2008 (Continued)
Notes In the process of retrieving full-text article
Yang 2012
Methods RCT
Participants People with post-stroke dysphagia diagnosed using VFSS
Interventions Anodal tDCS group (1 mA for 20 minutes) vs sham group (1 mA for 30 seconds)
Outcomes Functional dysphagia scale
Notes In the process of retrieving full-text article
Zeng 2017
Methods RCT
Participants 112 people with cerebral infarction and dysphagia
Interventions NMES vs control
Outcomes Water-drinking test, Hamilton Anxiety Scale test, Hamilton Depression Scale
Notes In the process of retrieving full-text article
Zhang 2007
Methods RCT
Participants People with stroke, dysphagia, and poor elevation of the larynx
Interventions Comparison of 2 methods of larynx elevation (15 minutes, 5 × day for 4 weeks)
Outcomes Not available in the study summary
Notes In the process of retrieving full-text article
Zhang 2015
Methods RCT
Participants 198 people with dysphagia after stroke
Interventions Huoshe Liyan Decoction vs control
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Zhang 2015 (Continued)
Outcomes Efficacy rate, swallow function (unclear)
Notes In the process of retrieving full-text article
Zhang 2016
Methods RCT
Participants People with dysphagia with medullary infarction
Interventions Traditional swallowing therapy vs sensory approach combined with traditional swallowing therapy vs motor approach
combined with traditional swallowing therapy
Outcomes Swallow function, quality of life, cognition
Notes In the process of retrieving relevant data
Zhang 2017
Methods RCT
Participants 80 people with stroke and dysphagia
Interventions Vitalstim Electroacupuncture of Fengchi (GB 20), Jinjin (EX-HN 12) and Yuye (EX-HN 13) with a Vitalstim
Electrostimulator, and manual acupuncture stimulation of Lianquan (CV 23), Tiantu (CV 22) vs control. Both
groups received conventional therapy
Outcomes Kubota swallowing ability test, dysphagia subscale (0 to 6 scores) of the neurological deficit degrees, videofluorography
assessment, Medical Outcomes Study Item Short Form Health Survey (SF-36)
Notes In the process of retrieving full-text article
Zhen 2014
Methods RCT
Participants 97 people with post-stroke deglutition dysfunction
Interventions Group A: acupuncture with conventional treatment
Group B: VitalStim electric stimulation with conventional treatment
Group C: conventional treatment only
Outcomes Swallow function (water-drinking test, stethocatharsis scoring, and fluoroscopic examination)
Notes In the process of retrieving full-text article
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Zhong 2003
Methods RCT
Participants People with stroke and dysphagia 15 to 40 days post stroke
Interventions Head acupuncture vs body acupuncture vs control
Outcomes Not available in the study summary
Notes In the process of retrieving full-text article
Zhu 2015a
Methods RCT
Participants People with dysphagia after stroke
Interventions Conventional training vs surface electromyographic biofeedback treatment with conventional training
Outcomes Upper oesophageal sphincter opening, pharyngeal transit time
Notes In the process of retrieving full-text article
Zhu 2015b
Methods RCT
Participants 68 people with dysphagia after ischaemic stroke
Interventions Combined treatment group (n = 34) receiving swallowing training, feeding strategies, and low-frequency electrical
stimulation
Control group (n = 34) receiving swallowing training and feeding strategies
Outcomes VFSS, Standardized Swallowing Assessment
Notes Study published; in the process of extracting data
ASHA-NOMS: American Speech-Language-Hearing Association National Outcomes Measurement System
EEG: electroencephalography
Hz: Hertz
NIHSS: National Institutes of Health Stroke Scale
NMES: neuromuscular electrical stimulation
PAS: Penetration Aspiration Scale
RCT: randomised controlled trial
rTMS: repetitive transcranial magnetic stimulation
SWAL-QOL: Swallowing Quality of Life Questionnaire
tDCS: transcranial direct current stimulation
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TRPV1: transient receptor potential vanilloid 1
VFSS: videofluoroscopic swallow study
V-VST: volume-viscosity swallow test
Characteristics of ongoing studies [ordered by study ID]
ChiCTR-ICR-15006004
Trial name or title Clinical observation of YiShen-TongQiao acupuncture on pharyngeal dysphagia after stroke
Methods RCT
Participants 90 stroke patients with pharyngeal dysphagia
Interventions Observational group: YiShen-TongQiao acupuncture treatment
Control group: rehabilitation training
Outcomes Kubota drinking water test score; Swallow Quality of Life
Starting date 2015
Contact information Yu Chuan; yuchuan106@126.com
Notes Funding: general planningproject of BeiJingMunicipal Science andTechnology Project ofTraditionalChinese
Medicine
ChiCTR-IOR-17010505
Trial name or title Fire N needle for patients with dysphagia caused by post-stroke pseudobulbar palsy: a randomized controlled
clinical trial
Methods Randomised, parallel controlled trial
Participants 64 participants with dysphagia after stroke, 30 to 75 years old, onset time < 8 months
Interventions Group A: fire needle
Group B: rehabilitation treatment of dysphagia
Outcomes Watian water test evaluation, TengShi swallowing disorder evaluation, swallowing-related quality of life,
dysphagia assessment scale of Traditional Chinese Medicine, pulse oximetry
Starting date 2017, but not yet recruiting
Contact information Xiaolu Qian; qian xiaolu@163.com
Notes Funding: Shanghai Municipal Commission of Health and Family Planning
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ChiCTR-IOR-17011359
Trial name or title The study on the effect of electroacupuncture at Lianquan and Fengfu on one side of brain swallowing
function
Methods Randomised parallel controlled trial
Participants 30 participants aged 18 to 65 years; inclusion criteria not clear
Interventions Electroacupuncture group
Sham acupuncture group
Outcomes MEP of mylohyoid muscle
Resting motion threshold of mylohyoid muscle
Starting date 2017
Contact information Lin Wang; 373670740@qq.com
Notes Funding: Education Department of Guangdong
ChiCTR-IPC-14005435
Trial name or title Research on mechanism of central regulation of transcranial magnetic stimulation on post-stroke dysphagia
patients
Methods Randomised parallel controlled trial, phase 1
Participants 20 virtual lesion group; 20 stroke patient group; 20 control
Interventions Virtual lesion group: continuous theta burst stimulation
Patient group: transcranial magnetic stimulation
Control: conventional treatments
Outcomes MEP; pharyngeal pressure waveform; upper oesophageal sphincter pressure waveform; centre network of
swallowing
Starting date 2013
Contact information Yue Lan; bluemooning@163.com
Notes Funding: National Science Foundation of China
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ChiCTR-ROC-17011673
Trial name or title Neuromodulation on post-stroke patients: a clinical control trial based on mapping swallowing musculature
motor cortex
Methods Clinical control (randomisation unclear)
Participants 120 participants with dysphagia post stroke
Interventions Experimental group: TMS
Control group: sham TMS
Outcomes Pharyngeal musculature MEP; MEP amplitude; latency of MEP; hotspot
Starting date 2017
Contact information Wanqi Li; 1170782244@qq.com
Notes Funding: -
ChiCTR1800014337
Trial name or title High frequency repetitive transcranial magnetic stimulation in the rehabilitation of post-stroke swallowing
disorder
Methods Randomised parallel controlled trial
Participants 40 participants with acute stroke (> 2 weeks post onset) with dysphagia
Interventions High-frequency rTMS + routine swallow training vs routine swallow training alone
Outcomes Surface EMG; VFSS; Standardised Swallowing Study; VGF (no explanation provided on website); PAS; water
drinking test scale for depression
Starting date 2018
Contact information Zhu Qixiu; szjzqxsx@163.com
Notes Funding: Shandong Province Science and Technology Plan
ChiCTR1800015837
Trial name or title A randomized controlled clinical study on stroke with dysphagia with treatment of combined of traditional
Chinese and west medicine
Methods Randomised parallel controlled trial
Participants 242 stroke patients with dysphagia from 2 weeks to 6 months
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ChiCTR1800015837 (Continued)
Interventions Treatment: acupuncture treatment based on surface electromyography
Control: traditional acupuncture treatment
Outcomes Water swallow test rating scale of depression, Standardized Swallowing Assessment, videofluoroscopic swal-
lowing study
Starting date 2016
Contact information Guoping Zhou; doctorzgp@sina.com
Notes Funding: Construction of High-level University Scientific Research Funding
ISRCTN14124645
Trial name or title Metoclopramide and selective oral decontamination for avoiding pneumonia after stroke (MAPS-2) Trial
Methods 2 × 2 factorial double-blind randomised controlled trial (treatment)
Participants Acute stroke within 9 hours of clinical onset
Interventions Metoclopramide and placebo paste
Metoclopramide and antibiotic paste
Placebo metoclopramide and antibiotic paste
Placebo metoclopramide and placebo paste
Outcomes Mortality up to the end of the study (90 days), pneumonia within 14 days, number of days of antibiotic
treatment for pneumonia within the first 30 days, neurological recovery (NIHSS), disability (mRS), quality
of life (EuroQol)
Starting date 1 January 2017
Contact information Christine Roffe - Institute for AppliedClinical Sciences (IACS), KeeleUniversityGuyHiltonResearchCentre,
Thornburrow Drive, Hartshill ST4 7QB, Stoke-on-Trent, United Kingdom
Notes Funding: Health Technology Assessment Programme
ISRCTN68981054
Trial name or title Treatment of dysphagia after stroke with He’s santong needling method: a prospective randomized controlled
study
Methods RCT
Participants 60 stroke patients with oral and pharyngeal dysphagia
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ISRCTN68981054 (Continued)
Interventions Experimental group: He’s santong needling method acupuncture combined with swallowing rehabilitation
Control group: swallowing rehabilitation
Outcomes Dynamics of swallowing function measured using FEES and Caiteng 7 Rank
Swallowing Quality of Life - SWAL-QOL, Modified MASA, surface EMG
Starting date 2017
Contact information Bin Li; libin@bjzhongyi.com
Notes Funding: Beijing Traditional Chinese Medicine Administration Administrative Project
NCT01758991
Trial name or title Therapeutic Impact of tDCS on dysphagia in the acute phase of stroke (improving swallowing after stroke
with transcranial direct current stimulation (iSWAT))
Methods RCT
Participants 100 acute stroke patients with dysphagia
Interventions Experimental group: tDCS
Control group: sham tDCS
Outcomes Videofluoroscopy; fiberoptic endoscopic evaluationof swallowing;NIHSS; clinical records; swallowing quality
of life - SWAL-QOL
Starting date 2013
Contact information Katalin de Fays; katalin.defays@uclouvain.be
Notes Funding: University Hospital of Mont-Godinne; Université Catholique de Louvain
NCT01919112
Trial name or title Non-invasive brain stimulation for swallowing recovery after a dysphagic stroke
Methods RCT
Participants Moderate to severe dysphagic patients with acute stroke documented by imaging
Interventions High dose vs low dose vs sham (control) anodal tDCS
Outcomes Improvement in swallowing
Starting date 2013
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NCT01919112 (Continued)
Contact information Sandeep Kumar; Beth Israel Deaconess Medical Center; 617-632-8917; skumar@bidmc.harvard.edu
Notes Funding: Beth Israel Deaconess Medical Center
NCT02322411
Trial name or title Effects of device-facilitated isometric progressive resistance oropharyngeal (I-PRO) therapy on dysphagia
related outcomes in patients post-stroke
Methods Randomised controlled pilot study
Participants 30 ischaemic stroke patients within 6 months of acute stroke diagnosis
Interventions Group 1: 12 weeks of Isometric Progressive Resistance Oropharyngeal Therapy plus compensatory treatment
Group 2: compensatory treatment only
Outcomes Change in maximum isometric tongue pressures; bolus flow durational measures; swallowing-related pres-
sures; swallowing quality of life - SWAL-QOL; functional oral intake scale; pneumonia diagnoses; hospital
admissions
Starting date 2014
Contact information Nicole Pulia; nicolepulia@gmail.com
Notes Sponsors and collaborators: University of Wisconsin, Madison
NCT02470078
Trial name or title Randomised controlled trial of pharyngeal electrical stimulation for the treatment of post-extubation dyspha-
gia in acute stroke patients
Methods Randomised parallel assignment trial
Participants 60 stroke patients with severe dysphagia post extubation due to acute stroke
Interventions Pharyngeal electrical stimulation vs sham stimulation
Outcomes Pneumonia rate; reintubation rate; length of stay; PEG tube placement; swallowing function; time until oral
nutrition
Starting date 2015
Contact information Rainer Dziewas; dziewas@uni-muenster.de
Notes Funding: University Hospital Muenster
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NCT02576470
Trial name or title Motor learning in dysphagia rehabilitation
Methods Randomised, parallel assignment trial
Participants 21 to 100 years with a swallowing problem
Interventions Investigating 3 forms of biofeedback for training swallowing manoeuvres or compensatory techniques and
pairing with adjuvant techniques - tDCS, TMS, and financial reward
Group 1: VFSS biofeedback
Group 2: submental EMG biofeedback
Group 3: mixed VFSS and submental EMG biofeedback
Group 4: VFSS biofeedback with anodal tDCS and TMS
Group 5: submental EMG biofeedback with anodal tDCS and TMS
Group 6: mixed VFSS, submental EMG with anodal tDCS and TMS.
Group 7: VFSS with sham tDCS
Group 8: submental EMG with sham tDCS
Group 9: mixed VFSS and submental EMG with sham tDCS
Group 10: VFSS with financial reward
Group 11: submental EMG with financial reward
Group 12: mixed VFSS and submental EMG with financial reward
Outcomes PAS, targeted dysphagia training biofeedback using VFSS images, submental EMGmeasures and both VFSS
and submental EMG measures; dysphagia manoeuvres, kinematic analysis, financial reward analysis
Starting date
Contact information
Notes Study completed; awaiting full published data
NCT02960737
Trial name or title Dysphagia evaluation after stroke-incidence and effect of oral screen intervention on swallowing dysfunction
(DESIRE)
Methods Interventional, randomised, parallel assignment. Double-blind (investigator, outcomes assessor)
Participants Acute stroke patients 6 (± 2) weeks after first-time transient ischaemic attack and stroke
Interventions Experimental group: intensive training with oral screen and traditional compensatory swallowing training
Control group: no intervention; traditional compensatory swallowing training only
Outcomes Swallowing ability, swallowing function, lip force, swallowing quality of life, dysarthria, oral health, activities
of daily living, global disability, NIHSS
Starting date 2016
Contact information Patricia Hägglund, PhD Student; +46907850000; patricia.hagglund@umu.se
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NCT02960737 (Continued)
Notes Sponsor: Umeå University
NCT03021252
Trial name or title The RETORNUS-2 study: impact of respiratory muscle training on swallowing disorders in stroke patients
Methods Interventional, randomised, parallel assignment; single-blind (outcomes assessor)
Participants Stroke onset 1 month
Interventions Experimental group: high-intensity inspiratory and expiratory muscle training (IEMT) (IEMT + standard
swallow therapy) vs control
Sham IEMT
Sham IEMT + standard swallow therapy
Outcomes Change in dysphagia severity, change in respiratory muscle strength
Starting date 2017
Contact information Anna Guillen-Sola; aguillen@parcdesalutmar.cat
Notes Funding: Parc de Salut Mar
NCT03247374
Trial name or title Bio-feedback treatment versus standard treatment for dysphagic post-stroke patients: a randomized controlled
trial
Methods RCT
Participants 40 patients (> 6 weeks onset) with post-stroke dysphagia
Interventions Experimental group: biofeedback (visual and verbal feedback)
Control group: standard SLT (verbal feedback)
Outcomes Functional Oral Intake Scale; change in pooling score during endoscopic evaluation; PAS
Starting date 2017
Contact information Sara Nordio; sara.nordio@ospedalesancamillo.net
Notes Funding: IRCCS San Camillo, Venezia, Italy
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NCT03274947
Trial name or title The utility of cerebellar transcranial magnetic stimulation in the neurorehabilitation of dysphagia after stroke
Methods RCT
Participants 72 participants with post-stroke dysphagia within 6 weeks of symptom onset
Interventions Protocol 1
Experimental group: cerebellar TMS
Control group: sham TMS
Protocol 2
Experimental group: low-level cerebellar TMS stimulation (once per day for 3 days) plus standard SLT
Experimental group: high-level cerebellar TMS stimulation (twice per day for 5 days) plus standard SLT
Control group: sham stimulation (twice per day for 5 days) plus standard SLT
Outcomes Protocol 1: videofluoroscopy before and at 1 hour
Protocol 2: videofluoroscopy; functional oral intake scale; dysphagia severity rating scale; feeding status; mRS
Starting date 2017
Contact information Shaheen Hamdy; shaheen.hamdy@manchester.ac.uk
Notes Funding: University of Manchester, Medical Research Council University of Nottingham
NCT03358810
Trial name or title Pharyngeal electrical stimulation evaluation for dysphagia after stroke
Methods RCT
Participants 270 acute ischaemic or hemorrhagic cerebral stroke within 7 to 28 days of baseline VFSS
Interventions Experimental group: pharyngeal electrical stimulation
Control group: sham pharyngeal electrical stimulation
Outcomes PAS (based on VFSS); time to removal of NG/PEG tube/transition to oral feeding or first diet upgrade;
functional oral intake scale
Starting date 2017
Contact information Phagenesis Ltd.
Notes Funding: Phagenesis Ltd.; Regulatory and Clinical Research Institute; Cytel
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NCT03499574
Trial name or title A randomized controlled feasibility trial of dysphagia therapy using biofeedback in patients with acute stroke
Methods RCT
Participants Participants with new diagnosis of acute stroke and dysphagia
Interventions Experimental: biofeedback using surface EMG with usual care
Control: usual care only
Outcomes Dysphagia Severity Rating Scale, Functional Oral Intake Scale, PAS, Dysphagia Handicap Index, modified
Rankin Scale, NIHSS, mortality, incidence of pneumonia
Starting date 2018
Contact information Timothy England; timothy.england@nottingham.ac.uk
Notes Funding: University of Nottingham
PACTR201710002724163
Trial name or title Effect of transcutaneous electrical nerve stimulation and conventional therapy in post-stroke dysphagic pa-
tients: a randomized controlled trial
Methods RCT
Participants Dysphagic patients following ischaemic stroke less than 1 month (aged 45 to 70 years)
Interventions TENS vs TENS + conventional treatment vs conventional treatment
Outcomes Swallow function
Starting date 2017
Contact information Rami Maged; ramimaged@hotmail.com
Notes Funding: Taheal Rehabilitation Centre
U1111-1188-0335
Trial name or title Program of rehabilitation with therapeutic efficacy control in oropharyngeal dysphagia after stroke
Methods Randomised, parallel trial
Participants 20 participants with dysphagia after stroke
Interventions Group 1: neuromuscular electrical stimulation associated with sour taste swallowing and cold temperature
Group 2: stimulation of swallowing sour taste and cold temperature
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U1111-1188-0335 (Continued)
Outcomes Decreased episodes of penetration and aspiration (verified by objective examination of swallowing), nasoen-
doscopy
Starting date 2015
Contact information Paula Cristina Cola, paccola@hotmail.com
Notes Funding: Faculdade Filosofia e Ciências de Marília
C: control
EMG: electromyography
EuroQoL: European Quality of Life Scale
FEES: Fibreoptic Endoscopic Evaluation of Swallowing
MASA: Mann Assessment of Swallowing Ability
MEP: motor evoked potential
mRS: modified Rankin Scale
NG: nasogastric
NIHSS: National Institutes of Health Stroke Scale
PAS: Penetration Aspiration Scale
PEG: percutaneous endoscopic gastroscopy
RCT: randomised controlled trial
rTMS: repetitive transcranial magnetic stimulation
Rx: treatment
SD: standard deviation
SLT: speech and language therapy
SWAL-QOL: Swallowing Quality of Life Questionnaire
tDCS: transcranial direct current stimulation
TMS: transcranial magnetic stimulation
VFSS: videofluoroscopy swallow study
VGF: no explanation provided on website as to abbreviation
127Swallowing therapy for dysphagia in acute and subacute stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Swallowing therapy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Functional outcome - death or
dependency, death or disability
at end of trial
2 306 Odds Ratio (M-H, Random, 95% CI) 1.05 [0.63, 1.75]
1.1 Behavioural interventions 2 306 Odds Ratio (M-H, Random, 95% CI) 1.05 [0.63, 1.75]
2 Case fatality at end of trial 14 766 Odds Ratio (M-H, Random, 95% CI) 1.00 [0.66, 1.52]
2.1 Behavioural interventions 2 306 Odds Ratio (M-H, Random, 95% CI) 0.83 [0.46, 1.51]
2.2 Drug therapy 3 148 Odds Ratio (M-H, Random, 95% CI) 1.40 [0.31, 6.28]
2.3 Pharyngeal electrical
stimulation
4 215 Odds Ratio (M-H, Random, 95% CI) 0.92 [0.38, 2.26]
2.4 Physical stimulation
(thermal, tactile)
1 19 Odds Ratio (M-H, Random, 95% CI) 1.05 [0.16, 6.92]
2.5 Transcranial magnetic
stimulation
4 78 Odds Ratio (M-H, Random, 95% CI) 0.28 [0.03, 2.93]
3 Length of inpatient stay (days) 8 577 Mean Difference (IV, Random, 95% CI) -2.90 [-5.65, -0.15]
3.1 Behavioural interventions 4 370 Mean Difference (IV, Random, 95% CI) -2.70 [-5.68, 0.28]
3.2 Pharyngeal electrical
stimulation
4 207 Mean Difference (IV, Random, 95% CI) -6.05 [-16.40, 4.31]
4 Proportion of participants with
dysphagia at end of trial
23 1487 Odds Ratio (M-H, Random, 95% CI) 0.42 [0.32, 0.55]
4.1 Acupuncture 8 676 Odds Ratio (M-H, Random, 95% CI) 0.31 [0.20, 0.49]
4.2 Behavioural interventions 6 511 Odds Ratio (M-H, Random, 95% CI) 0.45 [0.28, 0.74]
4.3 Drug therapy 1 17 Odds Ratio (M-H, Random, 95% CI) 0.48 [0.07, 3.35]
4.4 Neuromuscular electrical
stimulation
2 76 Odds Ratio (M-H, Random, 95% CI) 0.51 [0.18, 1.49]
4.5 Pharyngeal electrical
stimulation
3 66 Odds Ratio (M-H, Random, 95% CI) 0.55 [0.15, 2.11]
4.6 Physical stimulation
(thermal, tactile)
2 127 Odds Ratio (M-H, Random, 95% CI) 0.65 [0.07, 5.85]
4.7 Transcranial direct current
stimulation
1 14 Odds Ratio (M-H, Random, 95% CI) 0.29 [0.01, 8.39]
5 Swallowing ability 26 1173 Std. Mean Difference (IV, Random, 95% CI) -0.66 [-1.01, -0.32]
5.1 Acupuncture 6 496 Std. Mean Difference (IV, Random, 95% CI) -0.55 [-1.20, 0.11]
5.2 Behavioural intervention 3 121 Std. Mean Difference (IV, Random, 95% CI) -0.56 [-1.07, -0.05]
5.3 Drug therapy 1 71 Std. Mean Difference (IV, Random, 95% CI) -0.46 [-0.93, 0.01]
5.4 Neuromuscular electrical
stimulation
2 100 Std. Mean Difference (IV, Random, 95% CI) -1.34 [-3.39, 0.71]
5.5 Pharyngeal electrical
stimulation
3 194 Std. Mean Difference (IV, Random, 95% CI) 0.06 [-0.22, 0.34]
5.6 Physical stimulation
(thermal, tactile)
1 16 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-1.29, 0.68]
5.7 Transcranial direct current
stimulation
2 34 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-2.22, 1.56]
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5.8 Transcranial magnetic
stimulation
8 141 Std. Mean Difference (IV, Random, 95% CI) -1.29 [-2.37, -0.21]
6 Penetration aspiration score 11 303 Std. Mean Difference (IV, Random, 95% CI) -0.37 [-0.74, -0.00]
6.1 Behavioural intervention 1 27 Std. Mean Difference (IV, Random, 95% CI) -0.88 [-1.68, -0.08]
6.2 Neuromuscular electrical
stimulation
1 18 Std. Mean Difference (IV, Random, 95% CI) 0.57 [-0.38, 1.52]
6.3 Pharyngeal electrical
stimulation
4 177 Std. Mean Difference (IV, Random, 95% CI) -0.17 [-0.53, 0.19]
6.4 Transcranial magnetic
stimulation
5 81 Std. Mean Difference (IV, Random, 95% CI) -0.53 [-1.22, 0.16]
7 Chest infection or pneumonia 9 618 Odds Ratio (M-H, Random, 95% CI) 0.36 [0.16, 0.78]
7.1 Behavioural interventions 6 473 Odds Ratio (M-H, Random, 95% CI) 0.56 [0.31, 1.00]
7.2 Drug therapy 1 60 Odds Ratio (M-H, Random, 95% CI) 0.06 [0.01, 0.21]
7.3 Neuromuscular electrical
stimulation
1 57 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
7.4 Pharyngeal electrical
stimulation
1 28 Odds Ratio (M-H, Random, 95% CI) 0.43 [0.06, 3.09]
8 Pharyngeal transit time (seconds) 6 187 Mean Difference (IV, Random, 95% CI) -0.23 [-0.32, -0.15]
8.1 Drug therapy 1 17 Mean Difference (IV, Random, 95% CI) -0.21 [-0.91, 0.49]
8.2 Neuromuscular electrical
stimulation
3 126 Mean Difference (IV, Random, 95% CI) -0.23 [-0.39, -0.08]
8.3 Pharyngeal electrical
stimulation
1 28 Mean Difference (IV, Random, 95% CI) -0.15 [-0.67, 0.37]
8.4 Physical stimulation
(thermal, tactile)
1 16 Mean Difference (IV, Random, 95% CI) -0.19 [-0.34, -0.04]
9 Institutionalisation 3 447 Odds Ratio (M-H, Random, 95% CI) 0.75 [0.47, 1.19]
9.1 Behavioural interventions 2 306 Odds Ratio (M-H, Random, 95% CI) 0.76 [0.39, 1.48]
9.2 Pharyngeal electrical
stimulation
1 141 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.36, 1.48]
10 Nutritional (albumin) 3 169 Mean Difference (IV, Random, 95% CI) 0.37 [-1.50, 2.24]
10.1 Behavioural
interventions
2 64 Mean Difference (IV, Random, 95% CI) 0.20 [-4.77, 5.17]
10.2 Pharyngeal electrical
stimulation
1 105 Mean Difference (IV, Random, 95% CI) 0.40 [-1.62, 2.42]
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Analysis 1.1. Comparison 1 Swallowing therapy, Outcome 1 Functional outcome - death or dependency,
death or disability at end of trial.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 1 Functional outcome - death or dependency, death or disability at end of trial
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Behavioural interventions
Carnaby 2006i 35/51 72/102 49.5 % 0.91 [ 0.44, 1.89 ]
Carnaby 2006ii 72/102 34/51 50.5 % 1.20 [ 0.58, 2.47 ]
Total (95% CI) 153 153 100.0 % 1.05 [ 0.63, 1.75 ]
Total events: 107 (Treatment), 106 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.28, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.18 (P = 0.86)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Therapy better Therapy worse
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Analysis 1.2. Comparison 1 Swallowing therapy, Outcome 2 Case fatality at end of trial.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 2 Case fatality at end of trial
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Behavioural interventions
Carnaby 2006i 10/51 23/102 21.4 % 0.84 [ 0.36, 1.93 ]
Carnaby 2006ii 17/102 10/51 20.1 % 0.82 [ 0.35, 1.95 ]
Subtotal (95% CI) 153 153 41.5 % 0.83 [ 0.46, 1.51 ]
Total events: 27 (Treatment), 33 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.61 (P = 0.54)
2 Drug therapy
Lee 2015 19/33 10/38 15.6 % 3.80 [ 1.40, 10.32 ]
Perez 1997 1/8 1/9 2.0 % 1.14 [ 0.06, 21.87 ]
Warusevitane 2015 8/30 12/30 13.3 % 0.55 [ 0.18, 1.62 ]
Subtotal (95% CI) 71 77 30.9 % 1.40 [ 0.31, 6.28 ]
Total events: 28 (Treatment), 23 (Control)
Heterogeneity: Tau2 = 1.13; Chi2 = 6.66, df = 2 (P = 0.04); I2 =70%
Test for overall effect: Z = 0.44 (P = 0.66)
3 Pharyngeal electrical stimulation
Jayasekeran 2010a 0/4 0/6 Not estimable
Jayasekeran 2010b 2/16 0/12 1.8 % 4.31 [ 0.19, 98.51 ]
STEPS 2016 9/78 9/63 15.8 % 0.78 [ 0.29, 2.11 ]
Vasant 2016 1/18 1/18 2.1 % 1.00 [ 0.06, 17.33 ]
Subtotal (95% CI) 116 99 19.7 % 0.92 [ 0.38, 2.26 ]
Total events: 12 (Treatment), 10 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.05, df = 2 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.18 (P = 0.86)
4 Physical stimulation (thermal, tactile)
Bath 1997 7/11 5/8 4.7 % 1.05 [ 0.16, 6.92 ]
Subtotal (95% CI) 11 8 4.7 % 1.05 [ 0.16, 6.92 ]
Total events: 7 (Treatment), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
5 Transcranial magnetic stimulation
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Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Khedr 2009 0/14 1/12 1.6 % 0.26 [ 0.01, 7.12 ]
Khedr 2010 0/11 1/11 1.6 % 0.30 [ 0.01, 8.32 ]
Kim 2012i 0/10 0/5 Not estimable
Kim 2012ii 0/10 0/5 Not estimable
Subtotal (95% CI) 45 33 3.2 % 0.28 [ 0.03, 2.93 ]
Total events: 0 (Treatment), 2 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.06 (P = 0.29)
Total (95% CI) 396 370 100.0 % 1.00 [ 0.66, 1.52 ]
Total events: 74 (Treatment), 73 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 10.64, df = 10 (P = 0.39); I2 =6%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Chi2 = 1.36, df = 4 (P = 0.85), I2 =0.0%
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Analysis 1.3. Comparison 1 Swallowing therapy, Outcome 3 Length of inpatient stay (days).
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 3 Length of inpatient stay (days)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Behavioural interventions
Carnaby 2006i 51 19.2 (13.3) 102 21.4 (12.4) 28.9 % -2.20 [ -6.57, 2.17 ]
Carnaby 2006ii 102 19.1 (10.5) 51 19.2 (13.3) 30.9 % -0.10 [ -4.28, 4.08 ]
Yuan 2003i 11 31 (9.4) 24 37 (14.7) 10.4 % -6.00 [ -14.09, 2.09 ]
Yuan 2003ii 18 24 (8.5) 11 31 (9.4) 14.2 % -7.00 [ -13.80, -0.20 ]
Subtotal (95% CI) 182 188 84.4 % -2.70 [ -5.68, 0.28 ]
Heterogeneity: Tau2 = 1.77; Chi2 = 3.68, df = 3 (P = 0.30); I2 =19%
Test for overall effect: Z = 1.78 (P = 0.076)
2 Pharyngeal electrical stimulation
Jayasekeran 2010a 4 33.75 (18.63) 6 119.17 (124.97) 0.1 % -85.42 [ -187.07, 16.23 ]
Jayasekeran 2010b 16 43.19 (18.73) 12 54.92 (26.14) 2.4 % -11.73 [ -29.14, 5.68 ]
STEPS 2016 78 27.7 (22.7) 63 28.7 (23) 11.7 % -1.00 [ -8.59, 6.59 ]
Vasant 2016 14 56.07 (25.86) 14 66.43 (35.97) 1.4 % -10.36 [ -33.57, 12.85 ]
Subtotal (95% CI) 112 95 15.6 % -6.05 [ -16.40, 4.31 ]
Heterogeneity: Tau2 = 33.18; Chi2 = 4.10, df = 3 (P = 0.25); I2 =27%
Test for overall effect: Z = 1.14 (P = 0.25)
Total (95% CI) 294 283 100.0 % -2.90 [ -5.65, -0.15 ]
Heterogeneity: Tau2 = 1.83; Chi2 = 7.90, df = 7 (P = 0.34); I2 =11%
Test for overall effect: Z = 2.06 (P = 0.039)
Test for subgroup differences: Chi2 = 0.37, df = 1 (P = 0.54), I2 =0.0%
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Analysis 1.4. Comparison 1 Swallowing therapy, Outcome 4 Proportion of participants with dysphagia at
end of trial.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 4 Proportion of participants with dysphagia at end of trial
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Acupuncture
Bai 2007i 13/18 32/35 2.9 % 0.24 [ 0.05, 1.17 ]
Bai 2007ii 22/40 13/17 4.3 % 0.38 [ 0.10, 1.36 ]
Chen 2016a 8/103 17/97 9.0 % 0.40 [ 0.16, 0.97 ]
Han 2004 22/34 25/32 5.9 % 0.51 [ 0.17, 1.53 ]
Huang 2010 1/32 10/30 1.6 % 0.06 [ 0.01, 0.54 ]
Jia 2006a 27/40 28/32 4.6 % 0.30 [ 0.09, 1.02 ]
Liu 2000 16/54 19/30 8.0 % 0.24 [ 0.09, 0.63 ]
Liu 2004 1/44 3/38 1.3 % 0.27 [ 0.03, 2.72 ]
Subtotal (95% CI) 365 311 37.7 % 0.31 [ 0.20, 0.49 ]
Total events: 110 (Treatment), 147 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.65, df = 7 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 5.21 (P < 0.00001)
2 Behavioural interventions
Carnaby 2006i 18/51 45/102 14.8 % 0.69 [ 0.34, 1.38 ]
Carnaby 2006ii 31/102 19/51 14.2 % 0.74 [ 0.36, 1.49 ]
Song 2004 6/29 10/24 4.9 % 0.37 [ 0.11, 1.23 ]
Yuan 2003i 8/11 22/24 1.8 % 0.24 [ 0.03, 1.73 ]
Yuan 2003ii 6/18 9/11 2.2 % 0.11 [ 0.02, 0.68 ]
Zheng 2014 19/44 32/44 8.9 % 0.29 [ 0.12, 0.70 ]
Subtotal (95% CI) 255 256 46.8 % 0.45 [ 0.28, 0.74 ]
Total events: 88 (Treatment), 137 (Control)
Heterogeneity: Tau2 = 0.10; Chi2 = 6.90, df = 5 (P = 0.23); I2 =28%
Test for overall effect: Z = 3.18 (P = 0.0015)
3 Drug therapy
Perez 1997 3/8 5/9 1.9 % 0.48 [ 0.07, 3.35 ]
Subtotal (95% CI) 8 9 1.9 % 0.48 [ 0.07, 3.35 ]
Total events: 3 (Treatment), 5 (Control)
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Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
4 Neuromuscular electrical stimulation
Lee 2014 16/31 16/26 6.4 % 0.67 [ 0.23, 1.92 ]
Lim 2009 6/12 6/7 1.2 % 0.17 [ 0.02, 1.84 ]
Subtotal (95% CI) 43 33 7.6 % 0.51 [ 0.18, 1.49 ]
Total events: 22 (Treatment), 22 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.08, df = 1 (P = 0.30); I2 =7%
Test for overall effect: Z = 1.23 (P = 0.22)
5 Pharyngeal electrical stimulation
Jayasekeran 2010a 4/4 6/6 Not estimable
Jayasekeran 2010b 13/16 12/12 0.8 % 0.15 [ 0.01, 3.30 ]
Vasant 2016 6/14 7/14 3.2 % 0.75 [ 0.17, 3.33 ]
Subtotal (95% CI) 34 32 4.0 % 0.55 [ 0.15, 2.11 ]
Total events: 23 (Treatment), 25 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.85, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 0.86 (P = 0.39)
6 Physical stimulation (thermal, tactile)
Bath 1997 3/4 3/3 0.6 % 0.33 [ 0.01, 11.34 ]
Feng 2012 59/60 59/60 0.9 % 1.00 [ 0.06, 16.37 ]
Subtotal (95% CI) 64 63 1.5 % 0.65 [ 0.07, 5.85 ]
Total events: 62 (Treatment), 62 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.23, df = 1 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.70)
7 Transcranial direct current stimulation
Kumar 2011 6/7 7/7 0.6 % 0.29 [ 0.01, 8.39 ]
Subtotal (95% CI) 7 7 0.6 % 0.29 [ 0.01, 8.39 ]
Total events: 6 (Treatment), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
Total (95% CI) 776 711 100.0 % 0.42 [ 0.32, 0.55 ]
Total events: 314 (Treatment), 405 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 15.62, df = 21 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 6.37 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.10, df = 6 (P = 0.91), I2 =0.0%
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Analysis 1.5. Comparison 1 Swallowing therapy, Outcome 5 Swallowing ability.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 5 Swallowing ability
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Acupuncture
Bai 2007i 18 5.48 (1.2) 35 6.03 (1.39) 4.3 % -0.41 [ -0.98, 0.17 ]
Bai 2007ii 40 4.21 (1.44) 17 5.48 (1.2) 4.3 % -0.91 [ -1.50, -0.32 ]
Chan 2012 48 5.59 (0.98) 20 5.8 (1) 4.4 % -0.21 [ -0.73, 0.31 ]
Chen 2016a 65 9.35 (0.77) 68 9.77 (0.45) 4.7 % -0.67 [ -1.02, -0.32 ]
Wei 2005 32 5.51 (0.81) 33 5.01 (0.62) 4.5 % 0.69 [ 0.19, 1.19 ]
Xia 2016a 60 3.7 (1.1) 60 5.8 (1.3) 4.6 % -1.73 [ -2.15, -1.31 ]
Subtotal (95% CI) 263 233 26.8 % -0.55 [ -1.20, 0.11 ]
Heterogeneity: Tau2 = 0.61; Chi2 = 56.73, df = 5 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.63 (P = 0.10)
2 Behavioural intervention
Heo 2015 22 25.72 (10.03) 22 26.72 (10.45) 4.3 % -0.10 [ -0.69, 0.50 ]
Kang 2012 25 3.6 (1.2) 25 4.6 (1) 4.3 % -0.89 [ -1.47, -0.31 ]
Park 2016b 14 4.4 (0.8) 13 5.4 (1.7) 3.9 % -0.74 [ -1.52, 0.05 ]
Subtotal (95% CI) 61 60 12.6 % -0.56 [ -1.07, -0.05 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 3.80, df = 2 (P = 0.15); I2 =47%
Test for overall effect: Z = 2.14 (P = 0.032)
3 Drug therapy
Lee 2015 38 3.5 (1.5) 33 4.2 (1.5) 4.5 % -0.46 [ -0.93, 0.01 ]
Subtotal (95% CI) 38 33 4.5 % -0.46 [ -0.93, 0.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.91 (P = 0.056)
4 Neuromuscular electrical stimulation
Terre 2015 10 4.6 (2.5) 10 5.3 (2.5) 3.7 % -0.27 [ -1.15, 0.61 ]
Xia 2011 40 21.4 (3.5) 40 30.1 (3.8) 4.3 % -2.36 [ -2.94, -1.78 ]
Subtotal (95% CI) 50 50 8.1 % -1.34 [ -3.39, 0.71 ]
Heterogeneity: Tau2 = 2.04; Chi2 = 15.13, df = 1 (P = 0.00010); I2 =93%
Test for overall effect: Z = 1.28 (P = 0.20)
5 Pharyngeal electrical stimulation
Jayasekeran 2010b 16 6.3 (4.4) 12 5.6 (5.54) 4.0 % 0.14 [ -0.61, 0.89 ]
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Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
STEPS 2016 72 5.2 (4.1) 59 4.9 (3.6) 4.7 % 0.08 [ -0.27, 0.42 ]
Vasant 2016 18 4.28 (3.97) 17 4.59 (4.39) 4.2 % -0.07 [ -0.74, 0.59 ]
Subtotal (95% CI) 106 88 12.9 % 0.06 [ -0.22, 0.34 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
6 Physical stimulation (thermal, tactile)
Power 2006 8 24.9 (4.67) 8 26.3 (4.05) 3.5 % -0.30 [ -1.29, 0.68 ]
Subtotal (95% CI) 8 8 3.5 % -0.30 [ -1.29, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
7 Transcranial direct current stimulation
Kumar 2011 7 4.71 (1.7) 7 3.71 (1.11) 3.3 % 0.65 [ -0.43, 1.74 ]
Shigematsu 2013 10 3.5 (0.9) 10 4.7 (0.9) 3.5 % -1.28 [ -2.26, -0.30 ]
Subtotal (95% CI) 17 17 6.9 % -0.33 [ -2.22, 1.56 ]
Heterogeneity: Tau2 = 1.58; Chi2 = 6.67, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 0.34 (P = 0.73)
8 Transcranial magnetic stimulation
Du 2016i 13 18.91 (0.91) 6 22.73 (2.15) 2.8 % -2.62 [ -3.96, -1.27 ]
Du 2016ii 13 18.53 (0.74) 6 22.73 (2.15) 2.6 % -3.04 [ -4.49, -1.58 ]
Khedr 2010 11 1.4 (0.43) 11 3.74 (0.51) 2.2 % -4.77 [ -6.54, -3.01 ]
Kim 2012i 10 9.16 (2.55) 5 11.11 (4.43) 3.3 % -0.57 [ -1.66, 0.53 ]
Kim 2012ii 10 8.41 (3.3) 5 11.11 (4.43) 3.3 % -0.69 [ -1.80, 0.42 ]
Park 2013 9 25.3 (9.8) 9 21.2 (15.6) 3.6 % 0.30 [ -0.63, 1.23 ]
Park 2016a (i) 5 3.79 (1.54) 11 3.05 (1.55) 3.4 % 0.45 [ -0.62, 1.52 ]
Park 2016a (ii) 6 3.79 (1.54) 11 4.43 (1.86) 3.5 % -0.35 [ -1.35, 0.66 ]
Subtotal (95% CI) 77 64 24.7 % -1.29 [ -2.37, -0.21 ]
Heterogeneity: Tau2 = 2.02; Chi2 = 47.10, df = 7 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.35 (P = 0.019)
Total (95% CI) 620 553 100.0 % -0.66 [ -1.01, -0.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 173.48, df = 25 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.75 (P = 0.00018)
Test for subgroup differences: Chi2 = 12.20, df = 7 (P = 0.09), I2 =43%
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Analysis 1.6. Comparison 1 Swallowing therapy, Outcome 6 Penetration aspiration score.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 6 Penetration aspiration score
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Behavioural intervention
Park 2016b 14 4.9 (0.5) 13 5.5 (0.8) 10.8 % -0.88 [ -1.68, -0.08 ]
Subtotal (95% CI) 14 13 10.8 % -0.88 [ -1.68, -0.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.17 (P = 0.030)
2 Neuromuscular electrical stimulation
Park 2012 9 3.22 (2.08) 9 2.17 (1.37) 8.9 % 0.57 [ -0.38, 1.52 ]
Subtotal (95% CI) 9 9 8.9 % 0.57 [ -0.38, 1.52 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.17 (P = 0.24)
3 Pharyngeal electrical stimulation
Jayasekeran 2010a 4 3.71 (1.3) 6 4.83 (1.3) 5.6 % -0.78 [ -2.12, 0.56 ]
Jayasekeran 2010b 16 3.2 (1.5) 12 3.8 (1.3) 11.4 % -0.41 [ -1.17, 0.35 ]
STEPS 2016 70 3.7 (2) 56 3.6 (1.9) 18.3 % 0.05 [ -0.30, 0.40 ]
Vasant 2016 6 2.64 (1.8) 7 4.31 (2.5) 7.1 % -0.70 [ -1.84, 0.43 ]
Subtotal (95% CI) 96 81 42.4 % -0.17 [ -0.53, 0.19 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 3.41, df = 3 (P = 0.33); I2 =12%
Test for overall effect: Z = 0.93 (P = 0.35)
4 Transcranial magnetic stimulation
Kim 2012i 10 3.7 (1.02) 5 3.79 (1.29) 7.6 % -0.08 [ -1.15, 1.00 ]
Kim 2012ii 10 1.97 (0.76) 5 3.79 (1.29) 5.8 % -1.79 [ -3.10, -0.49 ]
Park 2013 9 1.37 (0.87) 9 3.11 (2.15) 8.4 % -1.01 [ -2.01, -0.01 ]
Park 2016a (i) 11 5.76 (2.55) 5 4.78 (1.8) 7.7 % 0.39 [ -0.68, 1.46 ]
Park 2016a (ii) 11 3.8 (2.72) 6 4.78 (1.8) 8.3 % -0.38 [ -1.38, 0.63 ]
Subtotal (95% CI) 51 30 37.9 % -0.53 [ -1.22, 0.16 ]
Heterogeneity: Tau2 = 0.31; Chi2 = 8.10, df = 4 (P = 0.09); I2 =51%
Test for overall effect: Z = 1.51 (P = 0.13)
Total (95% CI) 170 133 100.0 % -0.37 [ -0.74, 0.00 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 18.57, df = 10 (P = 0.05); I2 =46%
Test for overall effect: Z = 1.98 (P = 0.048)
Test for subgroup differences: Chi2 = 6.08, df = 3 (P = 0.11), I2 =51%
-2 -1 0 1 2
Favours active Favours control
138Swallowing therapy for dysphagia in acute and subacute stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.7. Comparison 1 Swallowing therapy, Outcome 7 Chest infection or pneumonia.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 7 Chest infection or pneumonia
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Behavioural interventions
Carnaby 2006i 13/51 48/102 20.4 % 0.38 [ 0.18, 0.81 ]
Carnaby 2006ii 28/102 13/51 20.2 % 1.11 [ 0.51, 2.38 ]
Kang 2012 5/25 6/25 14.3 % 0.79 [ 0.21, 3.03 ]
Song 2004 0/29 3/24 5.3 % 0.10 [ 0.01, 2.12 ]
Yuan 2003i 0/18 1/11 4.6 % 0.19 [ 0.01, 5.07 ]
Yuan 2003ii 2/11 10/24 11.2 % 0.31 [ 0.05, 1.76 ]
Subtotal (95% CI) 236 237 75.9 % 0.56 [ 0.31, 1.00 ]
Total events: 48 (Treatment), 81 (Control)
Heterogeneity: Tau2 = 0.11; Chi2 = 6.33, df = 5 (P = 0.28); I2 =21%
Test for overall effect: Z = 1.96 (P = 0.050)
2 Drug therapy
Warusevitane 2015 8/30 26/30 14.5 % 0.06 [ 0.01, 0.21 ]
Subtotal (95% CI) 30 30 14.5 % 0.06 [ 0.01, 0.21 ]
Total events: 8 (Treatment), 26 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 4.26 (P = 0.000021)
3 Neuromuscular electrical stimulation
Lee 2014 0/31 0/26 Not estimable
Subtotal (95% CI) 31 26 Not estimable
Total events: 0 (Treatment), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Pharyngeal electrical stimulation
Jayasekeran 2010b 2/16 3/12 9.6 % 0.43 [ 0.06, 3.09 ]
Subtotal (95% CI) 16 12 9.6 % 0.43 [ 0.06, 3.09 ]
Total events: 2 (Treatment), 3 (Control)
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Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: not applicable
Test for overall effect: Z = 0.84 (P = 0.40)
Total (95% CI) 313 305 100.0 % 0.36 [ 0.16, 0.78 ]
Total events: 58 (Treatment), 110 (Control)
Heterogeneity: Tau2 = 0.63; Chi2 = 17.04, df = 7 (P = 0.02); I2 =59%
Test for overall effect: Z = 2.60 (P = 0.0093)
Test for subgroup differences: Chi2 = 9.72, df = 2 (P = 0.01), I2 =79%
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Analysis 1.8. Comparison 1 Swallowing therapy, Outcome 8 Pharyngeal transit time (seconds).
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 8 Pharyngeal transit time (seconds)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Drug therapy
Perez 1997 8 2.19 (0.64) 9 2.4 (0.83) 1.5 % -0.21 [ -0.91, 0.49 ]
Subtotal (95% CI) 8 9 1.5 % -0.21 [ -0.91, 0.49 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
2 Neuromuscular electrical stimulation
Li 2014 38 0.8 (0.1) 40 1.1 (0.1) 52.0 % -0.30 [ -0.34, -0.26 ]
Lim 2009 16 0.86 (0.19) 12 0.97 (0.22) 20.3 % -0.11 [ -0.27, 0.05 ]
Terre 2015 10 1.15 (0.21) 10 1.5 (0.78) 2.8 % -0.35 [ -0.85, 0.15 ]
Subtotal (95% CI) 64 62 75.1 % -0.23 [ -0.39, -0.08 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 5.37, df = 2 (P = 0.07); I2 =63%
Test for overall effect: Z = 3.01 (P = 0.0026)
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Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
3 Pharyngeal electrical stimulation
Jayasekeran 2010b 16 1.089 (0.68) 12 1.24 (0.707) 2.6 % -0.15 [ -0.67, 0.37 ]
Subtotal (95% CI) 16 12 2.6 % -0.15 [ -0.67, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
4 Physical stimulation (thermal, tactile)
Power 2006 8 0.74 (0.14) 8 0.93 (0.17) 20.8 % -0.19 [ -0.34, -0.04 ]
Subtotal (95% CI) 8 8 20.8 % -0.19 [ -0.34, -0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.44 (P = 0.015)
Total (95% CI) 96 91 100.0 % -0.23 [ -0.32, -0.15 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 7.04, df = 5 (P = 0.22); I2 =29%
Test for overall effect: Z = 5.36 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.21, df = 3 (P = 0.98), I2 =0.0%
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Analysis 1.9. Comparison 1 Swallowing therapy, Outcome 9 Institutionalisation.
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 9 Institutionalisation
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Behavioural interventions
Carnaby 2006i 8/51 26/102 28.3 % 0.54 [ 0.23, 1.31 ]
Carnaby 2006ii 19/102 9/51 28.3 % 1.07 [ 0.45, 2.56 ]
Subtotal (95% CI) 153 153 56.6 % 0.76 [ 0.39, 1.48 ]
Total events: 27 (Treatment), 35 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.14, df = 1 (P = 0.29); I2 =12%
Test for overall effect: Z = 0.80 (P = 0.42)
2 Pharyngeal electrical stimulation
STEPS 2016 49/78 44/63 43.4 % 0.73 [ 0.36, 1.48 ]
Subtotal (95% CI) 78 63 43.4 % 0.73 [ 0.36, 1.48 ]
Total events: 49 (Treatment), 44 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.38)
Total (95% CI) 231 216 100.0 % 0.75 [ 0.47, 1.19 ]
Total events: 76 (Treatment), 79 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.15, df = 2 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 1.22 (P = 0.22)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.93), I2 =0.0%
0.2 0.5 1 2 5
Therapy better Therapy worse
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Analysis 1.10. Comparison 1 Swallowing therapy, Outcome 10 Nutritional (albumin).
Review: Swallowing therapy for dysphagia in acute and subacute stroke
Comparison: 1 Swallowing therapy
Outcome: 10 Nutritional (albumin)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Behavioural interventions
Yuan 2003i 11 36.8 (10.32) 24 36.6 (9.8) 6.7 % 0.20 [ -7.05, 7.45 ]
Yuan 2003ii 18 37 (6.7) 11 36.8 (10.3) 7.5 % 0.20 [ -6.63, 7.03 ]
Subtotal (95% CI) 29 35 14.2 % 0.20 [ -4.77, 5.17 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.08 (P = 0.94)
2 Pharyngeal electrical stimulation
STEPS 2016 63 37 (5.7) 42 36.6 (4.8) 85.8 % 0.40 [ -1.62, 2.42 ]
Subtotal (95% CI) 63 42 85.8 % 0.40 [ -1.62, 2.42 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
Total (95% CI) 92 77 100.0 % 0.37 [ -1.50, 2.24 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 2 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.39 (P = 0.70)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.94), I2 =0.0%
-10 -5 0 5 10
Therapy better Therapy worse
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
1. MeSH descriptor: [Cerebrovascular Disorders] this term only
2. MeSH descriptor: [Basal Ganglia Cerebrovascular Disease] this term only
3. MeSH descriptor: [Brain Ischemia] explode all trees
4. MeSH descriptor: [Carotid Artery Diseases] explode all trees
5. MeSH descriptor: [Cerebral Small Vessel Diseases] explode all trees
6. MeSH descriptor: [Intracranial Arterial Diseases] explode all trees
7. MeSH descriptor: [Intracranial Embolism and Thrombosis] explode all trees
8. MeSH descriptor: [Intracranial Hemorrhages] explode all trees
9. MeSH descriptor: [Stroke] explode all trees
10. MeSH descriptor: [Stroke, Lacunar] this term only
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11. (stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva*):ti,ab,kw (Word variations have been
searched)
12. ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery) near/5 (isch?emi*
or infarct* or thrombo* or emboli* or occlus*)):ti,ab,kw (Word variations have been searched)
13. ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher*) near/5 (h?emorrhag* or h?
ematoma* or bleed*)):ti,ab,kw (Word variations have been searched)
14. {or #1-#13}
15. MeSH descriptor: [Deglutition] this term only
16. MeSH descriptor: [Deglutition Disorders] explode all trees
17. ((swallow* or deglutit* or dysphag*) near/3 (disturbance* or disorder* or difficult* or dysfunction* or impair* or condition* or
abnormal* or damage* or injur*)):ti,ab,kw (Word variations have been searched)
18. MeSH descriptor: [Pharynx] this term only
19. MeSH descriptor: [Pharyngeal Muscles] this term only
20. ((pharyn* or oropharyn*) near/3 (disturbance* or disorder* or difficult* or dysfunction* or impair* or condition* or abnormal*
or damage* or injur*)):ti,ab,kw (Word variations have been searched)
21. {or #15-#20}
22. #14 and #21
Appendix 2. MEDLINE search strategy
1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
cerebral small vessel diseases/ or exp intracranial arterial diseases/ or exp “intracranial embolism and thrombosis”/ or exp intracranial
hemorrhages/ or stroke/ or stroke, lacunar/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$).tw.
3. ((brain$ or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial
or middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$
or infarct$ or thrombo$ or emboli$ or occlus$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. or/1-4
6. Deglutition/
7. exp Deglutition Disorders/
8. ((swallow$ or deglutit$ or dysphag$) adj5 (disturbance$ or disorder$ or difficult$ or dysfunction$ or impair$ or condition$ or
abnormal$ or damage$ or injur$)).tw.
9. Pharynx/ or pharyngeal muscles/
10. ((pharyn$ or oropharyn$) adj3 (disturbance$ or disorder$ or difficult$ or dysfunction$ or impair$ or condition$ or abnormal$
or damage$ or injur$)).tw.
11. or/6-10
12. randomized controlled trial.pt.
13. controlled clinical trial.pt.
14. randomized.ab.
15. placebo.ab.
16. random$.ab.
17. trial.ab.
18. groups.ab.
19. or/12-18
20. 5 and 11 and 19
Previous version of search strategy
1. stroke.mp.
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2. infarction.mp.
3. exp cerebral infarction/
4. exp cerebrovascular disease/
5. cerebrovascular disease.mp.
6. hemorrhage.mp.
7. exp cerebral hemorrhage/
8. cerebral haemorrhage.mp.
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. (dysphagia or deglutition or swallowing or deglutition disorders or swallowing disorders or malnutrition or undernutrition).mp.
11. (intervention or supplementation or feeding or nutrition or nutritional supplementation or therapy or swallowing therapy or
tube feeding or fluid or fluid supplementation or sip feeding or feeding route or timing or diet or hydration).mp.
12. 10 or 11
13. 9 and 12
14. (randomized controlled trial.pt. or controlled clinical trial.pt.or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or
randomly.ab. or trial.ti.) and humans.sh.
15. 13 and 14
Appendix 3. Embase search strategy
1. cerebrovascular disease/ or brain disease/ or exp basal ganglion hemorrhage/ or exp brain hematoma/ or exp brain hemorrhage/
or exp brain infarction/ or exp brain ischemia/ or exp carotid artery disease/ or exp cerebral artery disease/ or exp cerebrovascular
accident/ or exp intracranial aneurysm/ or exp occlusive cerebrovascular disease/ or exp vertebrobasilar insufficiency/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial
or middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$
or infarct$ or thrombo$ or emboli$ or occlus$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. or/1-4
6. dysphagia/
7. swallowing/
8. ((swallow$ or deglutit$ or dysphag$) adj3 (disturbance$ or disorder$ or difficult$ or dysfunction$ or impair$ or condition$ or
abnormal$ or damage$ or injur$)).tw.
9. exp pharynx/
10. ((pharyn$ or oropharyn$) adj3 (disturbance$ or disorder$ or difficult$ or dysfunction$ or impair$ or condition$ or abnormal$
or damage$ or injur$)).tw.
11. or/6-10
12. Randomized Controlled Trial/ or “randomized controlled trial (topic)”/
13. Randomization/
14. Controlled clinical trial/ or “controlled clinical trial (topic)”/
15. control group/ or controlled study/
16. clinical trial/ or “clinical trial (topic)”/ or phase 1 clinical trial/ or phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4
clinical trial/
17. Crossover Procedure/
18. Double Blind Procedure/
19. Single Blind Procedure/ or triple blind procedure/
20. placebo/ or placebo effect/
21. (random$ or RCT or RCTs).tw.
22. (controlled adj5 (trial$ or stud$)).tw.
23. (clinical$ adj5 trial$).tw.
24. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
145Swallowing therapy for dysphagia in acute and subacute stroke (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
25. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
26. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
27. (cross-over or cross over or crossover).tw.
28. (placebo$ or sham).tw.
29. trial.ti.
30. (assign$ or allocat$).tw.
31. controls.tw.
32. or/12-31
33. 5 and 11 and 32
Previous version of search strategy
1. stroke.mp.
2. infarction.mp.
3. exp brain Infarction/
4. cerebrovascular disease.mp.
5. exp cerebrovascular disease/
6. hemorrhage.mp.
7. exp cerebral hemorrhage/
8. cerebral haemorrhage.mp.
9. 9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. (dysphagia or deglutition or swallowing or deglutition disorders or swallowing disorders or malnutrition or undernutrition).mp.
11. (intervention or supplementation or feeding or nutrition or nutritional supplementation or therapy or swallowing therapy or
tube feeding or fluid or fluid supplementation or sip feeding or feeding route or timing or diet or hydration).mp.
12. 10 or 11
13. 09 and 12
14. ((RANDOMIZED-CONTROLLED-TRIAL/ or RANDOMIZATION/ or CONTROLLED-STUDY/ or MULTICENTER-
STUDY/ or PHASE-3-CLINICAL-TRIAL/ or PHASE-4-CLINICAL-TRIAL/ or DOUBLE-BLIND-PROCEDURE/ or SINGLE-
BLIND-PROCEDURE/) or ((RANDOM* or CROSS?OVER* or FACTORIAL* or PLACEBO* or VOLUNTEER*) or ((SINGL*
or DOUBL* or TREBL* or TRIPL*) adj3 (BLIND* or MASK*))).ti,ab) and human*.ec,hw,fs.
15. 13 and 14
Appendix 4. CINAHL search strategy
1. S1 (MH “Cerebrovascular Disorders”) OR (MH “Basal Ganglia Cerebrovascular Disease+”) OR (MH “Carotid Artery
Diseases+”) OR (MH “Cerebral Ischemia+”) OR (MH “Cerebral Vasospasm”) OR (MH “Intracranial Arterial Diseases+”) OR (
(MH “Intracranial Embolism and Thrombosis”) ) OR (MH “Intracranial Hemorrhage+”) OR (MH “Stroke”) OR (MH “Vertebral
Artery Dissections”) OR (MH “Stroke Patients”) OR (MH “Stroke Units”)
2. S2 TI ( stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex ) or AB ( stroke or
poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex )
3. S3 TI ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or
supratentorial or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery )
N5 ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus*)) OR AB ((brain or cerebr* or cerebell* or vertebrobasil* or
hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle cerebral artery or MCA* or anterior circulation
or posterior circulation or basilar artery or vertebral artery ) N5 ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus*))
4. S4 TI (( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* ) N5 ( haemorrhage* or
hemorrhage* or haematoma* or hematoma* or bleed* )) OR AB (( brain* or cerebr* or cerebell* or intracerebral or intracran* or
parenchymal or intraparenchymal or intraventricular or infratentorial or supratentorial or basal gangli* or putaminal or putamen or
posterior fossa or hemispher* ) N5 ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ))
5. S5 S1 OR S2 OR S3 OR S4
6. S6 (MH “Deglutition”) OR (MH “Gagging”)
7. S7 (MH “Deglutition Disorders”)
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8. S8 TI ( (swallow* or deglutit* or dysphag*) N3 (disturbance* or disorder* or difficult* or dysfunction* or impair* or condition*
or abnormal* or damage* or injur*) ) OR AB ( (swallow* or deglutit* or dysphag*) N3 (disturbance* or disorder* or difficult* or
dysfunction* or impair* or condition* or abnormal* or damage* or injur*) )
9. S9 TI ((swallow* or deglutit* or dysphag*) N3 (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or
evaluat* or diagnos* or detect* or hazard or risk or test)) OR AB ((swallow* or deglutit* or dysphag*) N3 (scale* or screen* or
checklist* or assess* or exam* or identif* or recogni* or evaluat* or diagnos* or detect* or hazard or risk or test))
10. S10 S6 OR S7 OR S8 OR S9
11. S11 MH Random Assignment or MH Single-blind Studies or MH Double-blind Studies or MH Triple-blind Studies or MH
Crossover design or MH Factorial Design
12. S12 TI (“multicentre study” or “multicenter study” or “multi-centre study” or “multi-center study”) or AB (“multicentre study”
or “multicenter study” or “multi-centre study” or “multi-center study”) or SU (“multicentre study” or “multicenter study” or “multi-
centre study” or “multi-center study”)
13. S13 TI random* or AB random*
14. S14 AB “latin square” or TI “latin square”
15. S15 TI (crossover or cross-over) or AB (crossover or cross-over) or SU (crossover or cross-over)
16. S16 MH Placebos
17. S17 TI ( ((singl* or doubl* or trebl* or tripl*) N3 (blind* or mask*)) ) OR AB ( ((singl* or doubl* or trebl* or tripl*) N3 (blind*
or mask*)) )
18. S18 TI Placebo* or AB Placebo* or SU Placebo*
19. S19 MH Clinical Trials
20. S20 TI (Clinical AND Trial) or AB (Clinical AND Trial) or SU (Clinical AND Trial)
21. S21 S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20
22. S22 S5 AND S10 AND S21
Previous version of review search strategy
1. S1. stroke
2. S2. infarction
3. S3. brain Infarction
4. S4. cerebrovascular disease
5. S5. hemorrhage
6. S6. cerebral hemorrhage
7. S7. cerebral haemorrhage
8. S8. S1 or S2 or S3 or S4 or S5 or S6 or S7
9. S9. dysphagia or deglutition or swallowing or deglutition disorders or swallowing disorders or malnutrition or undernutrition
10. S10. intervention or supplementation or feeding or nutrition or nutritional supplementation or therapy or swallowing therapy
or tube feeding or fluid or fluid supplementation or sip feeding or feeding route or timing or diet or hydration
11. S11. S9 or S10
12. S12. S8 and S11
13. S13. randomised controlled trials or controlled clinical trial or randomized or clinical trials
14. S14. S12 and S13
Appendix 5. Web of Science search strategy
1. TS=(stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva*)
2. TS=((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial
or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery) NEAR/5 (isch?
emi* or infarct* or thrombo* or emboli* or occlus*))
3. TS=((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or in-
fratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher*) NEAR/5 (h?emorrhag* or h?
ematoma* or bleed*))
4. #3 OR #2 OR #1
5. TS=((swallow* or deglutit* or dysphag*) NEAR/3 (disturbance* or disorder* or difficult* or dysfunction* or impair* or condition*
or abnormal* or damage* or injur*))
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6. TS=((pharyn* or oropharyn*)NEAR/3 (disturbance* or disorder* or difficult* or dysfunction* or impair* or condition* or abnormal*
or damage* or injur*))
7. #6 OR #5
8. TS=(random* or RCT or RCTs)
9. TS=(controlled NEAR/5 (trial* or stud*))
10. TS=(clinical* NEAR/5 trial*)
11. TS=((control or treatment or experiment* or intervention) NEAR/5 (group* or subject* or patient*))
12. TS=((control or experiment* or conservative) NEAR/5 (treatment or therapy or procedure or m.anage*))
13. TS=((singl* or doubl* or tripl* or trebl*) NEAR/5 (blind* or mask*))
14. TS=(cross-over or cross over or crossover)
15. TS=(placebo* or sham)
16. TS=trial
17. #16 OR #15 OR #14 OR #13 OR #12 OR #11 OR #10 OR #9 OR #8
18. #17 AND #7 AND #4
Previous version of review search strategy
1. stroke
2. infarction
3. brain infarction
4. cerebrovascular disease
5. hemorrhage
6. cerebral haemorrhage
7. cerebral hemorrhage
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
9. dysphagia or deglutition or swallowing or deglutition disorders or swallowing disorders
10. randomized controlled trial or controlled clinical trial randomized or placebo or clinical trials or trial
11. 8 and 9 and 10
Appendix 6. SpeechBITE search stategy
1. Speech Pathology Practice Area: Dysphagia
2. Type of intervention: Swallowing/ feeding
3. Within this population: Stroke/CVA
4. Research Design : Randomised Controlled Trial
5. Age group: Adults
1. Speech Pathology Practice Area: Dysphagia
2. Type of intervention: Swallowing/ feeding
3. Within this population: Stroke/CVA
4. Research Design: Non Randomised Controlled Trial
5. Age group: Adults
Appendix 7. US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov
(www.clinicaltrials.gov)
1. ( Dysphagia AND ( Brain Infarction OR Intracranial Hemorrhages OR Carotid Artery Diseases OR Brain Ischemia OR
Cerebral Hemorrhage OR Cerebrovascular Disorders OR Stroke ) ) [DISEASE]
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Appendix 8. World Health Organization International Clinical Trials Registry Platform
(apps.who.int/trialsearch)
1. stroke AND swallowing OR stroke AND dysphagia
Appendix 9. Google Scholar
1. Stroke
2. Dysphagia
3. Interventions
4. Randomised Controlled Trials
WH A T ’ S N E W
Date Event Description
28 March 2018 New citation required but conclusions have not changed More significant outcomes reported as compared to the
2012 review, but largely based on moderate- to low-
quality evidence. Changes made to authorship
28 March 2018 New search has been performed New studies added. 14 studies (883 participants) in-
cluded in the 2012 review. 27 studies (1777 participants)
added to this updated review. Total number of included
studies reported is 41 (2660 participants). Focus of this
review is limited to treatment of dysphagia in acute and
subacute stroke (nutritional, feeding, and fluid support
removed from this review and will become the focus of
a separate review)
H I S T O R Y
Protocol first published: Issue 1, 1997
Review first published: Issue 4, 1999
Date Event Description
14 March 2012 New citation required but conclusions have not changed Changes made to authorship. No changes made to con-
clusions
14 March 2012 New search has been performed Results of 27 new studies involving 6567 participants
added to the review. Total of 33 studies involving 6779
participants now included. 15 new ongoing studies also
added. Modifications made to analysis method, types of
stroke patients included, and outcomemeasures assessed
(Differences between protocol and review)
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(Continued)
13 April 2008 Amended Review converted to new review format
C O N T R I B U T I O N S O F A U T H O R S
Philip Bath: conceived and designed the review, undertook searches, analysed and interpreted data, wrote the original review, and
updated the review in 2007 (interim update), 2012, and 2018.
Han Sean Lee: undertook searches, extracted data, analysed and interpreted data, and updated the review in 2018.
Lisa Everton: undertook searches and data extraction, analysed and interpreted data, and updated the review in 2018.
D E C L A R A T I O N S O F I N T E R E S T
PB was chief investigator of two included trials (Bath 1997, academic; STEPS 2016, commercial - funded by Phagenesis Ltd); he
consults for this company and receives honoraria and expenses for this work; he did not contribute to decisions on PES studies including
deciding which trials should be included and extracting outcome data. No pharmaceutical or device companies, or other commercial
entities, were involved in data analysis, data interpretation, writing of this review, or comments on it.
SL: none known.
LE: none known.
S O U R C E S O F S U P P O R T
Internal sources
• King’s College Hospital Audit Committee, UK.
• Division of Stroke, University of Nottingham, UK.
External sources
• South Thames NHS Executive, UK.
• Trent NHS Executive, UK.
• Wolfson Foundation, UK.
• The Stroke Association, UK.
• Royal College of Physicians, UK.
• Dunhill Medical Trust, UK.
• National Institutes of Health Research Stroke Research Network, UK.
Support for recruitment of patients into UK-based trials
• National Institutes of Health Research - Cochrane Incentive Scheme, UK.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Separation of dysphagia treatment from nutritional support
For this version of the review, we removed all trials related to nutritional support and feeding to allow focus on swallowing therapy for
post-stroke dysphagia.
Modification of analysis method
We changed the analysis method from fixed-effect to random-effects models (odds ratio (OR), mean difference (MD)) because we noted
the presence of significant trial and statistical heterogeneity. Two studies included more than one interventional group (Yuan 2003;
Carnaby 2006), producing different treatment intensities. In these cases, we divided the low-intensity (middle) groups and entered data
from the study as two data sets (e.g. data set 1: medium (M), low (L), or none; and data set 2: high (H) or medium (M)). Similarly,
in the case of repetitive transcranial magnetic stimulation, when a trial compared high- versus low-frequency stimulation or unilateral
versus bilateral stimulation (Kim 2012i; Kim 2012ii; Du 2016i; Du 2016ii; Park 2016a (i); Park 2016a (ii)), we divided control group
participants equally between treatment groups to prevent counting control participants more than once, thereby artificially narrowing
the confidence intervals (CIs).
We combined different interventions, collectively referred to as ’swallowing therapy’, for the purposes of analysing their effects on main
outcomes to evaluate whether any intervention is better than no intervention, and to try to establish where the most positive effects
are seen, and where more research is needed.
Modification of type of stroke patients
We excluded trials in which a majority of participants did not present with stroke, along with trials for which enrolment occurred after
six months.
Addition or modification of outcome measures
Modification of search strategies: we have revised and updated the search strategies used for this review to account for newly identified
relevant terms keywords and indexing terms. We have included both versions of each search strategy in the review appendices.
We divided swallowing therapy into subcategories: acupuncture, drug therapy, NMES, PES, physical stimulation (thermal, tactile),
tDCS, and TMS.
We added additional outcome measures, especially focusing on intermediate outcomes: chest infection or pneumonia rates and pen-
etration aspiration scores. We retained outcomes related to improvement of dysphagia as listed with proportion of participants with
dysphagia at end of trial. However, we also included changes in some measurements on videofluoroscopy (pharyngeal transit time)
and changes in swallowing ability as determined by change in swallow scores. We included discharge destination within the outcome
’institutionalisation’: the number of participants discharged to long-term care.
I N D E X T E R M S
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Medical Subject Headings (MeSH)
Acupuncture Therapy [methods]; Acute Disease; Deglutition; Deglutition Disorders [etiology; mortality; ∗rehabilitation]; Nutritional
Support [∗methods]; Physical Stimulation [∗methods]; Randomized Controlled Trials as Topic; Stroke [∗complications]; Stroke Reha-
bilitation
MeSH check words
Humans
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